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Abstract
Previous studies have indicated that viruses can interact with mitochondria and affect 
their function. Further, emerging data now show that many more viruses may influence 
the mitochondrial pathway of apoptosis and thus there is widespread potential for 
interaction with the respiratory chain in this organelle. Such interactions could have 
consequences for the clinical outcome of persistent infections; however it is not known 
how widespread effects on respiration may be. We have therefore screened different 
human viruses for an effect on the mitochondrial respiration. We found that human herpes 
virus type one (HHV-1) and influenza virus (IV) caused a profound decrease in total cell 
respiration whilst measles virus (MV) and cytomegalovirus (CMV) did not. We have 
further analysed the integrity of the electron transport chain in the mitochondria of HHV- 
1 infected HeLa cells and located a block at complex II; electrons donated to this complex 
were unable to flow on to complex HI. Further investigation revealed that this block was 
established during the p phase of HHV-1 protein synthesis. Beta-phase proteins were 
assessed for potential involvement in this process using the reported literature and a short­
list of candidates was derived. Of these the p protein Us3 was cloned and expressed by 
transfection and was found to induce respiratory block in comparison with mock- 
transfected and luciferase-transfected cells. A mutant deficient in this protein was 
obtained and shown to be unable of inducing a similar effect. We thus conclude that 
taxonomically distinct viruses can indeed affect mitochondrial function and virus- 
specified proteins are responsible. In the case of herpes virus, HHV-1 protein US3 is 
capable of inducing this effect alone; no other virus proteins are required. Furthermore 
US3 appears to be the only HHV-1 protein capable of inducing this effect. These findings 
demonstrate that diverse viruses may induce mitochondiial impairaient and this could be 
a widespread phenomenon. This could underlie the induction of similar features of 
infection by different viruses and could be significant in the context of a persistent 
infection.
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Introduction Chapter 1
Chapter 1: Introduction
1.1 Introduction
Recent years have seen the emergence of an understanding of the crucial role played by 
mitochondria in the activity of the cell (Scheffler, 2001). Although electron transport and 
the generation of ATP to support cellular processes have been long known, these 
organelles perform other important functions. It has become apparent that mitochondria 
reside at the junction of two pathways controlling programmed cell death (apoptosis). 
Apoptosis may be viewed (amongst other things) as an antiviral defense response by the 
host at organism level; sacrificing the infected cell to save the organism as a whole. Many 
viruses have developed interactions with the apoptotic-signaling pathway that either 
activate or retard apoptosis and in view of the role played by mitochondria in regulating 
this process; such effects might well be mediated through interactions with these 
organelles. In this, regard several viruses are known to induce morphological effects on 
these organelles but little is known of any functional consequences. This concept 
underlies the work to be described in this thesis. The next two sections will review the 
structure and function of mitochondria and consider those known disorders associated 
with mitochondrial dysfunction.
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1.2 Mitochondria
Mitochondria are rod-like, granular or thread-like organelles that function in aerobic 
respiration. They are responsible for most of the useful energy derived from the 
breakdown of carbohydrates and fatty acids, producing ATP by the process of oxidative 
phosphorylation. This generates 36 molecules ATP per molecule of glucose (Sherratt, 
1991). In contrast only 2 molecules ATP are produced by glycolysis pathway in the 
cytoplasm. Although these organelles are clearly essential to life in eukaryotic cells, 
paradoxically they also play a role in controlling the pathways which lead to cell death or 
apoptosis. Mitochondria possess their own genome and their own transcription and 
translation machinery (Reviewed in Scheffler, 2001).
1.2.1 Structure and morphology;
The fundamental morphology of mitochondria has been defined by electron microscopy. 
They consist of a matrix enclosed by an inner membrane which itself is suiTOunded by a 
second, smoother outer membrane. Between these lies the inteimembrane space (IMS). 
According to new methods for studying mitochondria, such as electron microscope 
tomography, there are two distinct areas in the inner membrane: one area is called inner 
bounding membrane which lies closely against the outer membrane. The second regions 
of the inner membrane are folded into tubular' or lamellar’ structures called cristae which 
project into the organelle (Perkins et al, 1997) (Figure 1.1).
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Figure 1.1 A, Schematic diagram; B, electron micrograph (EM) o f mitochondrion and 
C, partial reconstruction o f a mitochondrion as viewed by electron tomography. 
Mitochondria contain two membranes that are separated by a space. Inside the space 
enclosed by the inner membrane is the matrix. The inner membrane is also very 
convoluted and forms cristae. Taken and revised from:
A: (Perkins & Frey, 2000), B: (Alberts et al, 2004), C: (Scheffler, 2001)
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1.2.2 Function
Human mitochondria have their own DNA (mtDNA) about 16,500 base pairs in length, 
comprising less than 1/300,000 of the total length of DNA molecules in the nucleus of a 
human cell. It encodes the two RNA species present in mitochondrial ribosomes (I2S and 
16S I'RNAs), 13 polypeptides, all constituents of respiratory chain complexes (Anderson 
et al, 1981), and a full set of transfer RNAs (tRNAs) (22 genes) required for synthesis of 
proteins essential for the formation of the respiratory chain. Amongst these are the 
components of the respiratory complexes I (NADH-ubiquinol-oxidoreductase), complex 
III (ubiquinol-cytochrome c oxidoreductase), complex IV (cytochrome c oxidase) and 
complex V (ATP synthetase) (O'Brien et al, 1990). Study of the mitochondria has shown 
that mitochondria perform energy-generating functions electron transport and oxidative 
phosphorylation. However, mitochondria have several important functions besides the 
production of ATP; they play a role in apoptosis, regulation of the cellular redox state, 
heme synthesis, steroid synthesis and cellular* proliferation. Defects in these vai*ied 
functions underlie a variety of mitochondiial diseases (Reviewed in Scheffler, 2001). 
Some functions are performed by the mitochondria of only some cell types. For example, 
mitochondria in liver cells contain enzymes that allow them to detoxify ammonia, and 
prevent hyperammonemia (Wong et al, 1994). These enzymes are not present in the 
mitochondria of other cells, cardiac cells for example.
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1.2.2.1 Oxidative phosphorylation and the electron transport chain
Oxidative phosphorylation is the process that produces most of the usable energy from 
the breakdown of carbohydrates or fats. In the inner mitochondrial membrane, oxidative 
phosphorylation is responsible for production of most of this energy (Saraste, 1999). The 
electrons from NADH and FADH2 (produced via Ki*ebs’ cycle) are transfened through a 
series of protein complexes (Complex I-IV) (Table 1.1) in the inner mitochondiial 
membrane. These complexes together with complex V (ATP synthetase) form the 
respiratory chain/oxidative phosphorylation system (Figure 1.2). During oxidative 
phosphorylation, electrons from NADH and FADH2 combine with O2 , and the energy 
released from these reactions is used to drive the synthesis of ATP from ADP. The 
electron must be passed through a series of carriers. Electrons from NADH (Nicotinamide 
adenine dinucleotide) enter the electron transport chain in complex I. These electrons are 
initially transfeixed from NADH to flavin mononucleotide and then, through an iron- 
sulfur canier, to coenzyme Q. Coenzyme Q (also called ubiquinone) is a small lipid- 
soluble molecule that canies electrons from complex I through the membrane to complex 
III, which consists of about ten polypeptides. In complex HI, electrons are transfeixed 
from cytochrome b to cytochrome c. Cytochorome c then canies electrons to complex IV 
where they are finally transfeixed to O2 (Reviewed in Hatefi, 1985).
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Table 1.1 Main respiratory chain components and their locations.
Complex
attribution
Main respiratory chain 
components Location
NADPH/ NADP Matrix space
Complex 1 NADH dehydrogenase Membrane spanning multi-subunit protein
Complex II succinate dehydrogenase Membrane spanning multi-subunit protein
ubiquinol / ubiquinone Dissolved in the inner membrane lipid
Complex III ubiquinohcytochrome c reductase
Membrane spanning 
multi-subunit protein
cytochrome c Inter-membranespace
Complex IV cytochrome c oxidase Membrane spanning multi-subunit protein
Complex V ATP synthetase Membrane spanning multi-subunit protein
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Complex 
I
Complex 
IV
NADH NAD+ 
2H+
%02+ 2H*
succinate fum arate ADP+P ATP 2H^
H20
Figure 1.2 Schematic representation o f the respiratory chain/oxidative phosphorylation 
system. NADH and FADH2 carry protons (H ) and electrons (e ) to the electron transport 
chain located in the inner mitochondrial membrane. The energy from the transfer o f electrons 
along the chain transports protons across the membrane and out o f the mitochondrion. This 
creates an electrochemical gradient or proton motive force across the inner membrane. At the 
end o f the electron transport system, two protons, two electrons, and half o f an oxygen 
molecule combine to form water. Protons re-enter the matrix by flowing through complex V 
(ATP synthetase). This flow down the proton gradient releases energy that is coupled to the 
synthesis o f ATP from ADP and phosphate by complex V.
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1.3 Mitochondria and human diseases
Mitochondria have been implicated in the pathogenesis of several human diseases (Figure 
1.3). Every mechanism that can affect and damage the oxidative phosphorylation 
(OXPHOS) can result in deficit in ATP production and consequently have an effect on a 
number of organ systems. The mitochondrial cytopathies are a group of multi-system 
disorders predominantly affecting the neuroskeletal and central nervous systems and 
associated with clinical manifestations including neurodegenerative disease (Wallace & 
Murdock, 1999). Both the central and peripheral nervous system are affected by 
mitochondrial dysfunction (DiMauro & Moraes, 1993) and manifestations are 
summarized in figure 1.3: Ophthalmologic manifestations are very common and the 
afferent and efferent visual pathways within the central nervous system are often 
involved. Bilateral optic neuropathy, ophthalmoplegia with ptosis, pigmentary 
retinopathy and retrochiasmal visual loss are the most common neuro-ophthalmic 
abnormalities seen (Biousse & Newman, 2003). Cardiac symptoms such as 
cardiomyopathy, are also common and can be very serious and dangerous to patients 
(Anan et al, 1995). The incidence of diabetes mellitus is high in mitochondrial disease 
(Suzuld et at, 2003; Yu gr al, 2004). Gastrointestinal manifestations including colonic 
pseudo-obstruction, hepathopathy are common in mitochondrial diseases (Finsterer, 
2004). Renal manifestations have been reported in mitochondrial diseases and the 
commonest renal disorder is a proximal tubulopathy, resulting in Fanconi syndrome 
(Niaudet, 1998).
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Figure 1.3 Relations between mitochondrial defects in oxidative phosphorylation and 
human diseases. The function o f the oxidative phosphorylation complexes can be disrupted 
by any defects in the subunits that are encoded by nDNA or mtDNA. These defects will be 
result in a decrease in ATP production, which subsequently has harmful effects on organ 
systems (Taken from: Johns, 1995).
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The respiratory system is also affected post mitochondria dysfunction and the most 
important pulmonaiy symptom in patients with mitochondria disorders is central 
hypoventilation (Chinnery & Turnbull, 1997; Howaid et ai, 1995).
As mentioned earlier, the biogenesis of functional mitochondria requires products from 
both mitochondrial and nuclear' DNA. Consequently genetically induced defects may 
result from mutations in either nuclear' or mitochondrial DNA (Reviewed in Johns, 1995).
However, as well as a role in energy generation, mitochondria also have a role in the 
activation/regulation of apoptosis. It is this that may constitute a virus target, and for this 
reason the following sections will review the apoptotic process, the role of mitochondria 
in that process and finally the loiown interactions of viruses with both mitochondria and 
apoptosis.
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1.4 Apoptosis
Apoptosis was first described by the Australian pathologist; John Kerr in 1965. He 
recognized a distinct form of cell death and named it “shrinkage necrosis”. In 1972 the 
term apoptosis was introduced by John Kerr, Alastair Currie and Andrew Wyllie for what 
was now recognized as a morphologically typical, dynamically controlled form of cell 
death (Kerr et at, 1972). The term apoptosis was suggested by James Cormac, professor 
of classical Greek at the University of Aberdeen and is derived from the Greek meaning 
“dropping off’ and so signifies the dropping of leaves from the tree, (Reviewed in Majno 
& Joris, 1995). Apoptosis or prograimned cell suicide is a genetically regulated, active 
process that eliminates cells in both physiological and pathological processes. It is 
characterized by profound and distinct changes in cellular* architecture leading to self 
destruction (Kerr et al., 1972; Ken* et al, 1994). It is a normal physiological response to 
specific suicide signals, or lack of survival signals. It has an essential role in shaping 
tissues during development, endocrine dependent atrophy and normal cell turnover in 
many tissues (Reviewed in Wyllie, 1997). It also limits the accumulation of harmful cells, 
such as self-reactive lymphocytes, virus-infected cells and tumour cells (Reviewed in 
Reed, 1995).
Significant progress has been made in defining the mechanisms of apoptotic control 
underlying the pathophysiology of viral infections, autoimmune diseases, 
neurodegenerative disorders, immunologic deficiencies, and cancers. In fact apoptosis 
itself plays a key role in the development of the immune system, controlling the immune 
response; deleting immune cells recognizing self-antigens, and cytotoxic killing.
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Defects in the regulation of apoptosis in the immune system may lead to autoimmune 
disease (Grodzicky & Elkon, 2002). In many virus-infected cells, virus replication will 
Idll the cell, releasing virus paitides. Since the cell is doomed anyway, it is in the host’s 
interest to destroy the infected cell sooner rather than later and thus prevent or minimize 
virus replication. In an immune individual this may be accomplished by the active 
immune response generating cytotoxic T cells or antibody dependent cell killing. 
However, apoptosis may be seen as an innate equivalent of this process that may well 
have predated the development of the more active immunological mechanisms in 
evolutionary terms.
Typically apoptotic cell death proceeds morphologically with several characteristic 
features such as chromatin maigination and nuclear fragmentation. Several endonucleases 
such as Caspase-activated DNase (CAD), lysosomal DNase II have been found 
responsible for DNA fragmentation in apoptotic cells (Reviewed in Nagata et al, 2003). 
Apoptotic cells shrink and finally give rise to the formation of apoptotic bodies, which aie 
small membrane-bound blebs containing the cell’s contents (Kerr et al., 1972; Wyllie, 
1980). The apoptotic bodies aie taken up by macrophages and degraded. This avoids the 
release of soluble cell contents that would otherwise lead to inflammation. The apoptotic 
process can therefore be divided into three morphological phases (Figure 1.4): phase one 
includes changes such as cell shrinkage and extensive chromatin condensation. Phase two 
includes fomiation of vacuoles inside the cells and cell fragmentation; phase three 
includes formation of apoptotic bodies (Reviewed in Pollack & Leeuwenburgh, 2001).
12
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1. Condensation-cell blebbingr..
Normal cell
3. Apoptotic bodies
2. Fragmentation
Nuclear changes
Figure 1.4 Morphological changes during apoptosis. Chromatin (DNA and its packaging 
proteins in the cell nucleus) undergoes initial degradation and condensation. The nuclear 
envelope becomes discontinuous and the DNA inside it is fragmented. The cell generates 
blebs and breaks apart into several vesicles called apoptotic bodies. Taken and modified 
from: http://www.bendermedsystems.com/uploads/pics/apo.gif, 11.01.06.
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It is important to distinguish between necrosis and apoptosis (Figure 1.5); Necrosis is 
considered to be a passive event that is lai'gely dependent on the type of the external 
injurious agent. After necrosis there are many changes in the cell structure. The most 
important changes are: clumping of the chromatin, swelling/rupture of mitochondiia and 
lysis of the plasma membrane. Cell contents spill out and a general inflammatory 
response is triggered. In contrast, the outer membrane of the cell remains intact in 
apoptosis and no inflammatory reaction is provoked, leaving the neighboring cells and 
tissues unhaimed. Moreover, the distinct morphological features in apoptosis, i.e. 
chromatin margination, nucleai* fragmentation, cellular shrinking and formation of 
apoptotic bodies do not take place in necrosis (Reviewed in KeiT et al, 1994). 
Intracellular ATP levels have been implicated as an important factor in the cell’s decision 
to die by apoptosis or necrosis; apoptosis is ATP-dependent but necrosis is associated 
with depletion of intracellular ATP indicating that this process does not require ATP 
(Eguchi et al, 1997; Eguchi et al, 1999; Leist et al, 1999; Tsujimoto, 1997). There is 
accumulating evidence that apoptosis and necrosis ai'e related phenomena (Leist & 
Nicotera, 1997) and in tumours, increased numbers of apoptotic cells are seen adjacent to 
necrotic areas (Arai & Katayama, 1997). In addition some of the well-recognized aspects 
of virus induced cell destruction (cytopathic effect) are actually apoptotic changes; 
chiefly these consist of pyknosis and nuclear disruption. However the blebbing typical of 
late stages of apoptosis is not normally associated with virus infection since at late times 
the virus may have succeeded in killing or severely damaging the cell leading to necrotic 
rather than apoptotic changes. This might be mediated for instance through virus induced 
mitochondrial dysfunction leading to a restriction in the supply of ATP and thus 
promoting necrosis.
14
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Healthy
Necrosis Apoptosis
Figure 1.5 Some morphological molecular characteristics o f healthy, apoptotic and 
necrotic ostcocytcs. Scanning electron microscopy (EM) images show morphological 
characteristics o f the ostcocytc cell line in culture after stimulation with inducers o f  
death (Taken and modified from Noble, 2003).
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A family of cysteine proteases (called caspases), which aie present in most cells aie 
responsible for apoptosis. Several members of this family have been identified and these 
are teimed caspase-1 to caspase-14 (Thornbeny & Lazebnik, 1998). The first known 
protease of the caspase family is interleukin-1 (5-converting enzyme (ICE, caspase-1) 
(Thomberry et al, 1992). They are themselves activated by specific proteolytic cleavage 
and then cleave their substrates on the carboxyl side of aspartate residues. Activation of 
these caspases is the main step in cells undergoing apoptosis and occurs by sequential 
proteolytic events that cleave the single peptide precursor into large and small fragments 
(Reviewed in Eamshaw et al, 1999). The crystal structures of mature caspase-1 and 
caspase-3 suggest that the active caspases are composed of tetramers consisting of two 
molecules of each subunit (Nicholson & Thornbeny, 1997).
There are two major pathways involved in programmed cell death: mitochondrial (or 
intiinsic) pathway and the death receptor (or extrinsic) pathway (Kaufmann & 
Hengaitner, 2001). These are illustrated in figure 1.6.
In the extrinsic pathway or Fas mediated apoptosis, the apoptotic signal is initiated by 
direct ligand-mediated trimerization of death receptors at the cell surface (McWhirter et 
al, 1999). There are many known death receptors and among them the most widely 
studied is CD95 (cluster of differentiation 95, Fas) (Wallach et al, 1999). Death receptors 
are a family of type I trans-membrane proteins, which belong to the tumor necrosis factor 
(TNF) family (Ekert & Vaux, 1997) and are expressed in several cell types. In this 
pathway the apoptotic process is begun by the binding of ligand (Fas-L) or anti-Fas 
antibodies to CD95/Fas, which then allows it to bind to the death domain of cytoplasmic 
proteins F ADD (Fas associating death domain).
16
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Figure 1.6 The pathways o f the apoptotic process. In the intrinsic pathway 
mitochondria are triggered by many death signals such as chemotherapeutics, DNA- 
damaging agents, growth-factor withdrawal and irradiation. This leads to the release o f 
multiple intermembrane space proteins including cytochrome c; AJF, apoptosis- 
inducing factor; endonuclease G; Smac/DIABLO (second mitochondria-derived 
activator o f caspases/direct lAP-binding protein with low pi) and Omi/ HtrA2; high 
temperature requirement A. Binding o f Apaf-1 to Cytochrome c induces caspase 
activation. Nuclear DNA degradation that is caspase-independent is induced by AIF and 
endonuclease G. Smae/DIABLO and Omi/HtrA2 also can induce the production o f 
XIAP, X-linked inhibitor-of-apoptosis protein, which is the neutralized form o f LAP 
which in turn leads to caspase activation. In extrinsic pathway, death receptors such as 
Fas, are ligated to their ligand (for example FasL) and results in binding the protein 
F ADD (Fas-associated death domain) to procaspase-8 and a protein complex called 
DISC (death-inducing signaling complex) is formed that activates procaspase-8. 
Activated caspase-8 then activates caspase-3 and then activated caspase-3 begins 
cleavage o f a variety o f substrates leading to apoptosis. The model was modified from 
(Van Loo et a i, 2002; Wang, 2001)
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This leads to the activation of procaspase-8 . Active caspase- 8  will activate procaspases-3, 
-7 and -6 . Eventually this leads to the proteolysis events that aie characteristic of the 
destruction of the cell. (Ekert & Vaux, 1997; Van Loo et al., 2002). In the intrinsic 
pathway, cytochrome c is released from the mitochondiia. Also Apaf-1 (apoptotic 
protease activating factor-1) binds to dATP or ATP, oligomerizes and binds to 
cytochrome c. This complex activates procapase-9. Active caspase-9 binds to this 
complex and forms an apoptosome with a size about 700 KDa. Subsequently caspases-3, 
7 and possibly 6  aie activated by the apoptosome (Gottlieb, 2000). The activation of 
caspases-3, - 6  and -7, whether by the direct action of caspase- 8  or the formation of a 
functional apoptosome, is the final common pathway in programmed cell death. 
Approximately 40 proteins are cleaved by caspases in cells undergoing apoptosis 
(Nicholson & Thomberry, 1997). The apoptotic process is regulated by the protein 
superfamily Bcl-2 (B-cell lymphoma 2), of which at least 15 family members have been 
identified in mammalian cells and several others in viruses (Adams & Cory, 1998) (see 
page 21). These proteins have a major role in preventing cell death mediated by most 
stimuli. As a conclusion for the apoptotic process, it is clear that the health of 
multicellular organisms depends not only on the body's ability to produce new cells but 
also on controlled cell death. Changes in cell survival contribute to the pathogenesis of 
disorders such as cancers, many viral infections, neuropathies and immunopathies.
In other words, apoptosis permits the safe disposal of cells when they have fulfilled their 
intended biological function. If we regard apotosis in the context of virus infection as a 
host defense mechanism then it is not surprising that viruses have developed means of 
counter attack to prevent the onset of apoptosis.
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Thus, many virus anti-apoptotic proteins are known (Boya et al, 2004). Given the central 
role of mitochondria in regulating the onset of apoptosis (Wang, 2001), it is also not 
surprising that many such proteins act on the mitochondria, although it is not known 
whether they may have additional effects on the energy generating function of these 
organelles. Such effects could be of short-lived significance in the context of an acute 
cytolytic infection, however continual interaction with the mitochondria during a 
persistent infection (where apoptosis is retarded so that both host and virus survive) could 
have long-term effects on the energy balance (and hence function) of the host cell. 
Persistent infections are described as those in which the virus is not cleared but remains in 
specific cells of infected persons. Many viruses can induce persistent infections and often 
by different mechanisms. These may include frequent release of infectious virus as in 
feline calicivirus, Epstein Ban* or cytomegalovirus infection, presence of defectively 
replicating virus as in measles virus-associated subacute sclerosing panencephalitis or 
persisting but non-replicating virus genetic information as in heipes simplex virus 
infection of neurons. We have selected some of these for investigation in this project as 
well as other acutely-infecting viruses such as influenza which has been associated with 
Reye’s syndrome, a condition associated with mitochondrial problems in the liver. 
However this list is by no means exhaustive and many other examples are known.
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1.5 Apoptosis and mitochondria
The role of mitochondria as the central coordinators of apoptosis has long been 
recognized (Gottlieb, 2000). Mitochondria release many apoptogenic proteins in response 
to a variety of apoptotic stimuli such as chemotherapeutics, DNA damaging agents and 
inadiation (Van Guip et at, 2003). A critical factor is the release of cytochrome c (Li et 
al, 1997), which binds to Apaf-1, the mammalian homolog of C. elegans cell death gene, 
Ced-4, and through association with procaspase-9 activates the caspase cascade. 
Apoptosis is regulated by Bcl-2 (B-cell lymphocytic-leukaemia proto-oncogene 2) family 
members (Figure 1.7) (Daniel et al, 2003) which includes both pro- and anti-apoptotic 
members (Reviewed in Adams & Cory, 1998). Proteins of the Bcl-2 family are present on 
the cytoplasmic surface of various organelles, including the mitochondiia (Park & 
Hockenbery, 1996). Bcl-2 protein itself is a potent inhibitor of apoptotic cell death, and 
acts by altering the properties of mitochondrial membranes that lead to release of 
apoptogenic proteins like cytochrome c and Smac (second mitochondiial-derived 
activator of caspases)/Diablo (direct lAP-binding protein with low pi) into the cytosol. 
Consequently through the action of Bcl-2 the caspase cascade of cell degradation is halted 
(Reviewed in Gross et al, 1999; Van Loo et al, 2002).
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Figure 1.7 Members o f the Bcl-2 superfamily (Source: Daniel et a l, 2003).
The legends:
Bad, Bcl-2-antagonist o f cell death; Bak, Bcl-2-antagonist/killer; Bax, Bcl-2-associated X 
protein; Bcl-2, B-cell lymphoma 2; BH, Bcl-2 homology domain; Bim, Bcl-2 interacting 
mediator o f cell death; Bok, Bcl-2-related ovarian killer protein; Bcl-G, Human apoptosis 
regulator BCL-G; BIK, BCL2-interacting killer; Hrk, BH3-only peptide hara-kiri; Bcl-2, B-cell 
lymphoma 2; BH3, BH3-only proteins o f  apoptosis; Bcl-XL, Bcl-2 like-1 (long form); Bcl-w, 
Bcl-2 like-2; M cl-l, myeloid cell leukemia sequence 1.
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These mitochondrial apoptogenic factors can be divided into two classes: Firstly, those 
whose function is independent of caspases such as AIF (apoptosis inducing factor) and 
endonucleases G and secondly, those whose functions activate caspases, such as 
cytochrome c (Van Gurp et al, 2003). Mitochondrial regulation of apoptotic cell death 
has been simplified in figure 1.8. As shown the main components of the penneability 
transition pore (FT) are the VDAC (voltage dependent anion channel) and the adenine 
nucleoside translocator (ANT). The complex is completed by peripheral benzodiazepine 
receptor (PER), Bax/Bcl-2 in the OMM, cyclophilin D and caidiolipin in the IMM. 
Respiratory chain substrates such as ATP aie transported from the mitochondrial 
intermembrane space to the cytoplasm via function of nonnal VDAC (Rostovtseva & 
Bezrukov, 1998).
The major apoptogenic proteins such as cytochrome c (12 kDa), second mitochondria- 
derived activator of caspases, direct inhibitor of apoptosis (lAP) binding protein, AIF (57 
IcDa), and others are mostly stored in vesicles created by infoldings of the IMM. During 
apoptosis induction, the apoptogenic proteins are released from their intercristal storage 
into the intermembrane space and then pass into the cytoplasm. The proteins, cytochrome 
c, caspases, ATP, and the cytoplasmic apoptosis protease activating factor-1 (Apaf-1) are 
combined in the cytosol to fonn apoptosome complexes (700 l<Da), which cleave 
downstream caspases (Reviewed in Mayer & Oberbauer, 2003) (Figure 1.8).
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Figure 1.8 Mitochondrial regulation o f apoptotic cell death. Details are described in 
the text (Taken and modified from Mayer & Oberbauer, 2003).
The legends:
VDAC, voltage dependent anion channel; AIF, apoptosis inducing factor; ANT, 
adenine nucleoside translocator ; Apaf-1, apoptotic protease activating factor-1; ADP, 
Adenosine di Phosphate; ATP, adenosine three phosphate; Bcl-2, B-cell lymphoma 2; 
Diablo, direct lAP binding protein with low pl; mtDNA, mitochondria DNA; IMM, 
intermitochondrial membrane; IMS, Intermembrane Space; OMM, outer mitochondrial 
membrane; Smac, second mitochondria-derived activator o f caspases; Bax, Bcl-2- 
associated X protein; Bid, BH3 interacting domain death agonist; tBid, truncated Bid; 
cyt c, cytochrome c; PT, permeability transition pore; PBR, peripheral benzodiazepine 
receptor; Cyp-D, cyclophilin-D.
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We wished to extend previous observations concerning the interaction of poliovirus with 
mitochondria (Koundouris et al, 2000) and to seek other viruses which could also affect 
cellular respiration. In this thesis we have examined positive and negative RNA stranded 
viruses and double stranded DNA viruses. In particulai" we have concentrated on the 
inhibition induced by human herpes virus 1 (HHV-1) and have identified the protein 
involved. In view of the focus of this thesis, the following sections will review cuiTent 
knowledge of interaction between viruses and mitochondria and relationship between 
apoptosis and viruses before discussing herpes virus itself.
1.6 Apoptosis and Viruses
Several viruses are known which can affect apoptotic pathways to permit the maintenance 
of latent viral infection or to maintain and enhance the efficiency of viral replication 
(Roulston et al, 1999). Early induction of apoptosis is assumed to inhibit virus replication 
and may thus be a host defense mechanism. Induction at late times (after replication is 
completed) may help in the release of virus by promoting disintegration of the host cell. 
Thus it is conceivable that some viruses might have evolved mechanisms to inhibit 
apoptosis at early times post infection, and to activate it later. Activation of apoptosis by 
eai'ly proteins might then be viewed as a successful host defense mechanism rather than a 
deliberate tactic in the virus’ replication strategy. Examples of early triggering include 
human immunodeficiency virus 1 (HIV-1). In this case apoptosis is triggered by protein R 
(Vpr) (Jacotot et al, 2000), this protein functions early in infection (Zhao et al, 1994).
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In this case interruption of apoptosis triggered by Vpr can lead to increased virus yields 
suggesting that it may represent a cellular defense mechanism (Stewart et al, 2000). 
Human papillomavirus (HPV) type 16 triggers apoptosis through early protein E4 made 
from mRNA EHE4 (a spliced derivative from both open reading frames). This protein 
binds to mitochondria inducing them to detach from micro tubules and cluster near the 
nucleus. Mitochondrial transmembrane potential is then reduced and apoptosis triggered 
(Raj et al, 2004). Although this is a trigger by an eaiiy protein of a virus, the authors 
suggest that the significance of this function might none-the-less be revealed at late stages 
when the tough, terminally differentiating kératinocytes might be rendered more fragile 
by sensitization to apoptosis and thus permit virus exit. Experiments to test the effect of 
opposing this E4-induced apoptosis were not performed. Interestingly both Vpr from HIV 
and EHE4 of HPV can also induce cell cycle arrest suggesting some similaiity in activity 
and it remains possible that the induction of apoptosis by HPV in the host cell does act to 
reduce virus yield rather than facilitate release. However this may represent an 
oversimplification of the situation and the interaction between host and virus, blow and 
counterblow may be even more subtle. An organism consists of many different cell types 
and it cannot be concluded that the same effect would hold true in all. For instance 
Influenza A virus (lAV) induces a protein PB1-F2 that acts in the early stages of virus 
replication. This protein localizes to the inner mitochondrial membrane causing a collapse 
in transmembrane potential and onset of apoptosis. The mitochondrial localization signal 
is predicted to form an amphipathic transmembrane helix that is similar to that formed by 
HTLV-1 protein pl3II and Vpr (Chen et al, 2001; Gibbs et al, 2003).
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However, expression of the PB1-F2 protein appeared to be cell type specific, having little 
pro-apoptotic effect in epithelial cells but more so in monocytes. This raises the intriguing 
possibility that a virus may be able to regulate this process such that replication in the 
major host tissue of the virus (epithelia) is not disrupted, whilst infection of monocytes 
which may be attempting to control the infection instead leads rapidly to cell death (Chen 
et al., 2 0 0 1 ).
Several reports have also shown that some virus late functions ai*e inducers of apoptosis. 
This mechanism may be used by virus to destroy the infected cells and facilitate virus 
exit. However, apoptosis if it goes to completion, would result in the sequestering of any 
cell-associated virus within apoptotic bodies and blebs, which aie themselves easily 
phagocytosed. Thus, such a mechanism continuing unchecked might actually oppose 
virus release. It is perhaps for this reason that most virus induced apoptosis is usually 
succeeded by necrosis. Examples of late function induction include the pl3 II protein 
encoded by HTLV-1 (Green, 2004). This protein traffics to the mitochondiia and induces 
mitochondrial alterations in morphology and ion flow. Cells expressing this protein 
appear to be more sensitive to apoptosis and show reduced capacity for tumorigenicity 
(D'Agostino et al., 2002; Silic-Benussi et al., 2004). Protein G4 of bovine leukemia virus 
(BLV) (a Deltaretrovirus resembling HTLV-1) exhibits similar' properties, localization to 
mitochondria by means of an amphipathic helix and a possible role in apoptosis (Lefebvre 
et al, 2002). Also it has been demonstrated that deletion of G4 leads to a drastic 
reduction in pro virus accumulation in vivo. Since G4 and pl3 II appear* to be related it is 
possible that both influence virus spread in the body (Kerkliofs et al, 2000).
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Anti-apoptotic effect of several viruses has been widely investigated. Reports show that 
in a number of instances, viral proteins formed at late stages of the viral life cycle have 
anti-apoptotic features. Such a process could be significant in prolonging cell viability to 
extend the period of productive virus release, but if such features were to be stable they 
could permit the emergence of persistent infections where both virus and cell co-exist. 
When such processes occur the infected cell may resist the induction of apoptosis by 
exogenously added inducers. This is seen for Kaposi's sarcoma-associated herpesvirus 
(KSHV) protein K7 (Feng et ai, 2002) which is induced some 24 hour post infection 
(Paulose-Muiphy et al, 2001). Vaccinia virus FIL protein is a protein that functions at 
the mitochondria to inhibit apoptosis (Stewart et al, 2005; Wasilenko et al, 2003). The 
myxoma virus protein M llL , prevents apoptosis by direct interaction with the 
mitochondrial permeability transition pore (Everett et al, 2002) and also blocks apoptosis 
of infected leukocytes (Everett et al, 2000). It has an important role in virulence of virus 
and transcription analysis indicates that M llL  is expressed as an early gene (Graham et 
al, 1992).
Epstein-BarT virus (EBV) that is a human herpesvirus and persists within the B-lymphoid 
system codes for a protein expressed eariy in the viral life (Takase et al, 1996), BHRFl 
protein localizes to the mitochondrial outer membrane and protects human B cells from 
programmed cell death (Henderson et al, 1993).
Hepatitis C virus (HCV) infection that leads to liver cancer encodes NS2 protein which, 
blocks cytochrome c release from mitochondria and prevents apoptotic cell death 
(Erdtmann et al, 2003). This protein has been shown to be important for the pathogenesis 
of chronic HCV infection (Dumoulin et a l , 2003)
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However these effects may not be simple and the interplay between multifunctional virus 
regulatory proteins and cellular control pathways may differ from cell to cell, or even 
within the same cell type under different circumstances. Such a complex system is 
exemplified by the X protein (HBx) of hepatitis B virus (HBV), a multifunctional protein 
with effects on virus transcription and cell cycle regulation. HBx is required to establish 
virus infection in hepatocytes (Chen et al., 1993), but not for the later stages or for 
particle release (Zoulim et at., 1994). It is also known to possess pro-apoptotic activity 
(Reviewed in Murakami, 2001). This may not be unconnected with its ability to traffic to 
mitochondria (Rahmani et al., 2000), but the protein also sensitizes cells toward apoptosis 
by inhibiting the anti-apoptotic functions of c-FLIP (Kim & Seong, 2003). However, the 
same protein also demonstrates an ability to inhibit apoptosis (Elmore et al., 1997) by an 
effect on caspase 3 (Gottlob et al., 1998). It is likely that these effects may be operative 
at different stages of virus infection or under different circumstances (eg virus protein 
level): a stimulation of apoptosis could be beneficial during productive infection but 
deleterious to a persistent infection since it is generally accepted that virus elimination 
when it occurs is mediated through apoptotic processes.
In conclusion it is clear that many virus proteins may influence apoptosis in infected cells. 
These influences may take place early and/or late in replication. The proteins responsible 
are often multifunctional with effects on transcription, cell cycle regulation and an ability 
to interact with the cytoskeleton as well as trafficking to nucleus and or mitochondria. 
Effects may differ between cell types or possibly even within the same cell under 
different conditions and arguments related to the cost/benefit of such interactions should 
always consider the wider, whole organism situation.
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1.7 Mitochondria and Viruses
There are many reports of a virus-mediated effect on mitochondrial structure or 
intracellular* location, in some cases the viruses (or* proteins) responsible are also known 
to affect apoptosis and or* mitochondrial function but in many cases this is not yet known. 
Several viruses affect appearance of this subcellular* organelle, for* example: Human 
immunodeficiency virus (HIV) induces mitochondria to cluster* and become disorganized, 
with protuberances, the number of cristae is reduced and vacuoles are located both within 
the mitochondria and, or* close to them (Radovanovic et al, 1999). Human T-cell 
leukemia virus type 1 encodes a number* of "accessory" proteins that one of these 
proteins, pl3 (II), is targeted to mitochondria and disrupts mitochondrial morphology 
(D'Agostino et ah, 2002) as well as causing transmembrane gradient to collapse (see 
above). After infection with hepatitis B virus, the HBx protein of the virus, can affect the 
mitochondiia and induce aggregation, finally leading to cell death (Takada et al, 1999). 
The protein interacts with the voltage dependent anion channel modifying the 
transmembrane potential (Rahmani et al, 2000). Rubella virus (RV) infection induces 
changes in mitochondrial morphology and distribution (Lee et al, 1999). Herpes simplex 
virus (HSV) infection also changes the distribution of the mitochondria inside the infected 
cells and they appear to gather in the perinuclear* region of the cytoplasm at 6  hours post­
infection and sometimes formed a ring-like structure (Murata et al, 2000).
In some cases the virus also affects mitochondrial function, either by insertion of an ion 
pore in the inner* membrane as in the amphipathic helices possessed by Vpr, PB1-F2 and 
pl3 II.
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In other cases interaction is with specific protein components of the organelle, HBx and 
VDAC (above) or Poliovirus which inhibits succinate dehydrogenase activity in both 
COS-1 and T47D cells causing a rapid decrease in total cell respiration and electron 
transport chain impairment (Koundouris et al, 2000). In other cases the mechanism is 
unknown; SV40 induces release of mitochondrial malic dehydrogenase from CV-1 cell 
mitochondria and this was followed by a reduction in oxygen consumption and damage to 
the electron transport system (Norkin, 1977). Herpes simplex virus infection causes the 
level of ATP generated by mitochondria to fall (Murata et al, 2000) and mtRNA levels 
decrease during herpes simplex virus type 2 infection (Latchman, 1988). It is thus 
possible that many viruses may affect mitochondria to some extent although this may not 
always be through the same mechanism or to the same degree. However, it is certainly 
possible that these interactions may be reflected in the pathogenesis of the infection, for­
ex ample oxidative injury may occur following hepatitis C (HCV) virus infection as a 
result of a direct effect of the virus core protein on mitochondria (Okuda et al, 2002), 
associated with increased lipoperoxidation interfering with mitochondrial function and 
possible depletion of mitochondrial DNA (mtDNA) (Barbaro et al, 1999). The 
mitochondrial interaction of the amino-terminal 2 2  amino acids of the influenza virus 
protein PB2 has been implicated as a mechanism for mitochondrial injury in Reye's 
syndrome (Woodfin & Kazim, 1993).
From the foregoing, it should be clear that more research on the potential interaction 
between viruses and mitochondria is warranted and that the outcomes of such interactions 
may be clinically relevant. Accordingly we have tested several viruses from different 
families for their capacity to induce dysfunction in respiration in the infected cell.
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This analysis revealed that both human heipes virus type 1 (HHV-1) and influenza virus 
(IV) are capable of such an effect and the mechanism of one such virus (HHV-1) was 
then investigated in detail. Since subsequent sections will consider this virus more 
closely, the following section presents a brief review of the cunent knowledge of HHV-1.
1.8 Human herpes virus 1 (HHV-1)
1.8.1 Structure and classification
The heipes viruses are a family of double-stranded DNA viruses who share basic 
structural features and characters of genomic organization. They are divided into 
subfamilies separated by sequence and biological features such as speed of replication 
host cell range and manner in which persistent infections may be established. Biological 
properties are becoming superseded by sequence analysis as a tool for classification. The 
current classification of the family is shown in table 1 .2 , which also lists the genome sizes 
of each class and generic biological properties.
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Table 1.2 Human herpesviridae family 
(Source: http://www.ncbi.nlm.nili.gov/ICTVdb/Ictv/fr-fst-g.htm, 10.08.05)
Classification of Human Herpes Viruses
Subfamily Viruses Synonym name Genome
(Kbp)
Biological
Properties
a
Human 
Herpes 
Virus 1
Herpes simplex 
virus 1 152 Rapid replication, 
broad host 
cell range, 
Latent 
infection in 
neural tissue
Human 
Herpes 
Virus 2
Herpes simplex 
virus 2 152
Human 
Herpes 
Virus 3
Variceil-zoster virus 125
P
Human 
Herpes 
Virus 6A
— 159 Slower replication, 
restricted 
host cell 
range 
Persist in 
lymphoid 
tissue
Human 
Herpes 
Virus 6B
— 162
Human 
Herpes 
Virus 5
cytomegalovirus 248
y
Human 
Herpes 
Virus 4
Epstein-Barr virus 172
Very slow 
replication, 
host range 
limited to 
one or two 
ceil types, 
Persist in 
lymphoid 
tissue
Human 
Herpes 
Virus 8
Kaposi’s sarcoma 
associated herpes 
virus
170
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Human heipes virus 1 (HSV-1 or herpes simplex virus 1) is classified in the subfamily 
Alphaherpesvirinae of the family Herpesviridae. The basic structure of all heipes viruses 
is illustrated with reference to HHV-1 in Figure 1.9; the HHV-1 capsid is an icosahedral 
shell 15 nm thick and 125 nm in diameter that 162 capsomers (12 pentons and 150 
hexons) forms its structure. The capsomers lie on a T=16 icosahedral lattice and are 
connected in groups of three by trivalent structures, called triplexes, that lie above the 
capsid level and fix the capsomers. There are a total of 320 triplexes in the capsid (Schrag 
et al, 1989). The capsid in HSV-1 and HSV-2 contain seven polypeptides that are called 
NC-1 through NC-7 and their molecular weight vaiies from 154,000 to 12,000 Da [154K 
(NC-1), 50K (NC-2), 40K (NC-3), 38K (NC-4), 33K (NC-5), 26K (NC-6 ), and 12K (NC- 
7)], and among them two polypeptides, NC- 1  and NC-7, had similar- peptide profiles 
(Cohen et al, 1980). 6  main proteins of the capsid; VP5, VP 19c, VP21, VP23, VP24, 
VP26 are encoded by U l19, U l38, U l26 , U l18 , U l26.5, U l35  genes of the virus (see 
table 5.1). Proteins encoded by U l4, U lI I , U l13 , U l21, U l25, U l36 , U l37 , U l46, U l49, 
U l56, Ug3, Us9, UslO and Ugll (see table 5.1) form the tegument layer (a shapeless layer 
of proteins, localized between the viral capsid and envelope). The structure and 
organization of HHV-1 genome has been described in chapter 5.
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hexon
S t! l
penton Glycoprotein tegument capsid spike
Figure 1.9 Human herpes virus 1 structure. Reconstructed structure (A) and 
electron micrograph (B) o f HSV-1. The herpes virus capsid is an icosahedron 
o f triangulation number T = 16. There are 12 pentavalent capsomers (one at 
each apex) and 150 hexavalent capsomers. Each capsomer has a deep central 
indentation. A lipid envelope derived from the host cell surrounds the 
nucleocapsid. For more details see the text. Taken and modified from:
A: (Baker ef a/, 1999)
B: http://www.people.virginia.edu/~jcb2g/research/background.htm, 11.01.06
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1.8.2 HHV-1 replication
The Herpesviridae show tight regulation of gene expression by means of transcriptional 
control (Boehmer & Lehman, 1997). Although recent use of genomic technology has 
revealed that some genes are transcribed to greater or lesser extents throughout infection, 
it remains generally true that transcription occurs in three waves. The infection begins by 
the fusion of viral envelope with the plasma membrane following attachment to the cell 
surface by specific interaction with one of several cellular* receptors tei*med HVEM 
(herpesvirus entry mediators). In the case of HHV-1, glycoproteins B (gB) and 
glycoproteins C (gC) are known to be involved in binding (Shukla et al, 1999) to the cell 
at the heparan sulfate receptors (Shieh et at, 1992; WuDunn & Spear, 1989). Another 
factor that is implicated in attachment is basic fibroblast growth factor receptor (FGFR) 
(Kaner et al, 1990). After binding to the cell, glycoprotein D (gD) plays the most 
important role for viral entry into the cells (Johnson & Li gas, 1988). Penetration into the 
cell occurs at the plasma membrane using gD as the main fusion protein. This also 
requires the action of a number of other viral glycoproteins including gB, gH, gl, and gL 
(Spear & Longnecker, 2003). The viral capsids and some tegument proteins enter the cell; 
the capsids migrate to nuclear pores along cellular* microtubules. Tegument protein vhs 
(virion host shutoff) inhibits host cell protein synthesis by initiating degradation of 
cellular mRNAs in the cytoplasm (Elgadi et al, 1999). a-TIF (a gene trans-inducing 
factor aka VP 16) is moved to the nucleus to stimulate the first round of virus mRNA 
transcription. This is termed a or immediate-early (IE) phase and genes expressed at this 
time compi*ise the major transcriptional regulatory proteins required for the transcription 
of the P and y gene classes.
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The transcription of a genes is induced by a-TIF which interacts with host transcription 
factor, Oct-1 (Koppers-Lalic et ah, 2001; Roizman, 1996), but the transcription itself is 
performed by cellular* RNA polymerase II (Costanzo et al, 1977). Five a mRNAs are 
synthesized from 5 genes (a 4-ICP4, a O-ICPO, a 27-ICP27/UL54, a 22-ICP22/US1, and 
a 47-ICP47/US12), transported into the cytoplasm and translated to make proteins 
(Boehmer & Lehman, 1997). The proteins are then transported into the nucleus where a 
new round of transcription synthesizes the p proteins. Some 31 proteins are synthesized in 
the p phase of protein synthesis (see table 5.1), among them DNA polymerase (Ul30), 
DNA binding proteins (U l42 and U l29 or ICP8 ), origin binding protein (OBP) (U l9), and 
the helicase/prirnase complex (U l5, 8 , and 52) are necessary for viral DNA replication 
(Roizman, 1996). In the next step, a new round of transcription/translation occurs and 
results in synthesis of the 7  proteins. In this step p proteins are necessary for transcription 
of late (7 ) mRNAs, most of these specify structural proteins and lead to capsid for*mation. 
Three classes of her*pesvirus capsids, designated A, B and C have been identified (Gibson 
& Roizman, 1972). Type A capsids are empty and are believed to be a dead end assembly 
product. Type B capsids have an electron lucent core and contain various virion scaffold 
proteins. These must be expelled and replaced with virus DNA forming type C capsids, 
which are thought to be the precursors to mature virions. At least three proteins of HHV-1 
have been shown to have a role in DNA packaging inside the capsid; U l17, U l25 and 
Ul6 . Among them U l17 protein seems to play a major role (Thurlow et al, 2005). After 
packaging of DNA, capsids are suixounded by the primary tegument protein, a nuclear 
phosphoprotein specified by gene U l31. This protein has an important role in the budding 
of the mature capsids through the inner nuclear membrane to the inter nuclear membrane 
space.
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In the inter nuclear membrane space the UL31 and UL34 gene products ( type II C- 
terminally anchored membrane protein) are added to the capsid, and the primary envelope 
is formed (Fuchs et al, 2002; Yamauchi et al, 2001). These capsids then fuse with the 
outer nuclear membrane losing their temporary envelope. In the cytoplasm, at least 15 
tegument proteins associate with the cytoplasmic capsids (among them are a-TIF and vhs 
that is thought to be involved in final envelopment). Final envelopment of the tegument 
capsid is proposed to occur in cytoplasm by budding into exocytotic vesicles of the trans- 
Golgi network, which contain all the glycoproteins associated with the mature virions. 
Eventually the vesicle membrane fuses with the plasma membrane and leads to release of 
mature virions (Reviewed in Mettenleiter, 2002). The schematic illustration of HHV-1 
replication process is shown in figure 1 .1 0 .
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Figure 1.10 Schematic representation o f HHV-1 replication. HHV-1 virion attaches to 
host cell with the envelope glycoproteins onto heparan sulphate then the viral 
envelope fuses to the plasma membrane. This releases both the nucleocapsid and the 
proteins o f the tegument into the cytoplasm. Virus protein vhs (virus host shutoff) 
reduces translation o f cellular proteins, whilst transcription activator VP 16 is moved 
into the nucleus. The capsid travels along the cytoskeleton to a nuclear pore where the 
viral DNA is released, enters the nucleus and is circularized. Once in the nucleus, the 
viral DNA is transcribed into mRNA by cellular RNA polymerase II, a process 
stimulated in the first instance by VP16. Transcription follows three stages o f gene 
activation, alpha genes (mainly activators), beta genes (mainly enzymes for nucleic 
acid metabolism) and gamma genes (mainly structural components required to 
assemble new progeny). However, some genes in each class are transcribed 
throughout infection. After transcription in the nucleus, all mRNA transcripts are 
translated into proteins in the cytoplasm, some products being imported to the 
nucleus. Capsid proteins assemble in the nucleus to form empty capsids. Full-length 
viral DNA is packaged within to form nucleocapsids. The nucleocapsids exit the cell 
by a process o f envelopment/de-envelopment: the nucleocapsids enter the nuclear 
inter membrane space through the inner nuclear membrane and the primary envelope 
is formed. This envelope is lost when the capsid fuses with the outer nuclear 
membrane and enters the cytoplasm. Final envelopment is occurred in cytoplasm by 
budding into exocytotic vesicles. Ultim ately the vesicle membrane fuses with the 
plasma membrane and the mature virion is released (detail o f release not shown).
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1.9 Aims of the study
The hypothesis prompting this work is fourfold:
1. Inhibition of mitochondrial respiration by viruses may be common.
2. Any such inhibition should be produced by virus-specific proteins.
3. Such processes may underlie the generation of similar outcomes of infection by 
divergent viruses.
4. Such outcomes may be significant in the context of persistent infection.
This thesis will examine the first two parts of this hypothesis and thus the aims of this 
study were as follows:
• To seek any viruses that can affect respiration. Testing common viruses for ability
to affect cellular respiration with emphasis on those able to induce persistent
infection.
• To detect the sites of any electron transport chain block.
• To determine the viral protein/s involved in this effect.
• To assess the influence of protein/s by transfection studies.
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Chapter 2: Methods
Specific methods developed in the course of this study will be outlined in the appropriate 
chapters. Details of common materials, solutions and buffers used are detailed in 
appendix 1.
2.1  Cell culture and growth
Measles (MV) virus was grown in HeLa (human cervical epithelial carcinoma) and 
VERO (African green monkey kidney) cell lines; Cytomegalovirus (CMV) in MRC5 
cells (human diploid lung), human heipes virus 1 (HHV-1) and Us3 deletion mutant virus 
were grown in HeLa cell and influenza virus (IV) in MDCK (Madin-Darby Canine 
Kidney) cells [all viruses were obtained from University of Cambridge, except Ug3- 
deletion mutant virus and wild type herpes simplex virus type 1 (HSV-1) that were 
obtained from University of Chicago, and all cell lines from European Collection of Cell 
Cultures (ECACC)]. All cell lines were grown in growth medium and were incubated at 
37°C in a humidified incubator in an atmosphere of 5% CO2 in air until confluent. For 
splitting and re-passage, monolayers were detached by rinsing in PBS and then in 5ml 
trypsin-versin- solution. Most of this was then poured off and the cells allowed to stand in 
the residual liquid until they had detached. They were then harvested into 10% FBS 
medium and collected by centrifugation for 5 minutes at 1500 x g before re-suspension in 
fresh medium. Cells were then transferred to fresh flasks achieving a subculture ratio of 
1/10 and grown as above.
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2.2 Freezing cells for Liquid nitrogen storage
Cells were frozen in liquid nitrogen at -196°C. Monolayers of cells were harvested as for 
passage but re-suspended in freezing medium: MEM supplemented with 20% foetal 
bovine serum, 1% antibiotic [Penicillin (10000 U/ml)/Streptomycin (10000 p.g/ml)], 1% 
nonessential amino acid (NBA) and 1% DMSO (dimethyl sulfoxide). An aliquot was 
counted and cells were adjusted to 10*^  cells/ml, they were placed inside an insulted 
polystryrene container and the whole placed in an -80°C freezer overnight to permit slow 
freezing. Then the cryotubes were removed and transfeixed quickly to liquid nitrogen 
storage.
2.3 Resuscitation of the cells
For resuscitation, vials of cells were collected from liquid nitrogen, and thawed rapidly at 
37°C in a water bath. They were transfeiTed to 5 ml of fresh growth medium (pre­
wanned to 37°C) in a 15 ml centrifuge tube. After mixing gently, the cells were 
centrifuged at 1500 x g the supernatant was discarded and the pellet was re-suspended in 
5 ml fresh growth medium. Finally the cells were transfeiTed to 25 cm^ tissue culture 
flask and incubated at 37°C. After 8 hour the medium was changed to remove the traces 
of DMSO and cultures were incubated until confluent.
2.4 Harvesting and growth of Viruses
Confluent monolayers of cell in 75 cm  ^ tissue culture flasks were rinsed with PBS and 
then infected with 1 ml virus inoculum, allowed to adsorb for 1 hour at room temperature 
with rocldng.
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Cells were then incubated in their respective media supplemented with 2% FBS at 37°C, 
in a humidified atmosphere of 5% CO2  in air. Cells were put in incubator until cytopathic 
effect (CPE) was observable. Because the speed and type of CPE induced by these 
viruses differs they were checked daily under the microscope until CPE was visible. This 
required 3 days for measles and human heipes virus type one, 5 days for cytomegalovirus 
and 1 day for influenza virus. Typical CPE presented in each case is described in chapter
3. Cell associated virus was released by one cycle of freeze-thaw: flasks were then placed 
at “70°C for 1 hour to freeze and allowed to thaw on the bench at room temperature. Cell 
debris was re-suspended thoroughly using a pipette and clarified at 377 x g for 5 minutes. 
Supernatant for inoculation was divided in 1 ml aliquots in plastic bijoux bottles and 
cryovials and snap frozen for storage at -70°C.
2.5 Viral titration
2.5.1 Plaque Assay
2.5 cm  ^ dishes were seeded with cells, incubated overnight at 37°C, and checked for 
confluence. Serial 10-fold dilutions of the virus were prepared in PBS. The growth 
medium was removed from each dish and the cell sheet was washed carefully with PBS.
0.2 ml of each dilution was then added to the sidewall of dishes in duplicate and allowed 
to adsorb for one hour on a rocking platform to ensure cells did not dry out. Inoculum was 
then thoroughly removed. Monolayers were rinsed in PBS and overlayered with pre­
warmed agar medium at 42"C and incubated overnight. After incubation, the cells were 
either stained using neutral red (for measles virus), a vital stain or fixed in 10% formal 
saline and then were stained with crystal violet (for heipes virus).
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The numbers of plaques were counted at the dilution giving appropriate numbers (usually 
within the range 20-200) and the titre (pfu/ml) was calculated by conecting arithmetically 
for dilution and volume plated per dish.
2.5.2 Infection Dose Titration (ID50)
As for the plaque assay, viruses were serially diluted tenfold and the dilution series was 
used to set up triplicate infections along three rows of the plate using 50 |il of each 
dilution per well. Finally 50 pi of growth medium (containing 15% FBS) was added to all 
wells and plates incubated at 37°C in a humidified incubator with 5% C02 overnight. The 
wells were observed under the microscope for appearance of CPE (see chapter 3). The 
number of healthy and infected wells at each dilution was determined and assembled as a 
cumulative total. The 50% end point (i.e. the theoretical dilution at which half of the wells 
would be infected) was calculated from these totals using the method of Reed and 
Muench.
Reed and Muench formula:
(Log dilution factor) x [(percentage infected above 50)-50]
Pd=
(Percentage infected above 50) - (percentage infected below 50)
2.6 Preparing the cells for oxygen electrode (OE)
Infected or mock-infected cells were detached from the flasks gently using a scraper and 
were then collected by slow sedimentation (170 x g for 5 minutes). The supernatant was 
poured off.
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The cells were re-suspended in 0.4 ml PBS and then were earned in an icebox and 
transferred into the chamber of OE. An aliquot was reseived when appropriate for 
determination of viable cell/total cell counts.
2.7 Measurement of total cellular respiration (TCR) by the oxygen 
electrode (OE)
For measurement of oxygen consumption or measurement of TCR, we used a Clark-type 
oxygen electrode (OE) (Oxyg32, Hansatech instruments Ltd, UK) . The OE consists of 
two electrodes that are set into an epoxy resin disc, the platinum cathode at the center of a 
dome surrounded by a well, which contains the silver anode. These electrodes are 
immersed in saturated KCl solution and separated from the reaction vessel by a thin 
Teflon membrane that is permeable to oxygen and prevents electrode poisoning. The 
electrolyte bridge between the anode and cathode is established by placing a drop of 
electrolyte (50% saturated solution of KCl) on top of the dome. A paper spacer and thin 
oxygen permeable polythene membrane are then stretched over the dome in order to trap 
a uniform layer of electrolyte between the electrodes. The membrane is fixed by means of 
an O-ring placed over the dome. At the platinum cathode electrons reduce oxygen 
molecules to water (4H + 4e“ + 02 = 2 H2O). The chloride anions migrate to the anode and 
release electrons (4Ag + 4CI = 4AgCl + 4e“). The overall result is that a transfer of 
electrons from the cathode to the anode occurs causing a current to flow between the two 
electrodes that can be measured in an external circuit. The cunent generated is very 
temperature dependent and it is therefore important to operate the electrode at constant 
temperature and in this case it is suiTounded by a water jacket fed from a constant 
temperature water bath.
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As the electrode consumes oxygen, the solution close to the electrode becomes 
progressively anaerobic. It is therefore necessary to stir the solution vigorously with a 
magnetic stirrer to ensure that the bulk solution under study is continuously brought into 
contact with the electrode. Figure 2.1 and 2.2 show different parts of OE and its chamber.
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Figure 2.1 Different parts of OE used in our study.
OUT*
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G
F
Figure 2.2 Schematic presentation of chamber and electrodes of OE. A, epoxy 
resin disc; B, platinum cathode; C, silver anode; D, O-ring groove; E, floor of 
the reaction chamber; F, magnetic stirrer; G, reaction chamber; H, tight-fitting 
plunger; I, small capillary hole in the plunger. The electrode can be 
maintained at a stable temperature by circulating coolant through the 
water jacket, which surrounds the reaction chamber. The coolant inlet 
and outlet connections are also shown.
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2.8 Viable and total cell count determination
We counted the cells using the Trypan blue protocol as follows: After taking the trace of 
OE for oxygen consumption, 50 p,l of cells were taken from the chamber and mixed with 
450 \x\ of PBS maldng a 1/10 dilution. 50 [Û of this was then added to 50 p,l of Trypan 
blue (0.1%) making a final dilution of 1/20, Viable and dead cells were then counted in a 
haemocytometer. Only non-viable cells are penetrated by the dye and appear blue. Live 
cells exclude the dye and remain colourless.
2.9 Measurement of mitochondrial respiratory chain activity
The electron transport activity of mitochondrial respiratory complexes can be measured 
by two techniques: polai'ographic methods such as the oxygen electrode or 
spectrophotometric methods. Spectrophotometric techniques aie usually applied to 
isolated mitochondrial preparations, especially for the investigation of specific enzyme 
activities. For our study we chose the oxygen electiode technique because our interest 
was to investigate the mitochondrial activity inside living cells. The basis of this 
procedure is to pemieabilise the plasma membrane and allow access of respiratory 
substrates to mitochondria. For this puipose we used digitonin. Mitochondrial respiration 
was detected using the Clark type oxygen electrode and supplement inhibitor 
combinations that peiinitted us to examine the functionality of specific complexes.
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2.9.1 Digitonin titration
Digitonin is a natural plant glycoside which selectively pemieabilizes the plasma 
membrane without disturbing the mitochondrial function (described in chapter 4). The 
amount of digitonin needed for optimal cell peraieabilization was titrated to determine the 
minimum concentration of digitonin required to peimeabilise 100% of cells. Cells were 
grown to near confluence in tissue culture flasks, trypsinised, and washed twice with 
respiration buffer by sedimentation at 1100 x g for 5 minutes. Cell pellets were re­
suspended in 0.4 ml respiration buffer and aliquotted to four tubes. Digitonin was then 
introduced to each tube generating a dilution series ranging from 0.125 mg/ml to 0.5 
mg/ml final concentration. After 5 minutes the cells were examined using the trypan blue 
exclusion technique. Permeabilised cells permit entry of the dye and the proportion of 
stained vs unstained cells was determined at each concentration of digitonin. This showed 
that a concentration of 0.375 mg/ml was required to peimeabilise 100% of the cells.
2.9.2 Measurement of mitochondrial respiratory chain activity
Confluent monolayers of cells were trypsinised and washed twice with respiration buffer. 
Mitochondrial respiratory chain activity was measured in cells re-suspended in the 
respiratory solution. Infected and mock-infected cells were transfeiTed to the chamber of 
the Clark-type oxygen electrode (2 x 10^  cells in 0.4 ml), and permeabilised by the 
addition of digitonin to final concentration of 0.375 mg/ml (determined above). 
Substrates and inhibitors of mitochondrial respiration were then added as described in 
chapter 3.
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2.10 Sodium dodecylsulphate - polyacrylamide gel electrophoresis (SDS- 
PAGE)
2.10.1 Preparing the samples
Confluent monolayers of HeLa cell were grown in 3.5 cm  ^ dishes (0.8 x 10  ^cell/dish). 
Cells were then infected with HHV-1 (m.o.i 10 pfu/cell) for 4-6-12-18 and 24 hours post 
infection and at each time point they were detached using scraper. The cells were 
suspended into 0.5 ml PBS, put into 1.5 ml eppendoif tube and were centrifuged at 22000 
X  g for 2 seconds. The pellet was re-suspended in PBS and was centrifuged again at the 
same speed. The supernatant was poured off and the pellet was suspended in 100 p,l Ix 
sample buffer. Samples were boiled for 1 minute and were syringed to shear any DNA 
before they were loaded onto the gel.
2.10.2 Gel electrophoresis
The Bio-Rad protean mini gel (Bio-Rad Lab. Ltd, UK) was used in our experiment. The 
proteins were separated on a 10% resolving gel. The gel mixture (see appendix 1) was 
polymerised by addition of ammonium persulphate and TEMED, poured between the 
glass plates and allowed to set. Running gels were poured to within 2 cm of the top of the 
plates and overlain with water-saturated butanol. When set, this was discarded and the gel 
surface rinsed with water and dried. The stacking gel was then poured between the plates 
and the comb inserted in it to form the wells for sample loading. Once the stacking gel 
was set the comb was removed and the gel was assembled into the tank, running buffer 
was added to all compartments and the samples were loaded. The power supply was set 
for 160 V for 60 minutes.
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2.10.3 Protein staining
The protein gel was rinsed and covered in the kenacid stain for one hour. The gel was 
then destained in successive changes of destain solution (125 ml propan-2-ol, 50 ml acetic 
acid, 325 ml MQ H2O) until the desired background had been achieved and the bands 
were clearly visible.
2.11 Western blotting
After proteins were separated by SDS-PAGE as described above, proteins were 
transferred to nitrocellulose membranes for antigen detection by western blotting. The gel 
was equilibrated in three changes of transfer buffer (25 mM Tris, 192 mM glycine, 20% 
methanol) over a period of 15 minutes, before being transfeiTed to nitrocellulose 
membrane (Immobolin, Millipore) using a Semi-dry blotter (Trans-blot cell, Bio-Rad 
Laboratories Ltd, UK) according to the manufacturer’s instructions. Four pieces of 3 MM 
paper (pre-soaked with transfer buffer), the membrane also soaked in transfer buffer, the 
gel, and four more pieces of pre-soaked 3 MM filter paper were placed on the bottom 
electrode (positive). The top electrode (negative) was then placed in position and the gel 
was electroblotted at 10-15 V while the cunent was checked for 30 min. The blot was 
then removed from the apparatus, placed in a clean box and covered with blocking buffer 
(5% dried milk in Ix TBS/Tween-20) to saturate and further protein binding capacity and 
was incubated at 4°C overnight. The proteins transfened on to nitrocellulose membrane 
can be detected immunologically using a combination of specific and detector antibodies, 
the latter being enzyme conjugated. Addition of appropriate substrates allows bound 
antibodies to emit light via the ECL (Enhanced Chemiluminescence) reaction using a 
reagents supplied by Pierce, UK.
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Detection of proteins was carried out as follows: Primary antibody was diluted at 1/1000 
dilution in blocking buffer and incubated with the membrane for 1 hour. Membranes were 
then washed in TBS/Tween-20 (twice for 30 seconds), then twice for 10 minutes. This 
procedure was repeated for secondary antibody. Then the blot was drained and 2 ml of 
substrates A and 2 ml of substrate B (from Pierce) were poured on top of it and left for 2 
minutes. Excess solution was removed, the membrane was wrapped in Saran wrap and 
exposed to X ray film.
2.12 RNA extraction and isolation
RNA was extracted from cells using RNAzol™ B (Biotecx Laboratories, Inc, USA). 
Cells were grown in 75 cm  ^ tissue culture flasks, infected with virus, and hai'vested by 
scraping. Cell pellets were collected by spinning 1100 x g for 5 min. 5 ml RNAzol™ B 
was added with 0.1 ml chloroform to cover the samples, shaken vigorously for 15 
seconds, and then allowed to stand on ice (or at 4°C) for 5 minutes. The suspension was 
centrifuged at 22000 x g (4°C) for 15 minutes. At this stage there were two phases in the 
tube: the lower was the blue phenol-chloroform phase and the upper the colorless aqueous 
phase. The aqueous phase containing the RNA was transfeiTed to a fresh tube and an 
equal volume of isopropanol was added and mixed before standing for 15 minutes at 4°C. 
Samples were centrifuged for 15 minutes at 22000 x g (4°C). RNA foiTns a white-yellow 
pellet at the bottom of the tube. Then the supernatant was removed and the pellet was 
washed with 75% ethanol and centrifuged for 5 minutes at 22000 x g (4°C). The final 
pellet in the tube was dried in a 37°C-heating block and then diethylpyrocarbonate-treated 
water (DEPC) was added to dissolve it.
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2.13 RT-PCR (Reverse transcription-PCR amplification of RNA)
PCR amplification of RNA was done in two stages; the first was making the cDNA using 
reverse transcriptase, followed by PCR amplification to generate DNA.
2.13.1 Reverse transcription (RT) of RNA
Primers were synthesised commercially by Sigma-Genosys, UK (see chapter 5). The RT 
reaction was set up in 0.5 ml sterile RNase-free microfuge tubes. All the additions for 
cDNA synthesis were made on ice. The following were added to the tube:
RNA 7pg
R everse  Primer 2.72 pg
5x 1®* Strand buffer 10 pi
dN T Ps 5 mM 5 pi
RNasin 1 pi
Final 50 pi volume with MQ H2O
The preparation was mixed and 2.5 pi RT (reverse transcriptase) enzyme of moloney 
murine leukaemia reverse transcriptase enzyme (M-MLV RT) (10,000 U/ml) was added 
and incubated at 37°C for 1 hour.
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2.13.2 PCR amplification of cDNA
A typical PCR reaction mix was made by the addition of the following to a 0.5 ml 
microfuge tube:
MQ HgO 60 pi
dNTP 2 mM 10 pi
10x PGR buffer 
(Prom ega) 10 pi
S e n s e  primer 
(2 .5  mM. 1/100  
Diluted)
10 pi
RT product 10 pi
Total volume 100 pi
Taq DNA polymerase (5 U) was then added, the reaction was overlaid with 100 pi of 
liquid paraffin to prevent evaporation. For amplification, the PCR mix was incubated in 
the theiinocycler PCR machine (Techgene™) as follows:
a. 94  °C 5 minutes warm up
b. 94  °C 30 seconds denature
0. 50°C 30 seconds anneal
d. 72°C 2 minutes extend
e . 7 2 “C 10 minutes chain completion step
Cycle was set for 40 times from step b to d.
During the procedure for avoiding contamination all PCR reagents were handled using a 
different set of pipettes.
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2.14 Agarose gel electrophoresis of DNA
DNA was analysed on 1.5% agarose gel prepared by dissolving 0.75 g agar in 5 ml Ix 
TBE and 45 ml MQ H2O. The mixture was boiled to melt and ethidium bromide (EtBr) 
was added to 0.5 pg/ml. The mix was then poured into a flatbed electrophoresis apparatus 
inserting a comb to form wells. When set, the gel comb was removed and the gel tank 
was filled by Ix TBE containing ethidium bromide (0.5 pg/ml). Samples were mixed in 
equal volume with sample buffer (2x TBE containing 20% glycerol and marker dyes; 
bromophenol blue and xylene cyanol) as described in appendix 1 and loaded. The gel was 
electrophoresed at 126 volts for 1 hour. DNA bands were visualised using a UV 
transilluminator (UVItec, UK). The DNA maikers used in our experiments were: 100 bp, 
1 kbp DNA ladder and bacteriophage lambda DNA ladder (all from Promega).
2.15 DNA Gel Extraction
For extraction and purification of DNA we used the QIAquick gel extraction kit. The 
desired band of DNA in gel was removed using a scalpel blade and was weighed in a 
microfuge tube. Three volumes of buffer QG were added for each volume of gel (100 mg 
-100 pi) and incubated at 50°C for 10 min (or until the gel slice was completely 
dissolved) and the colour of the mixture was yellow. One gel volume of isopropanol was 
added to the sample and mixed. The mixture was poured in to a QIAquick column tube, 
and centrifuged for 1 min at 18000 x g to bind DNA. The flow-through was discaided 
and centrifuged for an additional 1 minute at the same speed then QIAquick column was 
placed into a clean 1.5 ml microcentrifuge tube.
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For elution of the DNA 50 pi of buffer EB (10 mM Tris Cl, pH 8.5) was added to the 
centre of the QIAquick membrane and centrifuged for 1 minute at previous speed.
2.16 DNA ligations
DNA ligations were performed using T4 DNA ligase at a ratio of 5:1 insert DNA: vector 
DNA. For ligation of the Ug3 insert (PCR product) to the vector pGEMTeasy the reaction 
was set up as follows:
10x ligase  buffer 1 pi
25%  polyethylene  
glycol (PEG) 1 pi
Vector DNA 10 ng
Insert DNA 50 ng
L igase en zym e 1 pi
MQH 2O To 10 pl
The mix reaction was covered with liquid paraffin. The ligation mix then was kept chilled 
on ice and incubated at 18°C overnight in a water-bath inside cold room.
2.17 Transformation efficiency
For calculating transformation efficiency of E. coli DH5a cells, 5 pi of 10 ng/ml pUC 
DNA was added to 50 pi of E. coli DH5a cells and transformation was performed as was 
explained before. The efficiency was calculated based on the amount of plasmid used in 
the transformation and the number of colonies resulting
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2,18 Transformation of bacteria {E. coli DH5a cells) with plasmid DNA
Agar plates were prepared as described incorporating X-Gal and IPTG. A vial of 
competent bacteria was removed from the liquid nitrogen and thawed on ice. Meanwhile 
reaction tubes were pre-cooled for use when the cells had thawed. 50 p.1 of bacteria were 
transferred to pre-cooled 1.5 ml microfuge tubes and 7 p.1 ligation mix was added and 
mixed gently and left to stand on ice for 30 minutes. The cells were heat-shocked by 
transfer to a 42“C waterbath for 45 seconds and then kept in ice for 5 minutes. 200 pi of 
2x YT medium was then added, mixed gently and incubated at 37°C for 60 minutes. The 
transformation mix was then spread onto 2x YT agar plates described in appendix 1 and 
incubated overnight at 37°C. White colonies were picked and inoculated in 3 ml 2x YT 
medium containing ampicillin (50 pg/ml) overnight and these cultures were used as 
required. X-GAL is a chromogenic substrate for the enzyme beta-galactosidase, yielding 
an intense blue colour. IPTG was used to induce expression across the multiple cloning 
site and into the LacZ alpha peptide encoded on the vector provided. Expression of this 
peptide complements the deleted form of (3-galactosidase (LacZ) caiiied on the bacterial 
chromosome restoring activity of this enzyme. This then reacts with X-Gal and to 
produce a blue colour. Insertion of DNA fragments into the multicloning site (MGS) of 
these vectors usually disrupts the reading frame and thus blocks lacZ alpha peptide 
expression required to complement defective enzyme in these host cells. As a result 
bacterial cells containing recombinant plasmids will be white, those lacking inserted 
DNA will yield blue colonies.
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2.19 Isolation of plasmid DNA from bacterial transformants
2.19.1 DNA purification on silica particles
This method was developed by Carter & Milton (1993) and called alkaline lysis 
diatomaceous earth method: 1.5 ml of an overnight culture of transformed E. coli was 
transferred to a microcentrifuge tube and centrifuged for 30 seconds at high speed (18000 
X  g). After removing the supernatant 200 pi of resuspension buffer was added and mixed 
and then 200 pi of lysis buffer added. The mixture was kept for 1 to 2 minutes in room 
temperature with occasional inverting until the suspension became clear. Then 200 pi 
neutralization buffer was added and a white precipitate formed immediately. The tube 
was centrifuged for 5 minutes at the same speed and the supernatant was removed to a 
fresh microcentrifuge tube and the pellet disc aided. 1 ml of diatom suspension was added 
and allowed to stand at room temperature for 5 minutes with occasional inversion to mix, 
whilst the plasmid DNA bound to the silica. Diatoms were recovered by a brief spun at 
full speed and washed twice using 1 ml of pellet wash solution. Finally the pellet was 
washed in 1 ml of acetone which was removed and the pellet dried at 65°C in a dry heater 
block to remove the acetone. To elute the plasmid DNA, the pellet was re-suspended in 
100 pi of MQ H2O and kept on 65°C for 2 minutes. Finally the tube was centrifuged for 2 
minutes to remove the diatom.
2.19.2 DNA purification by QIAprep spin miniprep
Bacterial cell pellet was resuspend in 250 pi buffer PI (Resuspension buffer) and 
transfeiTed to a microcentrifuge tube; 250 pi buffer P2 (Lysis buffer) was added, mixed 
gently up to 5 minutes then 350 pi buffer N3 (Neutralization buffer) was added and 
centrifuged for 10 minutes at 18000 x g.
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The supernatant was placed to the QIAprep Spin Column and was centrifuged for 50 
seconds. Plow-through was discarded and the column was washed by adding 0.75 ml 
buffer PE (Wash buffer) and centrifuged for 50 seconds. Flow-through was once more 
discarded. The column was centrifuged for an additional 1 minute to remove all residual 
buffer thoroughly and after adding 50 pi EB buffer (Elution buffer; 10 mM Tris-Cl, pH 
8.5) to the centre of each QIAprep spin column, it was placed in a clean 1.5 ml 
microcentrifuge tube, stood at room temperature for 1 minute and then centrifuged again 
for 1 minute to elute the DNA.
2.20 Restriction enzyme digestion
The total reaction volume was adjusted according to the amount of DNA to be digested. 
We used 10 units (1 pi) of restriction enzyme per reaction. Commonly, 5 pg of DNA 
were digested with 1 pi of enzyme in a total reaction volume of 10 pi. In addition the 
reactions mix contained Ipl of appropriate standard restriction enzyme buffer, 1 pi lOx 
BSA and 5 pi MQ H2O. It was then kept at 37°C heat block for 1 hour. This procedure 
was caiiied out according to manufacturer’s instructions.
2.21 Cleaning up DNA
Occasionally, DNA prepaied as above had an unacceptable spectrum (OD 260/280 ratio < 
1.8) or proved insufficiently soluble. On such occasions the DNA was further purified by 
re-extraction using phenol chloroform performed as follows. 1/10 volume lOx TE was 
added and mixed by vortexing.
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One volume phenol/chloroform was added, vortexed for 1 minute and then phases were 
separated by centrifugation for 2 minutes at 18000 x g. The top layer containing DNA 
was transfeiTed into a new microfuge tube. The phenol layer was vortexed again with 
fresh Ix TE and the aqueous layer harvested as above and pooled with the first. Finally, 
the pooled aqueous layers were re-extracted using an equal volume of fresh phenol 
chlorofoiTu before the final aqueous layer was harvested. DNA was then precipitated 
from this layer by the addition of 1/30 volume of 3 M NaOAc and 2.5 volumes of ethanol 
and transfer to -20°C for 1 hour. DNA was recovered by sedimentation for 12 min at 
18000 X  g. The pellet was washed with 70% (v/v) ethanol as above, dried and re­
dissolved in fresh TE buffer. Concentration was checked by running the gel 
electrophoresis using known quantities of lambda DNA as concentration markers.
2.22 RNA transcription in viti'o
For the in vitro transcription of capped mRNA, we used an RNA polymerase SP6-based 
Idt (Cap-Scribe, Roche). The following reagents were added to a sterile microfuge tube 
on ice:
linearized DNA 0.5 pg
Cap Scribe buffer 4 pi
S P 6  polym erase 2 pi
RNAse free water was added to a final 20 pi 
volume then the mixture was put at 37°C for 
2 hours.
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2.23 Further purification of RNA
RNA prepared in vitro still contains the original template DNA and this was required to 
be removed. 1 pi RNase-free DNase was added and incubated at 37°C for 2 hours. 115 
pi DEPC-treated MQ H2O and 15 pi 6 M ammonium acetate were added and mixed. An 
equal volume of phenol/chloroform was then added and vortexed. It was spun for 2 
minutes at 18000 x g and the upper phase was transfeiTed to a clean tube. An equal 
volume of propan-2ol was added and kept in -20°C for 1.5 hours. RNA was recovered by 
sedimentation for 15 min at 4°C with 22000 x g speed. Supernatant was removed using 
glass pipette and pellets were dried in a heating block. Finally 20 pi DEPC-treated MQ 
H2O was added to dissolve the RNA product.
2.24 Determination of RNA and DNA concentrations
RNA and DNA concentration was determined spectroscopically using spectrophotometer 
(Biotech photometer UVllOl, UK) by their absorbance at 260 nm and 280 nm 
respectively. The sample stock was diluted and transfeiTed to the cuvette, and the 
readings at wavelengths of 260 nm and 280 nm was taken. The ratio of OD260/OD280 
was measured to be certain to have pure prépar ations of RNA or DNA (values of 2.0 to 
1.8, respectively). The reading at 260 nm was used for calculation of the concentration of 
RNA or DNA. Assuming that 1 O.D at 260 nm for DNA is 50 ng/pl and for RNA 
molecules is 40 ng/pl. Then, the concentration was calculated using the formula below: 
OD260 X  50 ng/pl (for DNA) or 40 ng/ pi (for RNA) x dilution factor
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2.25 In vitro translation of RNA using rabbit reticulocyte lysate system
Rabbit reticulocyte lysate translation systems (Promega) are used for characterizing 
protein products from RNA transcripts and investigating translational control. The mRNA 
was denatured at 65°C for 3 minutes and immediately cooled in an ice-water bath. (This 
increases the efficiency of translation, especially of GC-rich mRNA, by destroying local 
regions of secondary structure). The following translation reaction was assembled: 
rabbit reticulocyte lysate; 17.5 pi, amino acid mixture minus methionine ImM; 0.5 pi, 
[^ S^] methionine (1,200 Ci/mmol at 10 mCi/ml); 1 pi, RNAsin® ribonuclease inhibitor 40 
U/pl; 0.5 pi, mRNA; 1 pg/5.5 pi water. The lysate was gently mixed by stilling with a 
pipette tip after adding each component was briefly centiifuged to return the sample to the 
bottom of the tube and the mixture immediately was incubated at 30°C for 90 minutes. 
The result was analyzed by using SDS-PAGE analysis to deteimine the size of product.
2.26 RNA Transfection
3.5 cm  ^dishes were seeded until 50% confluent. 12 pi lipofectin (Invitrogen, UK) and 88 
pi OptiMEM (Gibco BRL, UK) were mixed and kept in room temperature for 45 
minutes. After this time, 1 pg RNA was added to OptiMEM up to 100 pi and combined 
with the above mixture and kept at room temperature for 15 minutes. During this time 
cells were washed using OptiMEM. For each dish, 200 pi final mixture and 800 pi 
OptiMEM were added and cells were incubated at 37°C. After 6 hours incubation, all the 
liquid was removed from the dishes and 2 ml fresh growth medium was added before 
cells were replaced in the 37°C incubator.
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2.27 Ludferase assay method using manual luminometer
Cells were rinsed with PBS and then cell lysis buffer (Promega) was added to cover the 
cells at room temperature. For complete lysis a single freeze-thaw cycle was earned out. 
Cells were scraped from the dishes and transfeiTed with all liquid to a microcentrifuge 
tube on ice. The microcentrifuge was vortexed for 10-15 seconds, centrifuged at 18000 x 
g for 15 seconds (at room temperature) and the supernatant was transferred to a new tube. 
For reading luciferase activity, 10 pi of cell lysate was added to a luminometer tube 
containing 100 pi of luciferase assay reagent (Promega) and then read by luminometer 
(Labtec international JADE).
2.28 Anti-Iudferase immunostaining of cells
Cells were fixed in 75% acetone in phosphate buffered saline (at 4°C) for 10 minutes then 
the acetone was removed and the cells were air-dried. Primary antibody [goat anti- 
luciferase antibody (Promega)] was diluted 1/1000 in blocking buffer (as described for 
Western blot analysis), then incubated at 37°C for 1 hour. Cells were then washed 3 
times, each time for 5 minutes in Ix TBS/Tween-20. After this wash, secondary antibody 
[HRP-conjugated polyclonal anti goat (DAKO, UK)] was diluted 1/1000 in blocking 
buffer. Cells were washed 3 times, each time for 5 minutes in Ix TBS/Tween20; then 
washed 2 times briefly with Tris/saline. Meanwhile substrate was prepared: one 30 mg 
4CN (4-chloro-napthol) tablet (Roche) was added to 10 ml ice cold methanol and kept in 
the dark by wrapping the tube in foil. This was then added to 50 ml Tris/saline (10 mM 
Tris pH 7.4, 150 mM NaCl) to which 30 pi hydrogen peroxide 30% (v/v) (BDH) had 
been added.
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Finally this substrate mixture was added to the antibody stained dishes, incubated for 30 
min at 37°C to allow reaction to proceed. Dishes were rinsed with water and examined 
under the microscope. Cells expressing luciferase enzyme were stained with black dots of 
precipitated reaction product and the percentage of stained cells was determined.
2.29 Statistics
Unless indicated otherwise, all data are presented as mean ± SD of at least 3 independent 
experiments. Significance was assessed using Student’s t-test.
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Chapter 3: Mitochondrial inhibition by
viruses
3.1 Introduction
As described in chapter 1, studies have implied that many viruses could interact with 
mitochondria and that such interactions have the potential to interfere with mitochondrial 
function. Potentially significant in this respect is any such effect on mitochondrial 
electron transport. This was felt of potential relevance in the context of persistent virus 
infections and so viruses that persist were of particular" (but not exclusive) interest. 
Several taxonomically distinct viruses were selected on the basis of their properties or 
information currently available. The viruses chosen were:
1. Herpes simplex virus-1 known to induce reanangement of mitochondria and 
decrease in availability of ATP late in infection (Murata et al, 2000). Associated 
with latent (non-replicating) persistent infections in neurones (Roizman & Sears., 
1996).
2. Measles virus known to persist in brain tissue where such a potential effect might 
interfere with neurone function (Schneider-Schaulies et al, 1999), and giving rise 
to the slowly progressive and fatal condition subacute sclerosing panencephalitis 
(SSPE). This condition is associated with persistence resulting from defective 
virus replication; virus proteins are detectable but a full set required for productive 
infection is not present.
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Although the condition progresses to coma and death thought to be due largely to 
neurone destruction, some of the early features might be accounted for by more 
subtle neurone dysfunction rather than destruction (Garg, 2002). This might be 
induced by mitochondrial abnoraiality and thus the possibility deserved 
investigation.
3. Cytomegalovirus known to persist in humans (Jordan et al, 1984) and is 
associated with frequent reactivations shedding infectious virus throughout life.
Further, all these three viruses have also been implicated serologically in chronic fatigue 
syndrome (CFS). This condition is characterised by fatigue and a tendency for muscles to 
move to anaerobic respiration rather more rapidly than normal (Lane et al, 1994). This 
could suggest a defect in mitochondrial function in such a condition. In one study among 
134 patients with fatigue syndrome, fifteen patients were identified who had severe, 
persistent fatigue of undetermined aetiology for more than two months. These 15 patients 
had considerably higher antibody titres against cytomegalovirus, herpes simplex and 
measles viruses (Holmes et al, 1987).
4. The final virus selected for study was Influenza A virus associated with Reyes 
syndrome in combination with aspirin. Reyes syndrome is accompanied by 
mitochondrial dysfunction in the liver although this is not of proven virus origin. 
However recent studies have also identified influenza virus proteins that traffic to 
mitochondria raising the possibility of some direct virus interaction with this 
organelle (Gibbs et al, 2003; Yamada et al, 2004)
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Other viruses that would be of interest for investigation are either non-cultivable 
(Hepatitis B and C viruses), or cannot be handled easily under the laboratory conditions 
available at Surrey University. These viruses could be investigated later using DNA 
expression techniques but this was outside the time envelope of the current study.
3.2 Measles virus (MV)
3.2.1 Morphology, replication and relationship to mitochondria, 
apoptosis and CFS
Measles virus is an extremely contagious agent inducing acute illness. Acute measles is 
characterized by a prodromal illness of fever, coryza, cough, and conjunctivitis, followed 
by the appearance of a typical generalized and maculopapular skin rash (Bedford, 2003). 
Measles belongs to the genus morbillivirus within the family Paramyxoviridae; particles 
are large, pleomorphic and enveloped, enclosing a long helical ribonucleoprotein (figure 
3.1).
___________________________________ .envelopenucleocapsid
Figure 3.1 Electron micrograph (EM) of the measles particle. The 
internal components (nucleocapsid) and the external surface projections 
are evident. Taken and revised from (Nakai & Imagawa, 1969).
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The genome is a nonsegmented single-stranded RNA molecule of negative sense 
approximately 15,000 nucleotides in length, in which the viral genes are aiTanged in a 
linear sequence encoding six proteins: the nucleoprotein (N, 60 kDa), the phosphoprotein 
(P, 70 IcDa), the matrix protein (M, 37 kDa), the haemagglutinin protein (H, 80 kDa), the 
fusion (F) protein [made of two subunits, Fi (40 l<Da) and F2 (20 kDa)], and the RNA 
dependent RNA polymerase termed the large (L) protein (250 kDa) (Bellini et al, 1994) 
(Figure 3.2).
NP protein
HN glycoprotein
F glycoprotein
L protein 
proteinP protein
Figure 3.2 Schematic representation of measles virus structure. The core 
structure of the measles virus (MV) is a ribonucleoprotein particle (RNP), 
consisting of the RNA genome tightly encapsidated by nucleocapsid proteins. 
The viral polymerase complex which consisting of the large protein (L) and the 
phosphoprotein (P) are shown. The RNP and the lipid envelope are linked 
together by the matrix (M) protein. The two viral glycoproteins fusion (F) and 
haemagglutinin (HN) form spikes projecting from the envelope. Taken and 
modified from: Carter & Meulen (1995).
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The viral nucleocapsid (N) protein packages the genomic RNA into a helical protein- 
RNA complex, termed the nucleocapsid. Within the infected cell, the viral polymerase 
uses the nucleocapsid (N-RNA) as a template for transcription of mRNAs encoding the 
viral proteins as well as replication of the viral genome. The viral polymerase has two 
components, the large (L) protein and the phosphoprotein (P). All of the catalytic 
activities associated with the polymerase reside within L (2183 amino acids), which is 
always found complexed with P. The P protein binds the polymerase to the nucleocapsid, 
through its interaction with N-RNA (Horikami & Moyer, 1995; Portner et al, 1988).
Upon exposure of the human host and during adsorption, the H protein recognizes cell- 
surface receptors such as CD46 (Manchester et al, 2000; Dorig et al, 1993) and the F 
protein facilitates fusion with the plasma membrane at physiological pH (Wild et al, 
1991). The nucleocapsid, containing the viral RNA polymerase, is released into the 
cytoplasm. All RNA viruses, with the exception of retroviruses, encode RNA-dependent 
RNA Polymerases (RdRps) which are employed in transcription and/or replication of the 
viral genome (Zanotto et al, 1996). Transcription of the N-encapsidated genome RNA 
(N-RNA) to form separate 5" capped and 3" polyadenylated mRNAs by the virus RdRp is 
the first step in intracellular replication. Viral RdRp begins all RNA synthesis at the 3' 
end of the genome and proceeds without termination along the entire genome. These 
mRNAs are translated into the viral proteins necessary for replication. Intracellular 
accumulation of N protein induces a switch from transcription of separate mRNAs to 
replication of the full-length genome. This associates with the N and P proteins to form 
new nucleocapsids.
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Viral mRNA is also translated into membrane glycoproteins that are transported to the 
cell plasma membrane and become clustered on the cell surface, underlain by a layer of 
virus matrix protein that brings them together and excludes host proteins laterally through 
the membrane. In the final step, the nucleocapsid buds out through these modified regions 
of plasma membrane and enveloped virus is released (Review in Rail, 2003).
Measles virus can induce apoptosis in infected cells (Table 3.1). This might well proceed 
by mitochondrial interaction. Furthermore a possible connection between MV and 
chronic fatigue syndrome has been reported (Holmes et al, 1987).
Table 3.1 Some reported effects of MV on apoptosis
Function Cell/tissue Reference
Induces apoptosis by Caspase 
activation T cells (Vuorlnen etal., 2003)
Induces Fas-medlated apoptosis Human dendritic cell (Servet-Delprat et al., 2000)
Induces apoptosis
Human central 
nervous system 
tissues
(McQuald S, 1997)
Induces apoptosis Human monocytic cell line (THP)-I (Ito etal., 1996)
Induces apoptosis Thymocyte of the SCID-hu mouse (Auwaerter etal., 1996)
Induces apoptosis
Vero cells and 
monocytic cell 
lines
(Esolen etal., 1995)
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3.2.2 Effect of measles virus on mitochondrial respiration
The effect of measles vims (Edmonston strain, kindly provided by Professor V ter 
Meulen University of Wurzburg) on cellulai* respiration was investigated by measuring 
total cellular oxygen consumption of infected and mock-infected HeLa cells using an 
oxygen electrode (OE). First, it was necessary to show that the response of the oxygen 
electrode is linear over the range used. For this purpose, we assessed oxygen consumption 
as a function of cell number using HeLa cells. The cells were processed as described, but 
re-suspended at different cell densities before introduction to the chamber and 
detennination of O2 consumption. The results are shown in figure 3.3. Oxygen 
consumption was observed to increase linearly with cell number.
45 ■ 
40 ■
0 0.5 1.51 2 2.5
Cells X 10^
Figure 3.3 Validation of the method: Total cellular respiration is directly 
proportional to the numbers of cells. HeLa cells were grown in MEM 
supplemented with 10% foetal bovine serum (FBS), Ix non-essential amino 
acid, 1 % penicillin/streptomycin and were incubated in humidified incubator 
with 5% CO2 in air at 37°C until confluent. Cells were detached using a 
scraper and counted. The desired numbers of cells were transferred to the 
OE chamber for OC measurement. Graph represents one experiment.
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Before measuring the respiration rate, it was essential to understand the time at which 
infection induced cell death. This is to rule out any effect on oxygen consumption due 
simply to a reduction in the number of viable cells rather than indicative of any specific 
effect of the virus on mitochondria. We therefore monitored the onset of cytopathic effect 
following infection at the same multiplicity as that to be used in the oxygen electrode 
experiment. Cultures were assessed visually for the appearance of cytopathic effect 
(CPE). Typical MV-induced CPE consists of cell fusion yielding syncytia that are shown 
in figure 3.4. The CPE changes commenced after 60 hours post infection and 
considerable CPE appeared after 3 days post infection under these conditions.
MV mock-infected HeLa cells MV infected HeLa cells
Figure 3.4 Mock-infected (A) and MV infected HeLa cells (B). Confluent monolayer of 
HeLa cells was infected with measles virus at a multiplicity o f 10 pfWcell and was then 
incubated in MEM supplemented with 2% FBS, Ix non-essential amino acid and 1% 
penicillin/streptomycin at 37°C, in a humidified atmosphere o f 5% CO2 in air. Considerable 
CPE changes were appeared after 3 days post infection. Large syncytia are shown (Arrow).
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The respiratory rate was measured after 6 , 12, 24 and 48 hours post measles virus 
infection, times when no CPE was evident in the cultures. Data were analysed as 
described and are presented in figure 3.5. Basal respiration in mock-infected and infected 
HeLa cells was not significantly different. We therefore concluded that measles virus 
infection has no effect on total cellular respiration (TCR) measurable in this way.
(j01Ic
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Figure 3.5 Measles virus infection does not result in changes in TCR. Cells 
were grown up to near confluence as we described under materials and 
methods. Then the cells were infected with MV (10 pfu/cell titrated in VERO 
cells) and allowed to adsorb for 1 hour at room temperature with gentle rocking. 
Inocula were replaced with MEM (2% FBS) and incubated for the desired time 
periods (6 h, 12 h, 24 h, 48 h) At each time point infected and control cell 
sheets were detached gently from the flasks using a scraper, resuspended in 0.4 
ml PBS and transferred into the OE chamber. The rate of oxygen consumption 
was measured as explained in chapter 2. Graph depicts a typical result from one 
experiment.
72
Mitochondrial inhibition by viruses Chapter 3
3.3 Cytomegalovirus (HHV-5)
3.3.1 Morphology, replication and its relationship to mitochondria, 
apoptosis and CFS
Human Cytomegalovirus (HMCV) now called human herpesvirus 5 (HHV-5) belongs to 
the family herpesviridae in the subfamiliy of betaherpesvirinae. It has the largest genome 
in the family with a complete genome sequence of -230 kbp, and like all herpesviruses, 
establishes latent infections in the host. Unlike alphaherpesviruses reactivation are 
common (Streblow & Nelson, 2003). Particles of HCMV show a typical herpes virus 
structure, the virion consisting of a core containing a linear double-stranded DNA, 
contained within an icosahedral capsid approximately 1 0 0  to 1 1 0  nm in diameter 
containing 162 capsomeres. Around the capsid is found an amorphous and 
asymmetrically-distributed proteinaceous material called tegument. This in turn is 
surrounded by the virus membrane within which viral glycoprotein spikes are embedded 
(Figure 3.6).
Viral g ly co p ro te in s
N ucleocapsid
Enveipe
N uc leo cap sidDNA ^
T egum en t T egum en t
Figure 3.6 Schematic representation (A) and electron micrograph of HCMV (B). The virion is 
formed of glycoproteins, envelope, a tegument layer, and an icosahedral capsid enclosing a 
dsDNA genome. EM picture taken and modified from: 
http://www.clinical-virology.org/gallery/images/em/CMV, 11.01.06
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This virus is found commonly throughout all geographic locations and socio-economic 
groups and usually causes mild or sub-clinical disease in immunocompetent adults 
(Pomeroy & Englund, 1987). Illness when it does occur in otherwise healthy persons may 
be similar to that seen in infectious mononucleosis (Epstein-BaiT virus) with fatigue as a 
prime symptom. However, CMV may cause severe morbidity or mortality in neonates or 
the immunocompromised (Cunningham & Margolis, 1998). During pregnancy, primary 
CMV infection causes a 30% to 40% risk of intrauterine transmission (Stagno et ah, 
1986).
Although HCMV has been shown to infect a broad spectrum of cells in vivo the only cells 
that are suitable for HCMV replication in vitro are human fibroblasts (Sinzger et at., 
1995). The lytic replication cycle of HCMV is initiated when the virus binds to the host 
cell receptor. The receptor for HCMV is found on the surface of fibroblasts (Adlish et ah, 
1990). After entering the cell, the viral DNA is introduced to the nucleus and viral gene 
expression occurs. The expression of immediate early (IE) genes is the main step for 
replication process (Fortunato et al., 2000). The replication steps are similar to replication 
of human herpes virus (HHV-1) that was described in chapter 1.
Many studies have shown the effects of the virus on apoptosis, some of these are 
summarized in table 3.2.
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Table 3.2 Some reports of HCMV modulation of apoptosis
Function Cell/tissue Reference
IE1 (immediate early 1) and IE2 
(immediate early 2) proteins of CMV 
block apoptosis
Fibroblast (Zhu et al., 1995)
mitochondria-iocaiized inhibitor of 
apoptosis (vMiA, a product of the 
viral Ul37 gene) inhibits Fas 
mediated apoptosis
Human MRC-5 
fibroblast
(Goidmacher V.S, 
1999)
viCA, encoded by the viral Ul36 
gene inhibits Fas-mediated 
apoptosis by binding to the pro­
domain of caspase-8 and preventing 
its activation
Human MRC-5 
fibroblast (Skaletskaya et al., 2001)
Fas mediated apoptosis T cell (Yoshida etal., 1995)
Fas-mediated apoptosis
Haematopoietic 
progenitor ceils 
in bone marrow 
of mice
(Mori etal., 1997)
induction of apoptosis Astrocyte (Lokensgard et al., 1999)
induction of apoptosis
Myeloid 
progenitor ceil 
line M07e
(Sindre et al., 2000)
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The coiTelation between HCMV and CFS is still debated. In one study EBV DNA was 
detected in the peripheral-blood lymphocyte by PCR samples taken from CFS patients, 
but HCMV DNA was not detected (Wallace et al., 1999). However, in a second study 
levels of HCMV IgG were elevated in a subset of 16 patients with CFS (Lemer et al., 
2002). Cytomegalovirus (CMV) was repeatedly cultured from a patient with chronic 
fatigue syndrome (Martin et al, 1994). However, detection of virus DNA, antibody or 
even virus itself may be of little significance for such a common and frequently 
reactivating persistent virus unless other factors firmly link these events to the occurrence 
of CFS.
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3.3.2 Effect of human cytomegalovirus on mitochondrial respiration
Human cytomegalovirus strain Ad 169 was kindly provided by Professor A.C. Minson 
(University of Cambridge). Before measuring the respiratory rate, it was essential both to 
demonstrate that oxygen consumption was linear over the cell concentrations to be used 
and also that determination was earned out before the onset of virus-induced cell 
destruction. As described for MV, we assessed oxygen consumption as a function of cell 
number using MRC-5 cells. Firstly, oxygen consumption was found to increase linearly 
with cell number confirming the validity of the conditions chosen (Figure 3.7). However 
the basal rate of oxygen consumption of MRC-5 cells (5 nmolOa/min/lO^ cells) was 
appreciably lower than that of HeLa cells (25 nmolOi/min/lO^ cells), which will make 
identification of subtle effects more difficult.
25 -
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Figure 3.7 Validation of the method: Total cellulai* respiration is directly 
proportional to the numbers of cells. MRC-5 cells were grown in MEM 
supplemented with 10% foetal bovine serum (FBS), Ix non-essential 
amino acid, 1 % penicillin/streptomycin and were incubated in humidified 
incubator with 5% CO2 in air at 37°C until confluent. Cells were detached 
using scraper and were counted. The indicated numbers of cells were 
transferred to the OE chamber for OC measurement. Graph represents one 
experiment.
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Secondly, the CPE developed after 4 days, significant changes being visible at 5 days post 
infection (Figure 3.8). The characteristic cytopathic effects of HCMV infection include 
swollen cells and formation of nuclear inclusions (Lamarea et a i,  2004).
HCMV Mock-infected MRC-5 cells HCMV infected MRC-5 cells
CPE
Figure 3.8 HCMV mock-infected (A) and HCMV infected MRC-5 cells (B). Confluent 
monolayer o f MRC-5 cells was infected with HCMVat a multiplicity o f 15 pfu/cell and was 
then incubated in MEM supplemented with 2% FBS, Ix non-essential amino acid and 1% 
penicillin/streptomycin at 37°C, in a humidified atmosphere o f 5% CO2 in air. After 5 days 
post infection considerable CPE changes were observed (Arrow).
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Finally the effect of HCMV on cellular respiration was investigated by measuring total 
cellular oxygen consumption at 24, 48 and 72 hour post infection, taking into account the 
slower growth of this virus compared with measles. No difference was identified by this 
approach (Figure 3.9): oxygen consumption by infected cells was not appreciably 
different from that of uninfected cells. We therefore concluded that HCMV induces no 
considerable inhibition in mitochondrial respiratory chain measurable by this method.
IoEs
15
10
24h 48h
time
72h
Figure 3.9 Human cytomegalovirus infection does not decrease total cell respiration. 
Cells were grown to confluence and were infected with HCMV (15 pfu/cell titrated in 
MRC-5 cells). Adsorption was allowed to continue for Ihour. After which time the 
inoculum was removed, fresh medium was added and incubation was continued for 
the times indicated. At each time point post infection cells were detached gently from 
the flasks using a scraper, re-suspended in PBS and transferred into the OE chamber. 
Oxygen consumption rate was measured. No considerable changes in oxygen 
consumption rate were observed in infected cells in comparison to mock-infected 
cells. Graph depicts a typical result from one experiment.
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3.4 Influenza virus (IV)
3.4.1 Morphology, replication and its relationship to mitochondria, 
apoptosis and CFS
One of the most frequent causes of acute respiratory infection is influenza which causes 
an acute febrile illness associated with myalgia, headache, and cough. The average 
duration of fever is three days, but cough and malaise often persist for 1-2 weeks (Monto 
et ah, 2000). It is responsible for dramatic pandemics (Cox & Subbarao, 2000), affects all 
age groups and re-infections are common owing to the antigenic variability of this virus 
(Shaw et ah, 1992). Influenza virus belongs to the family orthomyxoviridae (from the 
Greek myxo, meaning 'mucus'). There aie three types of influenza viruses (A, B, and C) 
that aie distinguished by the absence of serologic cross-reactivity between their internal 
proteins (Young & Palese, 1979; Lamb & Choppin, 1983). Two different antigens, the 
nucleoprotein (NP) and the matrix protein (M) are important for this differentiation 
(Figure 3.10). Type A is found in a wide variety of warm-blooded animals (birds and 
mammals). Influenza viruses are further classified into subtypes based on antigenic 
differences of their glycoproteins; the haemagglutinin (HA) and the neuraminidase (NA). 
There are 15 subtypes of influenza A virus (HI-HI 5); all of which are found in avian 
species. Types B and C are mainly human pathogens. Influenza viruses possess a 
negative-stranded, segmented RNA genome that genomes of influenza A and B viruses 
code for at least 10 proteins and the C virus codes for eight. Each RNA segment is 
encapsidated by the NP to form a ribonucleoprotein (RNP) complex. The RNPs are 
suiTOunded by a shell of M (Ml), which is enveloped by a lipid bilayer derived from the 
host cell upon budding through the cell membrane.
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Two surface glycoproteins: the rod-shaped HA and the mushroom-shaped NA are 
embedded in the membrane. A third integral membrane protein is the ion channel formed 
by the M2 protein in influenza A viruses formed by splicing the mRNA for Ml 
(Reviewed in Steinhauer & Skehel, 2002).
NS2
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5 k lû i ig S B I.iù ie j l l  •UIMIUMr I
8 RNA
Figure 3.10 Schematic representation (A) and electron micrograph (B) of influenza virus. The 
virion bears the hemagglutinin (HA) and the neuraminidase (NA) spikes on its surface that 
protrude from the lipid bilayer. The matrix protein (Ml) underlies the lipid bilayer. The ion 
channel (M2), the nucleocapsid (NP) and the non-structural proteins 2 (NS2) are shown. 
The virus genome consists of 8  RNA molecules each of which is complexed as a separate 
ribonucleocapsid within the particle. Figures taken and modified from:
A; http://zhuang.harvard.edu/CellularEntry/Figure%201.jpg, 11.01.06 
B; http://www.ncbi.nlm.nih.gOv/ICTVdb/Images/Ackerman/Animalvi/Orthomyx, 11.01.06
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The pathogenesis of influenza virus infection involves virus replication in epithelial cells 
of the respiratory tract and the degeneration of infected cells: The influenza virus attaches 
to its host cell by means of its haemagglutinin molecule which binds to sialic acid on the 
host cell (Weis et al, 1988). The virus subsequently enters by endocytoses and in the 
acidic environment of the endosomes, the virus HA undergoes conformational change, 
activating a membrane fusion activity and permitting the viral envelope to fuse with the 
endosomal membrane, which is resulted in releasing of the virus nucleocapsid into the 
host cytoplasm (Yoshimura & Ohnishi, 1984). From there, the nucleocapsid travels to the 
host nucleus. In the host nucleus, primary transcription commences to produce proteins 
necessary for replication. In influenza A and B, ten proteins are produced from the 
translation of the genome, including haemagglutinin, neuraminidase, PA, FBI, PB2, 
nucleoprotein, two matrix proteins, and two non-structural proteins (NS). After making 
sufficient proteins, complementary positive sense template RNAs are made from the 
negative sense RNA segments (Shapiro & Krug, 1988). From these cRNAs, negative 
sense progeny genomic RNA is produced and incorporated into new RNP structures. 
Glycosylation, acylation and multimerisation of the haemagglutinin and neuraminidase 
occur as the glycoproteins are manufactured in the rough endoplasmic reticulum and 
traffic to the cell surface. The haemagglutinin, neuraminidase, and the matrix protein 2 
(M2) travel together to the plasma membrane, combine with the other matrix protein 1 
(Ml) and begin the budding process that is an active ATP-dependent process (Hui & 
Nayak, 2001). At least eight RNA segments come to the site and the virus buds. The 
neuraminidase destroys the sialic acid receptors on the membrane of the infected cell, 
thus allowing the viruses to disperse as they leave the cell (for review see Steinhauer & 
Skehel, 2002).
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Many studies have suggested that influenza virus might frequently modulate apoptosis. 
Table 3.3 shows some examples of these reports. The relationship between influenza 
virus infection and CFS has not yet been investigated.
Table 3.3 Some reports of the effect of influenza virus on modulating apoptosis
Function Cell/tissue References
Influenza A virus Induces 
apoptosis
Bronchioiar epithelial 
ceiis (NCI-H292) (Brydon et ai., 2003)
influenza virus induces 
tumour ceiis apoptosis in 
vitro by 
the increased expression of 
FasL.
Heia, Raji, 
SMMC-7721 and SPC-A- 
1
(Li et al., 2003)
influenza virus induces 
Apoptosis in cultured
Human fetal membrane 
cells (Uchide et al., 2002)
the interferon antagonistic 
NS1 protein of influenza A 
viruses has IFN-dependent 
antiapoptotic potential
MDCK cell (Zhirnov et ai., 2002)
The expression of the non- 
structural (NS) gene of 
influenza A virus induces 
apoptosis
MDCK and HeLa cell (Schultz-Cherry et ai., 2001)
influenza A virus induces 
apoptosis Human lymphocyte (Nichois et al., 2001)
Neuraminidase of influenza 
A virus-has a role in 
inducing apoptosis
MDCK cell (Morris et al., 1999)
Influenza C viruses induces 
apoptosis MDCK cell (Hechtfischer ef al., 1997)
influenza A virus induces 
apoptosis in vivo
bronchial/bronchiolar 
epithelial cell (Mori et al., 1995)
influenza A and B viruses 
induce apoptosis MDCK cell (Hinshaw et ai., 1994)
influenza virus infection 
causes Fas mediated 
apoptosis
MDCK cell and HeLa 
cell (Takizawa et ai., 1993)
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3.4.2 Effect of Influenza virus on mitochondrial respiration
Influenza virus strain A/Puerto Rico/8/34 was kindly provided by Dr P Digard 
(University of Cambridge). Validation of the method with MDCK cells (Figure 3.11) 
showed that oxygen consumption increased linearly with cell number. The oxygen 
requirement of MDCK (9 nmolO2/min/1 0  ^ cells) was observed to be lower than that of 
HeLa cells (25 nmolO2/min/1 0 ‘^ cells), although higher than MRC5 cells (5 
nmolO2/min/1 0 *^ cells).
20 ■ 
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Figure 3.11 Validation of the method: Total cellular respiration was directly 
proportional to the numbers of cells. MDCK cells were grown in MEM 
supplemented with 10% foetal bovine serum (FBS), 1% non-essential amino acid, 
1% penicillin/streptomycin and were incubated in humidified incubator with 5% 
CO2 in air at 37°C until confluent. Cells were detached using a scraper, counted and 
desii'ed numbers of cells were transferred to the OE chamber for OC measurement. 
Graph represents one experiment.
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In our study CPE changes were first observed at 18 hours post infection and considerable 
CPE occurred after 24 hpi. The typical CPE changes included rounded refractive and 
detached cells figure 3.12.
IV mock-infected MDCK cells IV infected MDCK cells
CPE
Figure 3.12 Mock-infected (A) and IV infected MDCK cells (B). Confluent monolayer of 
MDCK cells was infected with IV at multiplicity of 10 ID50/cell and was then incubated in 
MEM supplemented with 2% FBS, Ix non-essential amino acid and 1% penicillin/streptomycin 
at 37°C, in a humidified atmosphere of 5% CO2 in air. CPE changes were observed after 18 hpi 
and considerable CPE observed after 24 hpi (Arrow).
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Finally the effect of IV on cellular respiration was investigated by measuring total cellular 
oxygen consumption of the cells using oxygen electrode. Respiration was measured at 6  
and 12 hours post infection (Figure 3.13). As seen the oxygen consumption decreased 
after infection. This decrease was calculated to be 30% after 6  hpi and 45% after 12 hours 
post infection in comparison with controls.
Figure 3.13 Influenza virus infection decreases TCR. Cells were grown to 
confluence and infected with IV (10 ID50/cell titrated in MDCK cells). At each 
time ( 6  h, 1 2  h) cells were detached gently from the flasks using a scraper, re­
suspended in PBS and transferred into the OE chamber. Oxygen consumption rate 
was measured. Significant changes in oxygen consumption rate were observed in 
infected cells in comparison to mock-infected cells. Asterisks indicate samples with 
significant divergence from control values; * (P<0.05), ** (p< 0.01). The error bars 
represent the standard deviation from the mean. Graph represents the combined data 
from three independent experiments.
86
Mitochondrial inhibition by viruses Chapter 3
3.5 Human herpes virus type 1 (HHV-1)
3.5.1 Morphology, replication and its relationship to mitochondria, 
apoptosis and CFS
Human herpes virus 1 (HHV-1) is a large, enveloped DNA virus and its genome contains 
at least 84 different genes (Roizman, 1996). Its structure and replication was discussed in 
detail in chapter 1. It has been shown that HHV-1 modulates apoptosis via many different 
mechanisms. This effect has been revealed by several studies, and we have summarized 
some of them in table 3.4. HHV-1 is a ubiquitous virus that often establishes latent 
infections. One study found that in fifteen patients who had severe persistent fatigue of 
undeteraiined etiology for more than two months, antibody titres against various 
components of EBV, cytomegalovirus, herpes simplex virus and measles viruses were 
significantly higher than control cases (Holmes et al, 1987). Despite this observation a 
role for HHV-1 in the aetiology of CFS remains controversial (Glaser & Kiecolt-Glaser, 
1998).
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Table 3.4 Some reported effects of HHV-1 on modulating apoptosis:
Function Cell/tissue Reference
Oncolytic herpes simplex virus-1 
induces apoptosis in neighbouring 
human cancer ceils
OCUM human 
gastric cancer 
ceil
(Stanziaie et al., 
2004)
Us3 protein kinase of herpes 
simplex virus 1 blocks apoptosis 
by phosporyiation of the Bcl-2 
family member Bad
HEp-2 ceil (Cartier et al., 2003)
Herpes simplex virus 1 mutants 
lacking glycoprotein D induces 
apoptosis
SK-N-SH, HEp-2, 
HeLa, and Vero 
cells
(Zhou & Roizman, 
2002)
gD and gJ of herpes simplex virus 
play a key role in blocking the 
apoptotic cascade leading to ceil 
death
SK-N-SH, HEp-2 
and Vero cells (Zhou et a!., 2000)
Wild-type herpes simplex virus 1 
blocks programmed ceil death and 
release of cytochrome c
HEL fibroblast ceil (Zhou & Roizman, 
2000)
Bcl-2 blocks a caspase-dependent 
pathway of apoptosis activated by 
herpes simplex virus 1 infection
HEp-2 ceil (Galvan et a!., 2000)
The protein kinase encoded by the 
US3 gene as the principal viral 
product is required to block 
apoptosis
Vero, HEp-2, and 
BHK cells (Leopardi et a!., 1997)
HSV-1 infection leads to apoptosis differentiated ND7 neuron-iike ceil
(Gautier et a!., 
2003)
HSV-1 infection induces apoptosis mice eyes and brain ceiis
(Qian & Atherton, 
2003)
HSV-1 induces apoptosis
peripheral 
blood 
mononuclear ceil
(Tropea etal., 
1995)
HSV-1 induces apoptosis hepatocyte (Koyama & Adachi, 1997)
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3.5.2 Effect of human herpes virus 1 on mitochondrial respiration
HHV-1 strain HFEM was kindly provided by Professor A. C M inson (University o f  
Cambridge). In our hands w e found replication o f  this strain to be slower than reports in 
the literature: CPE (cell rounding and clumping; cell fusion; syncytia cells) began after 2 
days and was considerable after 3 days post infection (Figure 3.14).
HHV-1 Mock-infected Heia cells HHV-1 Infected Heia cells
m u m i
/
C PE
B
Figure 3.14 Mock-infected (A) and HHV-1 infected HeLa cells with CPE changes post 
infection (B). Confluent monolayer of HeLa cells was infected with HHV-1 at multiplicity of 
10 pfu/cell and was then incubated in MEM supplemented with 2% FBS, Ix non-essential 
amino acid and 1% penicillin/streptomycin at 37°C, in a humidified atmosphere of 5% CO2 in 
air. After 3 days CPE changes were observed (Arrow).
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The effect of HHV-1 on cellular respiration was investigated by measuring total cellular 
oxygen at 0, 6 , 12 and 24 hours post infection as shown in figure 3.15. Oxygen 
consumption rates were decreased by 31% at 6  hpi, 54% at 12 hpi and 60% at 18 hpi in 
comparison to mock-infected cells at the same times. This inhibition of host cell 
respiration occurred well before the changes in cell morphology and cytopathic effect of 
the virus.
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Figure 3.15 Graph presents oxygen consumption rate in each time points in HHV-1 
mock infected and infected HeLa cells. Cells were grown to confluence as described 
under materials and methods, and infected with HHV-1 (10 pfu/cell titrated in HeLa 
cells). After 1 hour gentle rocking for adsorption of virus in room temperature, cells 
were incubated with 10% MEM for the desired periods. At each time point, cells were 
detached gently from the flasks using a scraper, re-suspended in PBS and transferred 
to the OE chamber. Oxygen consumption rate was measured. As shown, HHV-1 
infection leads to significant decrease in total cell respiration. Asterisks indicate 
samples with significant divergence from control values; ** (p< 0 .0 1 ); *** (p<0 .0 0 1 ). 
The error bars represent two standard deviations from the mean. Graph represents the 
combined data from three experiments.
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Chapter 4: Analysis of mitochondrial electron 
transport during HHV-1 infection
4.1 Introduction
Oxidative phosphorylation and the electron transport chain were described in detail in 
chapter 1. Electron transport may be analysed in permeabilised cells using specific 
electron donors to supply electrons directly to the different complexes of the chain. In this 
way a blockage can be located since it will prevent the flow to oxygen from donors 
upstream of any block, but will not prevent such flow from donors situated downstream 
of any block. For this purpose we have used the substrates and inhibitors as described in 
table 4.1.
Table 4.1 Substrates and inhibitors of respiratory chain used in our study.
Substrate/
inhibitor Function
Pyruvate / Malate Donate electrons Into complex I
Rotenone
Blocks NADH dehydrogenase (complex 1) and 
prevents flow for Cl- Oil. It has no effect on activity of 
Ciior Gill
Succinate An electron donor for complex II
Antimycin A
Blocks the respiratory chain between Oil and GUI by 
preventing transfer from cytochrome b and 
cytochrome c
TMPD
TMPD is tetramethyl phenyiene diamine, an artificial 
electron carrier which is readily reduced by 
ascorbate, and oxidised by cytochrome c, assists the 
transfer of electrons from ascorbate to cytochrome c.
NaNa Sodium azide is a cytochrome oxidase (complex IV) inhibitor, which is an inhibitor of terminal oxidation.
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4.2 The effect of antimycin A on cellular respiration
Before investigating the mitochondrial respiratory chain activity, we had to be confident 
that nearly all or most of the oxygen consumption measured in whole cells was related to 
mitochondria. To determine this, we used antimycin A (AA) that is an inhibitor of 
complex III to block mitochondrial oxygen consumption. After addition of antimycin A 
cellular respiration was completely blocked indicating that essentially all of the cellular 
consumption of oxygen measured was related to mitochondria (Figure 4.1).
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Figure 4.1 Total cellular O2 consumption was blocked after addition of antimycin A. 
HeLa cells were transferred into the chamber of a Clark-type oxygen electrode and 
TCR was monitored before and after the addition of antimycin A (AA) (3 |0.g/ml). As 
shown in each case there is a block in oxygen consumption after addition of AA 
which indicates that mitochondrial respiration accounts for most of cellular' O2 
consumption. A slight elevation in the trace is sometimes visible after antimycin A 
addition if respiration is blocked, this is most obvious when oxygen has already 
reached low levels in the chamber. This was attributed to small amounts of oxygen 
entering through the capillary hole in the plunger that seals the chamber. Such influx 
is not usually visible unless oxygen levels in the chamber are depleted. Graphs show 
tlnee independent experiments.
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4.3 Effect of HHV-1 infection on respiratory chain activity
During electron transport within mitochondria, electrons flow from NADH to oxygen via 
respiratory chain complexes. The mitochondrial respiratory chain comprises complexes I 
(NADH ubiquinone reductase), complex II (succinate-ubiquinone reductase), complex III 
(ubiquinol cytochrome coxidoreductase), complex IV (cytochrome c oxidase) and 
complex V (ATP synthase). The effect of HHV-1 infection on the mitochondrial 
respiration was examined in HeLa cells (permeabilised with digitonin) using the 
respiratory chain substrates and inhibitors described above. This property of digitonin 
(selectivity of glycoside for cholesterol) has resulted in its use as an agent to peimeablize 
the plasma membrane rather than the mitochondrial membrane. Digitonin is a plant 
glycoalkaloid saponin detergent obtained from Digitalis purpurea. It foims complexes 
with cholesterol and so permeabilises membranes rich in this component. Since the cell 
plasma membrane contains more cholesterol than the mitochondrial membrane both 
digitonin and saponin have been widely used to render the plasma membrane permeable 
to reagents normally excluded, but to preserve the integrity of mitochondria (Severs & 
Robenek, 1983; Akiyama er aZ., 1980).
Metabolic supplements and inhibitors (Table 4.1) were added to the chamber and the 
oxygen consumption rate was measured. As seen in figures 4.2 and 4.3, mitochondrial 
oxygen consumption was monitored following the addition of pyruvate plus malate 
(P/M), rotenone (Rot), succinate (Sue), antimycin A (AA), TMPD plus ascorbate (T/A) 
and NaNs. Six independent experiments were performed to examine any changes in 
oxygen consumption at 1 2  hours post infection.
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In each case the oxygen consumption patterns were the same. The rate of oxygen 
consumption in control and infected cells was the same after addition of pyruvate (5 mM) 
plus malate (P/M) (5 mM). We never observed any noticeable stimulation of respiration 
even after addition of increased amounts of P/M. This may be due to the presence of 
excess electron donors to this complex in the cells themselves. In agreement with this 
statement, the addition of rotenone (3 pg/ml) always led to a decrease in oxygen 
consumption in both infected and uninfected cells thus suggesting that complex I was 
nevertheless functioning even though we could not stimulate its activity above 
background. Analysis of complex II showed a large stimulation of oxygen consumption 
in all control cells experiments following addition of succinate. This was subsequently 
blocked by antimycin A (3 pg/ml) confirming that it arose by electron flow from complex 
II. In contrast, the ability of succinate to stimulate O2 consumption in HHV-1 infected 
cells was greatly diminished. This suggests that electrons added at complex II cannot flow 
to complex III after HHV-1 infection. The next step was to investigate the electron flow 
from cytochrome c to complex IV, TMPD (5 mM)/ascorbate (5 mM) were used for this 
purpose; TMPD is an artificial redox mediator that assists the transfer of electrons from 
ascorbate to cytochrome c. As shown in the graphs (Figures 4,2 and 4.3) the oxygen 
consumption was almost fully restored in infected and mock-infected cells. This indicates 
that the transport of electrons from cytochrome c to complex IV occurred. Finally we 
investigated the effect of sodium azide (NaNg) (5 mM) that is a cytochrome oxidase 
(complex IV) inhibitor. We observed that in all cases (infected and control) NaN] 
completely blocked the respiration (Figure 4,2 and 4.3). These data show that HHV-1 
infection leads to a severe decrease in cell respiration as an outcome of a block in electron 
transport at complex II.
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Figure 4.2 Effect of substrates and inhibitors on respiratory chain activity of HHV-1 
mock infected (control) cells: cells were grown up to confluent monolayer, scraped, 
and transferred into the chamber of the Clark-type oxygen elechode. Cells then were 
permeabilised by addition of digitonin. Oxygen consumption rate was measured by 
addition of substrates and inhibitors subsequently as explained in the text. The three 
graphs are derived from independent experiments.
The legends:
DIG, Digitonin 
P/M, Malate-fpyruvate,
ROT, Rotenone, 
s u e ,  Succinate,
AA, Antimycin,
T/A, TMPD(N,N,N’ ,N ' -tetramethyl-l,4-phenylenediamine )/ascorbate 
NaNs, Sdium azide
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Figure 4.3 Effect of HHV-1 infection on respiratory chain activity of infected cells: 
cells were grown up to confluent monolayer and infected with viruses ( 1 0  pfu/cell 
titrated in HeLa cells). After 12-hour post infection cells were scraped, washed 
twice with respiration buffer and permeabilised by the addition of digitonin. Oxygen 
consumption rate was measured by addition of substrates and inhibitors 
subsequently as explained in the text. The three graphs are derived from 
independent experiments.
The legends:
DIG, Digitonin 
P/M, Malate+pyruvate,
ROT, Rotenone, 
sue , Succinate,
AA, Antimycin,
T/A, TMPD(N,N,N’,N‘-tetramethyl-l,4-phenylenediamine )/ascorbate 
NaN], Sdium azide
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Chapter 5: Effect of Us3 protein kinase on 
mitochondrial respiration
5.1 Introduction
We have shown that HHV-1 infection has a significant effect on mitochondrial function 
in infected cells and leads to a decrease in total cellular respiration. Later study revealed 
that this inhibition was at complex O/III of the respiratory chain. It seemed plausible that 
these effects were mediated by virus proteins, but HHV-1 is a complex virus and 
identification of candidate proteins requires a consideration of HHV-1 molecular biology 
in order to relate gene expression to the time of the event and a review of cunent 
knowledge of candidate proteins. Likely proteins could then be assessed by measuring 
their effect on mitochondrial activity (oxygen consumption) in transfected cells.
5.2 Molecular biology of HHV-1
The general features of HHV-1 aie described in chapter 1. Here we consider the genome 
and regulation of gene expression. The genome of the virus is 152 kbp linear double­
stranded DNA and is divided into long and short regions of unique coding sequences, 
termed Ul and Us. These are bordered by regions of inverted repeats, termed internal 
repeats, and are specified by the symbols a, b and c in figure 5.1 (Roizman, 1996).
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ab b'a __ ca
Figure 5.1 Schematic representation of sequence arrangement in HHV-1 DNA and 
distribution of viral genes in the HHV-1 genome. The filled quadrangles represent 
terminal sequences a, b and c inverted and repeated internally to yield b’c ’a’ combined 
in the order above. Ul and Us represent unique coding regions of DNA and which can 
occur in either orientation. Taken from (Roizman, 1979).
Ul is flanked by the sequences ab and its inversion b’a’, accounting for approximately 9 
kbp each, whereas Us is flanked by the sequences a’ c’ and its inversion ca, 6.5 kbp each 
(Wadsworth et al., 1976). Therefore, the HHV-1 genome contains 15 kbp of sequence 
(b’a’c’), contains inverted repeats of terminal regions inserted between Ul and Us. In 
vivo, the HHV-1 genome has been found to exist in at least three different states: linear, 
circular, and concatemeric (Roizman, 1979). In the virion, genomes are linear, but after 
infection, the ends join together resulting in circulai* “endless genomes” (Poffenberger & 
Roizman, 1985). HHV-1 expresses 84 different polypeptides during replication (Whitley 
& Roizman., 2002) (Figure 5.2). This expression is transcriptionally controlled and 
occurs in three phases, tei*med a (immediate eaily), p (early) and y (late). However, these 
phases are not absolute, some genes are not confined to these phases, a few alpha genes 
for instance continue to be transcribed in beta phase and some of the gamma genes ai*e 
transcribed to some extent in the beta phase as well. However, such transcription is often 
at a lower level than that seen in the “coiTect” phase proper and thus protein expression 
overall does follow this three phase pattern.
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The identity and some of the functions of many of these proteins are well documented 
and is summarized in table 5.1. However, this is unlikely to be complete since many 
proteins are multifunctional and not all activities are yet understood.
»
a\ Genetic
Figure 5.2 Genetic map o f HHV-1. The genome is divided into six important 
regions: The "a” sequences, which are important in circularization and packaging the 
DNA in the virion. The long repeat (R l), which encodes immediate early regulatory 
protein and the promoter o f the "gene" for the latency associated transcript (LAT). 
The long unique region (U l)  that contains genes for the DNA replication enzymes 
and the capsid proteins. The short repeats (Rs) that encodes immediate early protein 
(a). The origins o f replication (ohl) that is in the middle o f the U l region. The 
unique short region (Us) that encodes a number o f important glycoproteins. Taken 
from; http://darwin.bio.uci.edu/~faculty/wagner/hsv3f.html, 11.01.06
100
Effect of Us3 protein kinase on mitochondrial respiration Chapter 5
Table 5.1 The function of HHV-1 virus genes.
Taken and revised from: http://dai win.bio.uci.edu/~faculty/wagner, 11.01.06
Expression
phase
Name of 
element 
or protein
Function
- "a" cis genome cleavage, packaging signal
- TRl Terminal Long Repeat
Alpha aO Immediate-early transcription regulator (mRNA spliced)
latent LAT
ca. 600 bases in 5' region facilitates 
reactivation. No protein invoived. 
RNA transcript oniy
latent LAT-intron
Stabie accumuiation in nucieus of 
iateritiy infected neurons, unknown 
function RNA transcript oniy
Beta g L iu j )
Virai entry, associates with gH - 
poiyadenyiation usage changes 
with time
Beta Ul2 uracil DNA glycosylase, DNA repair
Gamma Ul3 non-virion membrane associated protein
Beta Ul4 Tegument protein, unknown function
Beta Helicase/ Primase (Ul5) DNA repiication
Gamma Ul6 capsid protein, capsid maturation, DNA packaging
? Ul7 Unknown
Beta Helicase/ Primase (Ul8) DNA repiication
Beta Ori binding protein (Ul9) DNA replication
Gamma gM (UlIO) Glycoprotein of unknown function
Gamma Ul11 Tegument protein, capsid egress and enveiopement
Beta
Aikaiine
exonuciease
(Ul12)
DNA packaging (?), capsid egress
Beta Ul12.5
C-terminai 2/3 of Ul12, expressed 
by separate mRNA-specific 
function unknown
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Table 5.1 Continued
Expression
phase
Name of 
element 
or protein
Function
Gamma Protein kinase(Ul13)
Tegument associated
Gamma Ul14 Unknown
Gamma Ul15 DNA packaging, cleavage of replicating DNA(?), (spliced mRNA)
Gamma Ul16 Unknown
Gamma U J7 Cleavage and packaging of DNA
Gamma Capsid (Ul18) Triplex
Gamma Capsid (Ul19) Major capsid protein, hexon
Gamma Ul20 Membrane associated, virion egress
Gamma Ul21 Tegument
Gamma gH (Ul22) Viral entry, functions with gL
Beta Ul23 Thymidine kinase
Gamma Ul24 Unknown
Gamma Ul25 Tegument protein, capsid maturation, DNA packaging
Beta Ul26 Maturational protease
Beta Ul26.5 Scaffolding protein
Beta gB (Ul27) Glycoprotein required for virus entry
Beta Ul28 capsid maturation, DNA packaging
Beta Ul29 Singie-stranded DNA binding protein, DNA repiication
- OriL Origin of repiication
Beta DNA pol (Ul30) DNA replication
Gamma Ul31 Nuclear phosphoprotein, nuclear egress
Gamma Ul32 capsid maturation, DNA packaging
Gamma Ul33 capsid maturation, DNA packaging
Gamma Ul34 Membrane phosphoprotein, nuclear egress
Gamma Ul35 capsid protein, capsomer tips
? Ul36 iCPI/2, tegument protein
102
Effect of Us3 protein kinase on mitochondrial respiration Chapter 5
Table 5.1 Continued
Expression
phase
Name of 
element 
or protein
Function
Gamma U l3 7 Tegument phosphoprotein
Gamma U l3 8 Capsid protein, tripiex
Beta U l3 9 Large subunit ribonucleotide reductase
Beta U l4 0
Small subunit ribonucleotide 
reductase
Gamma U l4 1 vhs, virion-associated host shut off protein, destabilizes mRNA
Gamma U l4 2 Polymerase accessory protein, DNA replication
Gamma U l4 3 unknown
- U l4 3 .5
Anti-sense to U l4 3 ,  
encodes a protein which 
colocalizes in nuclear structures 
with capsid proteins
Gamma gC (U l4 4 ) initial stages of virus-ceii association
Gamma U l4 5 Membrane associated
Beta U l4 6 Tegument associated, modulates a-TlF
Beta U l4 7 Tegument associated, modulates a-TlF
- a-TIF( U l4 8 )
virion-associated transcriptional 
activator, enhances immediate- 
early transcription through cellular 
Oct-1 and CTF binding at 
"TATGARAT" sites
Beta? U l4 9 Tegument protein
Gamma U l4 9 .5 Unknown
Beta dUTPase( U l5 0 ) Nucleotide pool metabolism
Gamma U l5 1 Unknown
Beta Helicase/prlmase( U l5 2 ) DNA replication
Gamma gK(U l5 3 ) virion egress
Alpha a27( U l5 4 )
Immediate-early regulatory protein, 
inhibits splicing
Beta U l5 5 Unknown
Gamma U l5 6 Tegument protein, affects pathogenesis
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Table 5.1 Continued
Expression
phase
Name of 
element 
or protein
Function
- IRl Internal Long Repeat
- Rl/Rs Junction Joint region, contains "a" sequences
- IRs Internal Short Repeat
Alpha a4 immediate-early transcriptional activator
- Oris(cis-acting)
Origin of repiication
Alpha a22 (Usi)
immediate early protein, affects 
virus' ability to replicate in certain 
ceiis
Beta Us2 Unknown
Beta Us3
Tegument associated protein 
kinase, phosphoryiates Ul34 and 
Us9
Beta gG (Us4) glycoprotein of unknown function
Gamma gJ (Us5) glycoprotein of unknown function
Gamma gD (Us6) Virus entry, binds HVEM
Beta gl (Us7)
Glycoprotein which acts with gE, 
binds igG-Fc and Influences ceil to 
cell spread of virus
Beta gE (Us8)
glycoprotein which acts gi, binds 
igG-Fc and influences cell-to-cell 
spread of infection
Beta Us9 Tegument associated phosphoprotein
Beta Us10 Tegument associated protein
Beta Usil
Tegument-associated protein 
phosphoprotein, RNA binding, 
post-transcriptional regulation
Alpha a47 (Usi 2)
immediate-early protein that 
inhibits MHC1 antigen presentation 
in human and primate cells
- TRs Terminal Short Repeat
- "a" cis genome cleavage, packaging signal
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5.3 Determination of the phase of transcription in which 
mitochondrial effects are induced
HHV-1 is a complex virus and it was not considered feasible to examine each of the 84 
proteins in turn during the cuiTency of this research project. Accordingly we sought to 
limit the number of virus proteins that might be responsible by determining the 
transcription phase in which the effect was induced. There are broadly two approaches to 
this aim, the first is to use inhibitors of DNA synthesis since if DNA does not replicate 
then gamma phase is not activated or of protein synthesis, since if added early in 
infection, phase progression will be stalled in alpha phase. The second approach is to 
follow the onset of synthesis of selected phase marker proteins to determine the timing of 
phase switching. The former (dmg use) approach was considered unsuitable in this case, 
inhibition of protein synthesis would clearly also block the action of all virus proteins and 
remove any such effect on mitochondiia. Furthermore, the drugs (and especially 
actinomycin D used to inhibit virus DNA synthesis) are themselves potent inducers of 
apoptosis causing release of cytochrome c from mitochondria and subsequent loss of 
organelle function. Thus we considered that the drug-based approach was likely to make 
the detection of virus-induced mitochondrial defect difficult or impossible. Accordingly 
we opted to study the synthesis of marker proteins during virus infection.
The alpha phase is short lived and consists only of the expression of gene transactivators 
(Honess & Roizman, 1974) and it was likely that our effects (commencing between 6  and 
1 2  hpi) would be either a beta or gamma phase process.
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We therefore sought the time of onset of gamma phase using monoclonal antibodies 
specific for gamma phase structural proteins by Western blot. For this purpose infected 
cells were sampled at various times after infection and their proteins were sepaiated on a 
10% polyacrylamide gel. Analysis of total protein content in each sample by Coomassie 
blue staining failed to reveal obvious differences as infection progressed (data not 
shown).
In order to detect specific gamma-phase proteins we used two monoclonal antibodies 
kindly provided by Professor A C Minson (University of Cambridge) (table 5.2).
Table 5.2 Monoclonal antibodies used in the study.
Antibody
designation
Target protein Reference
LP10 Glycoprotein G (gG) (ikoma etaL, 2002)
LP2 Glycoprotein D (gD)
(Minson et al., 
1986)
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Both antibodies tai'get structural components of the virus, this type of protein forms the 
majority of expressed late phase genes. The LP2 antibody was directed to glycoprotein D 
(gD) (Minson et ah, 1986) of the virus and antibody LPIO detected glycoprotein G (gG) 
(Ikoma et al., 2002). Proteins were analyzed by polyacrylamide gel electrophoresis as 
above; however in this case gels were not fixed and stained but were processed for 
Western blotting in order to ti'ansfer the proteins they contained to nitrocellulose 
membranes. Blotted proteins were then probed with the monoclonal antibodies. In each 
case the proteins targeted by the antibodies were not detected until 24 hours post infection 
(Figure 5.3). This indicated that ganuna phase did not activate until 24 hours post 
infection. Although some alpha proteins continue to be expressed during beta phase, these 
were felt unlikely to be responsible since the effect was not detectable before 1 2  hours 
post infection. However, this analysis cannot exclude the possibility that the effect is 
induced by gamma phase proteins expressed earlier than anticipated. This possibility was 
considered less likely that attribution to a true beta phase protein, since these are 
primarily concerned with intracellular activities rather than virion construction, and it was 
decided to concentrate on beta phase proteins at first.
The molecular weights of the glycoproteins were all found to be significantly heavier than 
expected on the basis of gene sequence and also differed from those given in some 
previous reports. The differences observed were consistent with vaiiation in protein 
glycosylation, which has been found to influence the apparent moleculai* weight of 
glycoproteins from different virus strains and in different host cell types (Dcoma et al, 
2002; Ghiasi et al, 1992; Cranage et al, 1983; Buckmaster et al, 1984; Liljeqvist et al, 
1998; Ho et al, 1993).
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I  83
)  625
Figure 5.3 Induction of glycoprotein D (gD) (A) and glycoprotein G (gG) 
(B) detected by monoclonal antibody LP2 and LPIO. Confluent monolayers 
HeLa cells were grown in 3.5 cm dishes, infected with HHV-1 (m.o.i 10 
pfu/cell) for time courses post infection (as indicated above), harvested and 
prepared for polyacrylamide gel electrophoresis. Proteins were separated on 
a 10% resolving gel using the mini gel apparatus, transferred to a 
nitrocellulose membrane using a semi-dry blotter, and probed with 
monoclonal antibodies. Bound murine antibody was detected using anti­
mouse IgG conjugated to peroxidase and visualised using ECL (Enhanced 
Chemiluminescence) (Arrows).
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5.4 Selection of beta phase proteins for examination
Although relatively few proteins are made in beta phase (approximately 31, see table 
5.2.1) this was still too many to tackle individually, so we sought to limit the candidates 
to those most likely to be involved by screening their known properties for potential 
involvement in such a process. Proteins considered as candidates were selected from the 
following criteria:
• Known to co-localise to mitochondria (or to the perinuclear region of the cell to 
which mitochondria aie re-directed following infection).
• Proteins that aie known to modulate apoptosis (and thus might act via
mitochondrial regulators).
• Proteins that could alter intracellulai* trafficking (and thus might prevent
incorporation of essential cellular proteins to mitochondria).
Using these criteria, we selected the proteins U l46, U s9, Ug5 and Ug3 shown in table 5.3. 
From these, we judged that Ug3 and Ug5 (especially Ug3) were the most likely as they 
showed perinuclear accumulation (Reynolds et al, 2002), the same area to which
mitochondiia aie clustered in virus infection (Murata et al, 2000) and apoptotic
modulation (Table 5.3). We therefore held U l46 and Ug9 in reserve and decided to 
concentrate on Ug3 and Ug5. Attempts to clone Ug5 were unsuccessful but are ongoing in 
the laboratory. The mRNA for Ug3 protein was successfully cloned for expression and the 
evaluation of its effect in the infected cell.
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Table 5.3 The specifications of U l46, U s9, Ug5 and Us3.
Gene
Roles and evidences for 
probable effect on 
mitochondria
References
Ul46
Tegument proteins, modulates a-TIF, 
Ul46 product was diffusely detectable 
in the cytoplasm after infection by 
pseudorabies virus,
Ul46 accumulates in the perinuclear 
region where the mitochondria are 
transported and accumuiated
(Kopp etaL, 2002; 
Murata etaL, 2000)
Us9
Tegument associated 
phosphoprotein, and is ubiquitinated, 
The function of Us9 has been not 
ciearly known yet
(Brandimarti & 
Roizman, 1997)
Us5
glycoprotein J {Us5 gene product) 
inhibits caspase activation and 
apoptosis induced by granzyme B or 
Fas
(Jerome et aL, 2001 )
UsS gene of herpes simplex virus 
inhibits apoptosis
(Jerome et aL, 1999)
Us3
Expression of Us3 results In the 
suppression of sorbltol-lnduced 
apoptosols of HEp2 cells
(Murata et aL, 2002)
The antlapoptotlc activity of the Ug3 
protein kinase Is mediated by the 
phosphorylation of protein kinase A 
(PKA) substrates
(Benetti & Roizman, 2004)
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Table 5.3 Continued.
Gene
Roles and evidences for 
probable effect on 
mitochondria
References
Us3
PRV Us3 blocks apoptosis Induced by 
Bax
apoptosis Induced by antl-Fas antibody 
and sorbitol Is blocked by Us3
Us3 protein kinase (Us3 pk) protects HSV- 
Infected primary afferent neurons from 
apoptotic cell death
Herpes simplex virus prevents apoptosis 
by the action of two genes, UgS and Us3
(Ogg ef a/., 2004)
(Cartier e t  aL, 2003)
(Asano e t  aL, 2000)
(Jerome etaL, 1999)
The Us3 protein kinase protects HSV-2- 
Infected cells from apoptotic death in (Asano e t  aL, 1999)
VIVO
The protein kinase encoded by the Us3 Is 
required to block apoptosis (Leopardi etaL,  1997)
The Us3 Protein Kinase Blocks Apoptosis 
Induced by the d120 Mutant of herpes 
simplex virus 1
(Munger etaL,  2001)
Us3 protein kinase targets the pro- 
apoptotlc BAD member of the Bcl-2 
family and blocks Its cleavage
(Munger & Roizman, 2001)
The Us3 protein appears In the cytoplasm 
of Infected cell at 4 h post Infection and Is 
mainly detected In the cytoplasm at 12 h
(Goshlma etaL,  1998)
Us3 of pseudorabies virus (PRV) protects 
swine-testlcle (ST) cells from apoptosis 
Induced by either sorbitol or 
staurosporlne.
(Geenen ef aL, 2005)
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5.5 Cloning of the U§3 coding sequence
5.5.1 Primer design and RT-PCR
RT-PCR amplification of a paiticular mRNA sequence requires two PCR primers 
(forward and reverse) that are specific for that mRNA sequence. The position of our 
primers was determined by the necessity to amplify the entire gene coding sequence. It 
was necessary to add suitable restriction sites for subsequent cloning without introducing 
exogenous stop codons. Each primer was designed to have a melting temperature between 
55-60°C using the rule that each C and G adds 4°C to the temperature and each T and A 
only 2°C. We also screened the sequence we wished to clone for potential restriction sites 
in order to ensure that cloning sites incorporated into the primers did not also occur 
internally. This would prevent us from excising the inserted DNA as a single band. The 
restriction enzymes chosen in our study were Xbal (TCTAGA) for the reverse primer and 
Hindlll (AAGCTT) for the forwairi primer. Finally, we ensured that any sequences added 
upstream of the initiating AUG codon provided a good Kozak consensus context for the 
AUG function (Kozak, 1980). Considering all these matters led to the design of the 
primers illustrated in table 5.4. The primers were ordered and made by Genosys 
Biotechnologies Ltd (UK).
112
Ejfect of Us3 protein kinase on mitochondrial respiration Chapter 5
Us3 reverse with 
Xbal
GTCAG TCTAGA TCATTTCTGTTGAAACAGCGG
Us3 forward with 
Hind i n
CG AAGCTT CGA ATGGCCTGTCGTAAGTTTT
Table 5.4 Sequence of the two primers; Us3 reverse and Ug3 forward. The underlined sequences 
regions indicate the Xbal and Hindll recognition sequences.
The Us3 coding sequence was produced by RT-PCR amplification from HHV-1 mRNA 
extracted from HHV-1 infected HeLa cells. cDNA was synthesised using reverse 
transcriptase and the anti-sense primer (Us3end reverse). The single stranded cDNA 
produced by RT reaction was then amplified in the PCR reaction using the sense primer 
(Us3start forward) and Taq DNA polymerase. Finally Ug3 cDNA PCR products were 
detected by gel electrophoresis on a 1.5% agarose gel and sized by compaiison with the 
1000 bp DNA marker (Promega). As seen in figure 5.4 A; a prominent band was 
observed of the expected size (1446 bp). The PCR product was then extracted and re- 
electrophoresed to assess the quantity of the DNA using XDNA concentration markers 
(Figure 5.4 B).
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1000
750
Figure 5.4 A) Agarose gel electrophoresis of Us3 cDNA PCR 
product: band indicated by arrow corresponds to the expected size 
(1446 bp) of Us3. Lane 1 is 1 Kbp DNA size markers. B) Ug3 
cDNA PCR product after gel extraction (Arrow). Lane 1, DNA 
size markers; lane 2, X marker (100 ng); lane 3, X marker (50 ng).
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5.5.2 Ligation of the Us3 PCR product into the pGEM-T easy vector
The vector pGEM-T easy (Figure 5.5) was used for initial cloning of the PCR product. 
This Vector has been prepaied commercially by cutting with EcoRI and adding a 
3 Terminal thymidine (T) to both ends. This single 3 -T significantly improves the 
efficiency of ligation of a PCR product into the plasmids, prevents re-circulaiisation of 
the vector and provides a compatible overhang for PCR products that have been 
generated by thermostable polymerase (Tag). This enzyme often adds a single 
deoxyadenosine (A) to the 3 "-ends of the amplified fragment. This vector also contains a 
multiple cloning region (MCS) for simple manipulation after cloning.
Ug3/pGEM-T easy vector ligation was successfully performed (Figure 5.6) using T4 
DNA ligase at a molar ratio of 5:1 (Ug3 insert: pGEM-T easy vector) as we described in 
detail in chapter 2 .
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Figure 5.5 Gene map and the promoter and multiple cloning site (MCS) of the pGEM-T 
easy vector used in our experiments (source: Promega catalogue, technical manual no: 
042)
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5.5.3 Transformation of E. coli DH5a by pGEM-T easy /Us3 ligation 
product
E, coli (DH5a) was transformed with the products of the ligation reaction. Seven white 
colonies were selected and cultured overnight. Plasmid DNA was purified and presence 
of the insert was determined by restriction enzyme digestion and agarose gel 
electrophoresis. EcoRI sites in the vector flank the position of the A/T insertion and thus 
this enzyme can be used to excise the inserted cDNA. Four colonies showed the presence 
of a 1446 bp fragment coixesponding to the Us3 cDNA (Figure 5.6). Restriction enzyme 
sites had been incorporated for expression sub-cloning. These were Xba-1 and HindUI. 
Presence of these sites was confirmed by digestion: Hindlll should linearise the plasmid 
and analysis showed that this was indeed the cases (Figure 5.7). We also attempted to 
digest the recombinant Us3 cDNA using Xbal restriction enzyme but the clone was not 
cut by this enzyme as seen in the figure 5.8. Subsequent sequencing analysis (see below) 
confiimed that this site was present and we attribute this failure to cut to méthylation of 
the DNA. However, the multiple cloning site (MCS) of the vector contributed a variety of 
sites adjacent to the insert that could potentially be used for forced orientation cloning. 
We selected the Spel restriction site located close to the Xbal site of the insert in 
recombinant cDNA. Furtheimore Spel and Hindlll enzymes will cleave in the same 
buffer and the Spel restriction site sequence is compatible with the Xbal site to be used in 
the expression vector. Using these enzymes successfully released the insert as expected 
(Figure 5.9).
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Figure 5.6 1.5% agarose gel electrophoresis of recombinant 
pGEM-T/Us3 digested by EcoRI. Lane 1: 1 kbp DNA size 
markers, lanes 2-8: plasmids derived from 7 white colonies. 
Arrows indicate the expected fragment corresponding to Us3 
cDNA cloned into the vector.
4000—  300
1500—
Figure 5.7 1.5% agarose gel electrophoresis of recombinant 
pGEM-T/ Us3 digested by Hindlll. Lane 1: Ikb DNA size 
markers, lanes 2-6 (Arrow): plasmids derived from 5 white 
colonies indicate the expected 4.5 kbp fragments that indicated Ug3 
cDNA/plasmid.
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40003000
Figure 5.8 1.5% agarose gel electrophoresis of recombinant pGEM- 
TAJs3 digested by Xbal. Lane 1: Ikb DNA size markers, lanes 2-6: 
plasmids derived from 5 white colonies show that the supercoil has not 
been linearised (Arrow).
3000—
1000-
Figure 5.9 1.5% agarose gel electrophoresis of recombinant pGEM-T/ 
Us3 digested by Hindlll and Spel restriction enzymes 5 white colonies 
lanes 4-8. Lane 1: Ikb DNA size markers, lanes 5, 7 and 8 show insert 
(Arrow) and vector separated in expected size.
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5.5.4 Sequencing the pGEM-Teasy/Us3 recombinant clone
100 ng/|ul of recombinant was sent to be sequenced by Lark Co (UK). The sequence 
returned was as expected and is shown in figure 5.10. Interestingly the Xba-1 site that 
failed to cleave was found to be present and intact in the construct.
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O q C  A A T T C A C  T A  G T G  A T  T G T C A G  T C T A G  A T C A  T T T C T G T T  G A A A C A  G C G G CAP
EraSI Sv«I xbal
US3 liicert
p CEM-T easy
f ------
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B
Figure 5.10 Sequence chromatograms o f  the pGEM-T easy/Us3 recombinant clone.
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5.5.5 Subcloning of Us3 coding sequences into pSP64 poly (A) vector
In order to express the Ug3 coding sequence and make the mRNA in vitro it was 
necessary to subclone the characterized cDNA into an expression vector. The pSP64 poly 
(A) Vector was chosen (Figure 5.11) in view of the labs extensive experience with this 
plasmid. This vector has a homopolymeric stretch of 30 dA:dT base pairs inserted 
between the Sad and EcoRI sites. Consequently, when foreign DNA is cloned into any 
site other than EcoRI, linearization of the recombinant plasmid with EcoRI allows the use 
of SP6  RNA polymerase to prepare RNA copies of the inserted sequences that contain a 
synthetic 30-residue “polyA” tail. The vector was lineaiised by digestion at the Hind III 
and Xba I restriction sites and was purified by gel extraction. The Us3 cDNA insert was 
excised by Hindlll and Spel restriction enzymes from pGEM-T easy vector and gel 
extracted then the purified Us3 insert was ligated into the lineaiised pSP64 vector (Figure 
5.12) via the compatible teimini and the products of the ligation reactions were 
transformed into E.coli DH5a cells. Finally, to confiim the ligation product was as 
expected, the pSP64/ Us3 recombinant was digested using Hindlll and BamHI restriction 
enzymes. These enzymes successfully released the inserts and vector at the expected sizes 
(Figure 5.13).
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Figure 5.11 pSP64 Poly (A) Vector map, promoter and multiple cloning region 
sequence (source: Promega catalogue, technical manual no: 052)
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Figure 5.12 1.5% agarose gel electrophoresis of recombinant 
pSP64/Us3. Lane 1: Ikb DNA size marker, lanes 4, 5 and 6 show 3 
samples of recombinant in expected size 4476 bp (Arrow).
Figure 5.13 1.5% agarose gel electrophoresis of recombinant 
pSP64AJs3 digested by Hindlll and BamHI. Lane 1; Ikb DNA size 
markers; lanes 3; 3 bands were released after digestion in expected 
sizes; 3000 bp, 1100 bp and 400 bp (Arrows).
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5.5.6 Preparation of Us3 cDNA for in vitro transcription
The pSP64/Us3 construct was linearized using EcoRI restriction enzyme (Figure 5.14). 
The EcoRI site in the vector lays beyond the poly A tail. Failure to cut would result in 
long read through transcripts with exogenous plasmid sequences present 3’ to the poly A 
tail. This would decrease the efficiency both of transcription and translation. Cleavage by 
this enzyme was therefore assessed by electrophoresis before the DNA was used for 
mRNA manufacture. Linearised DNA was then re-purified by extraction and used to 
manufacture mRNA (explained later in this chapter). Linearized DNA was then cleaned 
up as we explained in chapter 2; the Us3 mRNA was successfully made using in vitro 
transcription (Figure 5.15).
40003000
1000-
Figure 5.14 1.5% agarose gel electrophoresis of recombinant 
pSP64/ US3 linearized by EcoRI. Lane I: Ikb DNA size markers, 
lanes 3, 4 and 5 show 3 bands (Arrows) of linearized plasmid.
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bp
3000
1500 —
Figure 5.15 1% agarose gel electrophoresis of Us3 mRNA. Lane 
1: 1 kbp DNA size markers; lane 2 eukaryotic RNA marker and 
lanes 4-5 Us3 mRNA (Arrows).
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5.5.7 In vitro translation of U§3 protein
Before use in transfection studies it was necessary to demonstrate functionality of the 
synthetic mRNA. The RNA was therefore tested for its capacity to direct protein 
synthesis in vitro using a rabbit reticulocyte lysate translation system (Figure 5.16).
kDa
175-
83 
62 -
« 47 ■■£I
5 32.5-
oz
25
16.5
Figure 5.16 Us3 protein translated in vitro  is shown in 
lane 1 (Arrow). Translation product was analyzed by 
electrophoresis on a 10% protein gel and then was 
visualized using autoradiography.
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The size obtained in this experiment was 6 8  kDa in agreement with the size reported for 
Us3 elsewhere for this protein (Frame et aL, 1987). Finally in order to determine the 
optimum procedure for transfection and the efficiency of any transfection achieved, it was 
necessary to use a positive control whose expression would generate a measurable signal. 
To achieve this, mRNA for the enzyme luciferase was chosen.
5.6 Use of Luciferase (lue) gene as control for in vivo 
transcription and transfection
We used the commercially available vector Luciferase SP6  control DNA (Figure 5.17). 
This vector is commonly used as a control in translation systems. The Control DNA 
contains the gene for luciferase and also canies a 30 base pair homopolymeric A/T region 
at the 3’ end to generate a polyA tail. The vector was linearized with XmnI restriction 
enzyme and efficiency of cleavage was confirmed by electrophoresis. The vector contains 
2 sites for this enzyme and cleavage leads to the products of predicted sizes 1841 bp and 
2906 bp. These were all observed as expected in the digest (Figure 5.18). Following 
satisfactory cleavage, mRNA was transcribed (as described in chapter 2) using sp6  cap 
scribe™ (Roche) (Figure 5.19)
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Figure 5.17 Luciferase SP6  Control DNA vector map and sequence reference points 
(source: Promega catalogue, technical manual no: 126)
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Figure 5.18 1.5 % agarose gel electrophoresis of SP6//mc digested 
with XmnI enzyme. Lane 1: 1 kbp DNA size markers; lane 2: 200 
ng 1 marker. Lane 3: midiprep purification of undigested sp6//wc. 
Lane 4: digested with XmnI shows 2 bands corresponded to 
released bands (2900 bp and 1847 bp) (Arrow).
1 2
28S—M
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Figure 5.19 1% agarose gel electrophoresis of lue mRNA 
using SP6 //MC DNA vector. Lane 1: eukaryotic RNA marker 
(18S and 28S) and lane 2 lue mRNA (Arrow).
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5.7 Luciferase activity assay
HeLa cells were transfected with lue mRNA to determine both the efficiency of 
transfection and the optimum time for expression from transfected mRNA. The time 
course of expression was determined by measuring luciferase activity by luminometry. 
The results (Figure 5.20) show that good expression was achieved 6  hours after 
transfection. Expression was greatly diminished by 24 hours the time point recommended 
by the suppliers of lipofectin.
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Figure 5.20 Luciferase activity after HeLa cell transfection with lue mRNA. 
HeLa cells were grown up to 50% confluence in 3.5 cm  ^dishes, harvested by 
scraping and 4 x 10^  cells were transferred to a microcentrifuge tube, 
centrifuged at 17900 x g for 15 seconds. 10 pi of cell lysate supernatant was 
added to a luminometer tube containing 100 pi of luciferase assay reagent and 
then was read by luminometer. Each graph represents the mean of 3 
independent experiments. The error bars represent the standard deviation  
from the mean.
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5.8 Anti-Luciferase immunostaining assay
In order to assess the transfection efficiency, transfected HeLa cells were immunostained 
at 6  hours post transfection using anti-luciferase antibody as we described in detail in 
chapter 2. The cells were then observed by light microscopy. Transfected cells showed a 
dense deposition of stain and any cell showing this deposition was scored as positive. For 
3 experiments, both stained and unstained cells present in one microscpic field were 
counted and the percentage of transfection efficiency was calculated that was 80% (data 
not shown).
5.9 The effect of Us3 on mitochondrial respiration
We investigated the effect of Us3 on mitochondrial cellulai* respiration using the oxygen 
electrode to determine 0% consumption in mRNA transfected cells. HeLa cells were 
grown in 75 cm^ flasks and when 50% confluent were transfected using the same 
procedure as that for transfection in small dishes (explained in chapter 2 ) but scaled up on 
the basis of monolayer area. Three flasks per sample (9 in all) were transfected with 
mRNA as follow: 10 pg of synthetic mRNA was mixed with 1 ml OptiMEM and then 
mixed with a volume of 120 pi lipofectin and 880 pi OptiMEM (explained in chapter 2). 
Three samples were prepaied, 3 flasks received mRNA for Us3, a further three mRNA for 
lue, whilst a final set received lipofectin alone (no RNA). Monolayers were allowed to 
stand in the presence of the reagent mixture for 1 hour and then media were removed and 
replaced with fresh growth medium.
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This was taken as time 0, and 6  hours later cells were harvested by scraping and 
respiration was measured in the oxygen electrode. As seen in figure 5.21, transfection 
with the mRNA for Us3 protein led to a statistically significant reduction in oxygen 
consumption (P< 0.001). This decrease was calculated to be 47% in comparison with 
controls. OC in Lwc-mRNA transfected cells and no-RNA controls cells did not differ 
significantly from each other.
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Figure 5.21 The effect of Ug3 protein on total cell respiration. Cells were 
grown to 50% confluent, transfected with RNA (or no RNA) (2.5 pg 
mRNA/10^  HeLa cells) and transferred to the chamber of the Clark-type oxygen 
electrode. 6 hours later, Oxygen consumption rate was measured. Asterisks 
indicate samples with significant divergence from control values; (p<0.001). 
The error bars represent the standard deviation from the mean. Each 
graph represents the mean of three independent experiments.
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HHV-1 induced a block only at one point in the respiratory chain and thus the block 
associated with US3 expression is assumed to act at this point. Thus, it was not necessary 
to repeat chain dissection using transfected cells.
5.10 The effect of Us3-deletion mutant virus of herpes simplex 
virus type 1 (HSV-1) on mitochondrial respiration
The experiments above clearly implicate protein Ug3 in the induction of mitochondrial 
dysfunction. They show that protein Ug3 alone is capable of inducing this defect and 
contributions from no other virus proteins are required. However, they do not inform as to 
whether Ug3 is the only virus protein capable of exerting such an effect. If this is so, then 
one prediction from these data is that any viruses which lack this protein should fail to 
reduce oxygen consumption by infected cells. Accordingly we made use of a Ug3 deletion 
mutant Idndly supplied by Professor B. Roizman (University of Chicago) and examined 
the effect of infection by this virus on oxygen consumption of infected cells. Since we 
could not assume that the parental virus from which this mutant had been obtained was 
identical to the strain of HHV-1 used in this study, we also used the parental (wt) virus 
supplied by Professor Roizman as control. Both viruses were propagated in HeLa cells in 
MEM supplemented with 2 % PCS, stored at -80°C before use and the stocks titrated by 
the ID50 method. Speed of replication was also examined and infections by both wt and 
mutant virus were followed to check the time of onset of CPE. Although, the onset of 
CPE was marginally slowed in Ug3 deleted virus infections, the differences were not 
appreciable; wild-type (wt) virus infected cells showed CPE to commence from 24 hours 
and the mutant between 24 and 36.
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For measuring oxygen consumption, HeLa cells were grown in 75 cm^ flasks and when 
near confluence were infected with Ug3-deletion mutant virus and paiental wild-type (wt) 
virus: contiol monolayers were mock-infected. 1 2  hours later, the oxygen consumption 
rates of both cultures were measured using the Clark-type oxygen electrode. As shown in 
figure 5.22, the rate of 0% consumption by cells infected with the wild-type (wt) virus was 
significantly reduced (49%) compared with that of control (mock-infected) cells. A 
finding entirely consistent with those for our own strain (Chapter 3). In contrast O2 
consumption by the Us3-deletion mutant virus infected cells was not significantly 
different from that of the mock-infected controls. This finding was reproduced in three 
independent experiments and data are assembled in the figure presented. These findings 
imply that not only is US3 capable alone of inducing a defect in respiration detected by 
these techniques, it is the only virus protein that can do so. Consequently, the 
identification of the block in electron transport induced by whole virus with that induced 
by Us3 alone is justified.
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Figure 5.22 The effect of Us3-deletion mutant virus of herpes simplex virus 
type 1 (HSV-1) on total cellular respiration. Cells were grown up to near 
confluence as we described under materials and methods, infected with Ug3- 
deletion mutant virus and 12 hours later transferred to the chamber of the Clark- 
type oxygen electrode. Oxygen consumption rate was measured and compared 
with oxygen consumption rate of wild type HSV-1 virus infected cells and mock 
infected cells at the same time. Each graph represents the mean of 3 independent 
experiments. The error bars represent two standard deviations from the 
mean. Asterisks indicate samples with significant divergence from control values;
(p<0 .0 0 1 ).
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Chapter 6: Discussion and Conclusions
There are many reports that show viruses and viral proteins may affect mitochondrial 
function, induce mitochondiial abnormalities or affect apoptosis, sometimes by effects 
mediated at the mitochondria (Reviewed in chapter 1). Apoptosis is a common cell 
process that can be viewed as part of the host cell response to infection. Since cell suicide 
would reduce the yield of any infecting virus it would be widely applicable as a defence 
mechanism (McFadden et aL, 1998; Boy a et al, 2001) and it also plays a crucial role in 
pathogenesis of many diseases caused by viruses. Therefore, it should not surprise us that 
many and diverse vimses have engaged with the apoptotic process (often via 
mitochondrial regulation) to oppose this cellulai* defence. Thus, mitochondria may form a 
common target during viral infection (Boya et al, 2004) and therefore, it is feasible that 
many viruses might affect energy generation by the mitochondrion even if their primaiy 
role for engaging with that organelle is anti-apoptotic.
One study has already shown a viral effect on cell respiration in vitro (Koundouris et al, 
2000). This showed that poliovirus infection of the cell caused a rapid decrease in total 
cell respiration that was related to mitochondrial dysfunction and blockage of electron 
transport around complex II and III.
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Probably such effects will be of limited significance within the context of an active, 
productive and lytic infection, where the host cell has no long-term future. However, 
infected cells clearly survive in the context of persistent infections; this must indicate that 
apoptosis is held in check in such cases and in these instances long-teim reduction in a 
cell’s ability to generate energy might adversely affect cell function.
Thus, our hypothesis is that similar effects might be induced by diverse viruses and might 
underlie conditions where no single virus aetiology has been proven. Obvious candidates 
for such events could be muscle (both skeletal and heart), liver cells and neurones. This 
thesis has set out to deteimine whether disparate viruses can indeed affect mitochondrial 
energy generation as the first step in validity this hypothesis. Further, we consider that 
one example of such a situation might be provided by so-called chronic fatigue syndrome 
or post viral fatigue syndrome, and this situation is described more fully below.
Chronic fatigue syndrome (CFS) is defined by two criteria: Severe chronic fatigue of six 
months or longer duration (other known medical conditions excluded by clinical 
investigation); and concunent display of four or more of the following symptoms: 
substantial impairment in short-term memory or concentration, sore throat, tender lymph 
nodes, muscle pain, multi-joint pain without swelling or redness, headaches of a new 
type, pattern or severity, unrefreshing sleep and post-exertional malaise lasting more than 
24 hours (Fukuda et al, 1994).
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CFS remains a poorly understood and controversial disease, because no causal agents 
have been identified; physical signs and symptoms are variable, and diagnostic laboratory 
tests have poor sensitivity and specificity (Holmes et ah, 1988). Psychological effects 
may present with a similar spectrum of signs. However even when all other causes of 
CFS are eliminated, the residual patients show eaiiy fatigue con elated with an eaiiy 
switch to anaerobic respiration in muscles (Lane et ah, 1994). This strongly suggests a 
mitochondrial impainnent such as might be induced by viruses according to our 
hypothesis above.
Further the multiplicity of different viruses which might affect mitochondria, could 
explain why viruses have fallen from favour as aetiological agents for CFS. Most (all) of 
the past attempts to conelate CFS with virus infection have sought evidence for elevated 
antibody levels or persistence of virus genetic infoimation in these patients, but have 
sought for only one or a few such viruses. If the condition may be caused by several 
unrelated agents, then incidence detected in studies such as those above might indeed 
merely reflect population average incidence unless all such agents aie considered.
A brief consideration of virus involvement in CFS follows:
Viral infection was initially thought to be a cause of CFS, most probably Epstein-BaiT 
virus (EBV or HHV-4); a type of heipes virus that is generally accepted as causing 
infectious mononucleosis (or glandulai* fever). Many reports have demonstrated the 
higher antibodies to EBV in patients with CFS (Lemer et al, 2004; Kroenke, 1991; 
Hotchin etal, 1989; Sairenji et al, 1995).
138
Discussion and Conclusions Chapter 6
Serological evidence has also been gathered and implicates several other viruses: It has 
been shown that many CFS patients had significant active HHV- 6  infection and these 
patients had elevated IgG antibody titres to HHV- 6  capsid antigens and the presence of 
HHV- 6  IgM antibody (Ablashi et al, 2000). Patients with CFS had significantly higher 
antibody titres against various components of cytomegalovirus (CMV or HHV-5) than 
controls (Holmes et al, 1987; DuBois et al, 1984; Lemer et al, 2002). Antibody titres to 
measles vims and various heipes viruses are often elevated in patients with CFS (Holmes, 
1991). According to Yamanishi (1992), in some CFS patients, elevated titres of 
antibodies to lymphotropic virus (HTLV-I) and (HTLV -II) have been observed. Other 
viral agents that might be responsible for etiology of CFS aie enteroviruses (EV), which 
are members of the family Picomaviridae. Three types of enteroviruses have been 
concerned: polio, coxsackie and echovirus (Kennedy, 1991). In one study enteroviral 
RNA was found in 24% of biopsy and also EBV DNA in 9% of biopsy samples from 
CFS patients (Cunningham et al, 1991). Despite these findings one study reports that 
there was no serological or antigen testing differences between patients with disabling 
unexplained fatigue and matched controls for detecting enteroviruses as CFS aetiology 
(Swanink et al, 1994). However it has become cleai* that during persistence in murine 
heart muscle, the bulk of enteroviral RNA is double stranded and unavailable for reverse 
transcription; an essential first step before PCR detection of persistent virus, consequently 
methods that omit to melt the RNA before reverse transcription fail to generate positive 
PCR signals even from animals known to be caiTying the virus (Tam & Messner, 1999). 
Since most human studies have also failed to include this initial melting step, most would 
probably also fail to detect the RNA.
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Others have sought to detect different viruses within CFS tissue; one report identified 
Borna virus nucleic acid in a patient with chronic fatigue syndrome (Nowotny & 
Kolodziejek, 2000). A high rate of Boma disease virus (BDV) infection has been 
confiraied in patients with chronic fatigue syndrome (CFS) (Nakaya et ai, 1999). One 
control-case study with the absence of serological confirmation showed that CFS may 
follow acute parvovirus B19 infection (Ken* et al., 2002).
In our study we have screened four viruses for their possible effect on cellular 
mitochondrial respiration:
Measles virus (MV), a member of paramyxovirus family has been shown to induce 
mitochondrial structural abnormalities in dendrites during persistent infection of the brain 
termed subacute sclerosing panencephalitis (SSPE) (Paula-Baitosa et al, 1984) and also 
has been associated with apoptosis and CFS (reviewed in chapter 3).
Despite these observations MV did not decrease total cellular respiration in our 
experiments. Other work in this laboratory indicates that more subtle effects might still be 
involved. Coxsackie virus B4 induces a change in mitochondrial trans-membrane 
potential difference after infection. This effect is readily demonstrated by FACS 
(Fluorescence Activated Cell Sorting) using Pd sensitive dyes, but is not detectable by the 
oxygen electrode. Thus our negative results here do not imply that MV does not affect 
mitochondria at all.
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Cytomegalovirus a member of Betaherpesvirinae (subfamily of herpesviruses) forms a 
lifelong persistent infection in humans, associated with frequent reactivations and protein 
synthesis (chapter 3). Symptoms of HHV-5 infection are rare, but when they do occur 
they resemble those of infectious mononucleosis (IM) and feature fatigue as a primary 
sign (Reviewed in Gandhi & Khanna, 2004). It would also be desirable to study the actual 
causative agent of IM (Epstein Ban* Virus or HHV-4) but this is restricted in use at SuiTey 
University because of its association with B cell tumours (Magrath et al, 1992). HCMV 
is amenable to study and grows in a restricted number of cells. In the lab the usual host 
are MRC5 cells derived from normal lung tissue. The result of this experiment was the 
same as measles virus. There was no noticeable change in oxygen consumption between 
control and infected cells in each time points studied.
However, comparison of the rate of oxygen consumption by HeLa cells with that of 
MRC5 cells showed that MRC5 cells use oxygen much more slowly. Baseline total 
cellular respiration was itself already low and thus reductions from this level may not 
have been easy to detect (described in chapter 3). Other studies have shown that 
mitochondrial network disruption occurs following CMV infection (McCormick et al, 
2003), and thus we cannot exclude an effect by this virus on mitochondrial activity. 
Consequently CMV should also be studied by the FACS method mentioned above.
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The third virus studied was HHV-1 a member of the Alphaherpesvirinae, subfamily of the 
Herpesviridae. We found an obvious effect of HHV-1 on oxygen consumption in infected 
cells. HHV-1 infection resulted in a decrease in total cellulai* respiration. It is known that 
mitochondrial proteins and DNA are decreased during HHV-1 infection (Latchman, 
1988; Lund & Ziola, 1986). The mitochondrial membrane may become fragile and 
mitochondrial RNA polymerase appears in extracts of infected cells (Tsurumi & Lehman, 
1990). HHV-1 has also been implicated in CFS (Holmes, 1991).
In one study (Ablashi et al, 2000), the levels of HSV IgM antibody and IgG antibody in 
CFS patients were found to be higher than in healthy controls. However persistence of 
HHV-1 is via latency, this occurs in neuronal cells rather than muscle and is not 
associated with protein synthesis, rather RNA transcripts tei*med LAT (the latency 
associated transcripts) are induced (Tenser et al, 1993). This suggests that a direct effect 
of HHV-1 on muscle mitochondria would be unlikely, although some effect mediated 
through motor neurone dysfunction cannot cunently be ruled out and the full 
functionality of latently infected neurones has not been determined.
The finding presented in chapter 4 strongly suggested that complex II is not responding to 
the specific substrate stimulation and clearly showed the respiratory block was in 
complex II or between II and III during HHV-1 infection. This is the same site previously 
reported for poliovirus infection and may indicate a common site for virus involvement.
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Further assessment of electron flow from cytochrome c to complex IV using TMPD and 
ascorbate showed that downstream activity was unaffected. It is known that the first 
mitochondrial substance released from the mitochondrial intermembrane space in 
apoptotic cell death is cytochrome c (Adams & Cory, 1998). Since we find cytochrome c 
to be functional, it is likely that the upstream electron transport blockage observed at this 
time is not related to apoptosis.
One possible explanation for the effect of HHV-1 on mitochondrial cell respiration was 
that the virus synthesises proteins targeted to the organelle and therefore it would be 
interesting to express those proteins that are most likely to be involved.
Pseudorabies virus (PRV) Ug3 unlike HHV-1 encodes two Us3 isoforms, an abundant 
short isoform (95% of the Ug3 protein in infected cells) of 41 kDa and a long isofonn (5% 
of Us3 protein in infected cells) of 53 IcDa (Van Zijl et al., 1990), It has been recently 
shown that the N-terminus of the Ug3 long isoform (Ug3a) of pseudorabies virus (PRV) 
contains a mitochondiial localization signal (Calton et al., 2004) and exclusively locates 
on mitochondiia (Van Minnebruggen et al, 2003). HHV-1 Ug3 has a key role in 
modulating of apoptosis and an important effect on mitochondrial dysfunction described 
in chapter 5. Although several other viral encoded proteins such as ICP4, ICP27, ICP22, 
Ug5, and Ug6  have been found to show anti-apoptotic characteristics that may act at early 
stages in infection (Reviewed in Aubert & Blaho, 2001). These might also affect 
mitochondrial respiration to some degree but our experiments with the mutant virus 
indicate that any such effects must be small.
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In conclusion, the work presented in this thesis extends the number of viruses that are 
able to inhibit mitochondrial respiration to include HHV-1 and influenza. Other viruses 
showed no effect demonstrable by this technique (OE) but in view of the low levels of 
basal respiration rate in their host cells, and fact that FACS demonstrates that Coxsackie 
virus B4 may affect mitochondrial membrane potential in the absence of any effect on 
respiration, more subtle effects induced by other viruses cannot be excluded and further 
investigation is waiTanted. Finally, the observation of such effects in three unrelated 
viruses strengthens the possibility of a link between persistent viral infections and their 
consequences through a common effect on mitochondria. One such example could be 
CFS.
144
References
References:
Ablashi, D. V,, Eastman, H. B., Owen, C. B., Roman, M. M., Friedman, J., 
Zabriskie, J. B., Peterson, D. L., Pearson, G. R. & Whitman, J. E. (2000).
Frequent HHV- 6  reactivation in multiple sclerosis (MS) and chronic fatigue 
syndrome (CFS) patients. J Clin Virol 16, 179-191.
Adams, J. M. & Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. 
Science 281, 1322-1326.
Adlish, J. D., Lahijani, R. S. & St Jeor, S. C. (1990). Identification of a putative cell 
receptor for human cytomegalovirus. Virology 176, 337-345.
Akiyama, T., Takagi, S., Sankawa, U., Inari, S. & Saito, H. (1980). Saponin- 
cholesterol interaction in the multibilayers of egg yolk lecithin as studied by 
deuterium nuclear magnetic resonance: digitonin and its analogues. Biochemistry 
19, 1904-1911.
Alberts, B., Bray, D., Hopkin, K., Johnson, A., Lewis, J., Raff, M., Roberts, K., 
Walter, P. (2004). Essential cell biology. Second edition. Garland Science/Taylor 
& Francis Group: New York, Abingdon.
Anan, R., Nakagawa, M., Miyata, M., Higuchi, I., Nakao, S., Suehara, M., Osame, 
M. & Tanaka, H. (1995). Caidiac involvement in mitochondrial diseases. A 
study on 17 patients with documented mitochondrial DNA defects. Circulation 
91, 955-961.
Anderson, S., Bankier, A. T., Barrel!, B. G., de Bruijn, M. H., Coulson, A.R., 
Drouin,J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., Schreier, P.
H., Smith, A. J., Staden, R., Young, I. G. (1981). Sequence and organization of 
the human mitochondrial genome. Nature 290, 457-465.
Arai, E. & Katayama, I. (1997). Role of apoptosis in spontaneous regression of 
peripheral T-cell lymphoma arising in the skin or subcutis. Hum Pathol 28, 472- 
477.
145
References
Asano, S., Honda, T., Goshima, F., Nishiyama, Y. & Sugiura, Y. (2000). US3 protein 
kinase of heipes simplex virus protects primaiy afferent neurons from virus- 
induced apoptosis in ICR mice. Neurosci Lett 294, 105-108.
Asano, S., Honda, T., Goshima, F., Watanabe, D., Miyake, Y., Sugiura, Y. & 
Nishiyama, Y. (1999). US3 protein kinase of heipes simplex virus type 2 plays a 
role in protecting corneal epithelial cells from apoptosis in infected mice. J Gen 
Virol 80 (Pt 1), 51-56.
Aubert, M. & Blaho, J. A. (2001). Modulation of apoptosis during herpes simplex virus 
infection in human cells. Microbes Infect 3, 859-866.
Auvraerter, P. G., Kaneshima, H., McCune, J. M., Wiegand, G. & Griffin, D. E. 
(1996). Measles virus infection of thymic epithelium in the SCID-hu mouse leads 
to thymocyte apoptosis. J Virol 70, 3734-3740.
Baker, T. S., Olson, N. H. & Fuller, S. D. (1999). Adding the third dimension to virus 
life cycles: three-dimensional reconstruction of icosahedral viruses from cryo- 
electron micrographs. Microbiol Mol Biol Rev 63, 862-922, table.
Barbaro, G., Di, L. G., Asti, A., Ribersani, M., Belloni, G., Grisorio, B., Filice, G. & 
Barbarini, G. (1999). Hepatocellular mitochondiial alterations in patients with 
chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 
94, 2198-2205.
Bedford, H. (2003). Measles: the disease and its prevention. Nurs Stand 17, 46-52.
Bellini, W. J., Rota, J. S. & Rota, P. A. (1994). Virology of measles virus. J Infect Dis 
170 Suppl 1,815-823.
Benetti, L. & Roizman, B. (2004). Herpes simplex virus protein kinase US3 activates 
and functionally overlaps protein kinase A to block apoptosis. Proc Natl Acad Sci 
t / 8  A 101, 9411-9416.
146
References
Biousse, V. & Newman, N. J. (2003). Neuro-ophthalmology of mitochondiial diseases. 
Curr Opin Neurol 16, 35-43.
Boehmer, P. E. & Lehman, I. R. (1997). Hei*pes simplex virus DNA replication. Annii 
Rev Biochem 6 6 , 347-384.
Boya, P., Panlean, A. L., Poncet, D., Gonzalez-Polo, R. A., Zamzami, N. & Kroemer, 
G. (2004). Viral proteins targeting mitochondria: controlling cell death. Biochim 
BiophysActa 1659, 178-189.
Boya, P., Roques, B. & Kroemer, G. (2001). New EMBO members' review: viral and 
bacterial proteins regulating apoptosis at the mitochondrial level. EMBO J 20, 
4325-4331.
Brandimarti, R. & Roizman, B. (1997). Us9, a stable lysine-less heipes simplex virus 1 
protein, is ubiquitinated before packaging into virions and associates with 
proteasomes. Proc Natl Acad Sci U S A94, 13973-13978.
Brydon, E. W., Smith, H. & Sweet, C. (2003). Influenza A virus-induced apoptosis in 
bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. 
J Gen Virol 84, 2389-2400.
Buckmaster, E. A., Cranage, M. P., McLean, C. S., Coombs, R. R. & Minson, A. 
(1984). The use of monoclonal antibodies to differentiate isolates of herpes 
simplex types 1 and 2  by neutralisation and reverse passive haemagglutination 
tests. J Med Virol 13, 193-202.
Calton, C. M., Randall, J. A., Adkins, M. W. & Banfield, B. W. (2004). The
pseudorabies virus serine/threonine kinase Us3 contains mitochondrial, nuclear 
and membrane localization signals. Virus Genes 29, 131-145.
Carter, M. J., ter Meulen, V. 1995. Measles, chapter 10 in Principles and Practice of 
Clinical Virology, pp. 337-361. Edited by A. J. Zuckeiman, J. E, Banatvala and J. 
R. Pattison, third edition, John Wiley & sons Ltd, Alden press, Oxford, UK.
147
References
Carter, M. J. & Milton, I. D. (1993). An inexpensive and simple method for DNA 
purifications on silica paiticles. Nucleic Acids Res 21, 1044.
Cartier, A., Komai, T. & Masucci, M. G. (2003). The Us3 protein kinase of heipes 
simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family 
member Bad. Exp Cell Res 291, 242-250.
Chen, H. S., Kaneko, S., Girones, R., Anderson, R. W., Hornbuckle, W. E., Tennant, 
B. C., Cote, P. J., Gerin, J. L.,Purcell, R. H., Miller, R. H. (1993). The
woodchuck hepatitis virus X gene is important for establishment of virus infection 
in woodchucks. J Virol 67, 1218-1226.
Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., 
O'Neill, R., Schickli, J., Palese, P., Henklein, P., Bennink, J. R., Yewdell, J. 
W. (2001). A novel influenza A virus mitochondrial protein that induces cell 
death. Nat Med 7, 1306-1312.
Chinnery, P. F. & Turnbull, D. M. (1997). Mitochondrial medicine. QJM 90, 657-667.
Cohen, G. H., Ponce de, L. M., Diggelmann, H., Lawrence, W. C., Vernon, S. K. & 
Eisenberg, R. J. (1980). Structural analysis of the capsid polypeptides of heipes 
simplex virus types 1 and 2. J Virol 34, 521-531.
Costanzo, F., Campadelli-Fiume, G., Foa-Tomasi, L. & Cassai, E. (1977). Evidence 
that herpes simplex virus DNA is transcribed by cellular RNA polymerase B. J 
Virol 21,996-1001.
Cox, N. J. & Subbarao, K. (2000). Global epidemiology of influenza: past and present. 
Annu Rev Med 51, 407-421.
Cranage, M. P., McLean, C. S., Buckmaster, E. A., Minson, A. C., Wildy, P. & 
Coombs, R. R. (1983). The use of monoclonal antibodies in (reverse) passive 
haemagglutination tests for heipes simplex virus antigens and antibodies. J Med 
Virol 11, 295-306.
148
References
Cunningham, E. T. & Margolis, T. P. (1998). Oculai* Manifestations of HIV Infection. 
N Engl J Med 339, 236-244.
Cunningham, L., Bowles, N. E. & Archard, L. C. (1991). Persistent virus infection of 
muscle in postviral fatigue syndrome. Br Med Bull 47, 852-871.
D Agostino, D. M., Ranzato, L., Arrigoni, G., Cavallari, I., Belleudi, F., Torrisi, M. 
R., Silic-Benussi, M., Ferro, T., Petronilli, V., Marin, O., Chieco-Bianchi, L., 
Bernard!, P., Ciminale, V. (2002). Mitochondrial alterations induced by the 
p i311 protein of human T-cell leukemia virus type 1. Critical role of arginine 
residues. J Biol Chem 277, 34424-34433.
Daniel, P. T., Schulze-Osthoff, K., Belka, C. & Guner, D. (2003). Guaidians of cell 
death: the Bcl-2 family proteins. Essays Biochem 39, 73-88.
DiMauro, S. & Moraes, C. T. (1993). Mitochondrial encephalomyopathies. Arch Neurol 
50, 1197-1208.
Dorig, R. E., Mardi, A., Chopra, A. & Richardson, C. D. (1993). The human CD46 
molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
DuBois, R. E., Seeley, J. K., Brus, I., Sakamoto, K., Ballow, M., Harada, S., 
Bechtold, T. A., Pearson, G. & Purtilo, D. T. (1984). Chronic mononucleosis 
syndiome. South Med J  77, 1376-1382.
Dumoulin, F. L., von dem, B. A., Li, J., Khamzina, L., Wands, J. R., Sauerbruch, T. 
& Spengler, U. (2003). Hepatitis C virus NS2 protein inhibits gene expression 
from different cellulai* and viral promoters in hepatic and nonhepatic cell lines. 
Virology 305, 260-266.
Earnshaw, W. C., Martins, L. M. & Kaufmann, S. H. (1999). Mammalian caspases: 
structure, activation, substrates, and functions during apoptosis. Annu Rev 
Biochem 68, 383-424.
Eguchi, Y., Shimizu, S. & Tsujimoto, Y. (1997). Intracellular ATP levels determine cell 
death fate by apoptosis or necrosis. Cancer Res 57, 1835-1840.
149
References
Eguchi, Y., Srinivasan, A., Tomaselli, K. J., Shimizu, S. & Tsujimoto, Y. (1999).
ATP-dependent steps in apoptotic signal transduction. Cancer Res 59, 2174-2181.
Ekert, P. G, & Vaux, D. L. (1997). Apoptosis and the immune system. Br Med Bull 53, 
591-603.
Elgadi, M. M., Hayes, C. E. & Smiley, J. R. (1999). The heipes simplex virus vhs 
protein induces endoribonucleolytic cleavage of taiget RNAs in cell extracts. J 
Virol 73,7153-7164.
Elmore, L. W., Hancock, A. R., Chang, S. F., Wang, X. W., Chang, S., Callahan, C. 
P., Geller, D. A., Will, H. & Harris, C. C. (1997). Hepatitis B virus X protein 
and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl 
Acad Sci USA94,  14707-14712.
Erdtmann, L., Franck, N., Lerat, H., Le, S. J., Gilot, D., Cannie, I., Gripon, P., 
Hibner, U. & Guguen-Guillouzo, C. (2003). The hepatitis C virus NS2 protein is 
an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 278, 18256-18264.
Esolen, L. M., Park, S. W., Hardwick, J. M. & Griffin, D. E. (1995). Apoptosis as a 
cause of death in measles virus-infected cells. J Virol 69, 3955-3958.
Everett, H., Barry, M., Lee, S. F., Sun, X., Graham, K., Stone, J., Bleackley, R. C. & 
McFadden, G. (2000). M llL: a novel mitochondria-localized protein of myxoma 
virus that blocks apoptosis of infected leukocytes. J Exp Med 191, 1487-1498.
Everett, H., Barry, M., Sun, X., Lee, S. F., Frantz, C., Berthiaume, L. G., McFadden, 
G. & Bleackley, R. C. (2002). The myxoma poxvii*us protein, M llL , prevents 
apoptosis by direct interaction with the mitochondrial permeability transition pore. 
J Exp Med 196, 1127-1139.
Feng, P., Park, J., Lee, B. S., Lee, S. H., Bram, R. J. & Jung, J. U. (2002). Kaposi's 
sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular 
calcium-modulating cyclophilin ligand to modulate intracellular calcium 
concentration and inhibit apoptosis. J Virol 76, 11491-11504.
150
References
Finsterer, J. (2004). Mitochoiidriopathies. Eur J Neurol 11, 163-186.
Fortunate, E. A., McElroy, A. K., Sanchez, I. & Specter, D. H. (2000). Exploitation of 
cellular signaling and regulatory pathways by human cytomegalovirus. Trends 
Microbiol 8, 111-119.
Frame, M. C., Purves, F. C., McGeech, D. J., Marsden, H. S. & Leader, D. P. (1987).
Identification of the herpes simplex virus protein kinase as the product of viral 
gene US3. J Gen Virol 68 ( Pt 10), 2699-2704.
Fuchs, W., Klupp, B. G., Granzew, H., Osterrieder, N. & Mettenleiter, T. C. (2002).
The interacting UL31 and UL34 gene products of pseudorabies virus are involved 
in egress from the host-cell nucleus and represent components of primary 
enveloped but not mature virions. J Virol 76, 364-378.
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G. & Komaroff, A. 
(1994). The chronic fatigue syndrome: a comprehensive approach to its definition 
and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 
121, 953-959.
Galvan, V., Brandimarti, R., Munger, J. & Roizman, B. (2000). Bcl-2 blocks a 
caspase-dependent pathway of apoptosis activated by herpes simplex virus 1 
infection in HEp-2 cells. J Virol 74, 1931-1938.
Gandhi, M. K. & Khanna, R. (2004). Human cytomegalovirus: clinical aspects, immune 
regulation, and emerging treatments. Lancet Infect Dis 4, 725-738.
Garg, R. K. (2002). Subacute sclerosing panencephalitis. Postgraduate Medical Journal 
78, 63-70.
Gautier, I., Coppey, J. & Durieux, C. (2003). Early apoptosis-related changes triggered 
by HSV-1 in individual neuronlike cells. Exp Cell Res 289, 174-183.
151
References
Geenen, K., Favoreel, H. W., Olsen, L., Ënquist, L. W. & Nauwynck, H. J. (2005).
The pseudorabies virus US3 protein kinase possesses anti-apoptotic activity that 
protects cells from apoptosis during infection and after treatment with sorbitol or 
staurospoiine. Virology 331, 144-150.
Ghiasi, H., Kaiwar, R., Nesburn, A. B. & Wechsler, S. L. (1992). Baculovirus- 
expressed glycoprotein G of herpes simplex virus type 1 partially protects 
vaccinated mice against lethal HSV-1 challenge. Virology 190, 233-239.
Gibbs, J. S., Malide, D., Hornung, F., Bennink, J. R. & Yewdell, J. W. (2003). The
influenza A virus PB1-F2 protein tar gets the inner mitochondrial membrane via a 
predicted basic amphrpathic helix that disrupts mitochondrial function. J Virol 77, 
7214-7224.
Gibson, W. & Roizman, B. (1972). Proteins specified by herpes simplex virus. 8. 
Characterization and composition of multiple capsid forms of subtypes 1 and 2. J 
Virol 10, 1044-1052.
Glaser, R. & Kiecolt-Glaser, J. K. (1998). Stress-associated immune modulation: 
relevance to viral infections and chronic fatigue syndrome. Am J Med 105, 35S- 
42S.
Goldmacher, V. S., Bartle, L. M., Skaletskaya, A., Dionne, C. A., Kedersha, N. L., 
Vater, C. A., Han, J. W., Lutz, R. J., Watanabe, S., Cahir McFarland, E. D. 
Kieff, E. D., Mocarski, E. S., Chittenden, T. (1999). A cytomegalovirus- 
encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to 
Bcl-2. Proc Natl Acad Sci U SA  96, 12536-12541.
Goshima, F., Daikoku, T., Yamada, H., Oshinia, S., Tsurumi, T. & Nishiyama, Y. 
(1998). Subcellular* localization of the US3 protein kinase of herpes simplex virus 
type 2. Arch Virol 143, 613-622.
Gottlieb RA. (2000). Role of mitochondria in apoptosis. Crit Rev Eukaryot Gene Expr 
10, 231-9.
152
References
Gottlob, K., Fulco, M., Levrero, M. & Graessmann, A. (1998). The hepatitis B virus 
HBx protein inhibits caspase 3 activity. J Biol Chem 273, 33347-33353.
Graham, K. A., Opgenorth, A., Upton, C. & McFadden, G. (1992). Myxoma virus 
M llL  ORF encodes a protein for which cell surface localization is critical in 
manifestation of viral virulence. Virology 191, 112-124.
Green, P. L. (2004). HTLV-1 p30II: selective repressor of gene expression. 
Retrovirology 1, 40.
Grodzicky, T. & Elkon, K. B. (2002). Apoptosis: a case where too much or too little can 
lead to autoimmunity. Mt Sinai J Med 69, 208-219.
Gross, A., McDonnell, J. M. & Korsmeyer, S. J. (1999). BCL-2 family members and 
the mitochondria in apoptosis. Genes Dev 13, 1899-1911.
Hatefi, Y. (1985). The mitochondrial electron transport and oxidative phosphorylation 
system. Annu Rev Biochem 5 4 ,1015-1069.
Hechtfischer, A., Marschall, M., Helten, A., Boswald, C. & Meier-Ewert, H. (1997).
A highly cytopathogenic influenza C virus variant induces apoptosis in cell 
culture. J Gen Virol 78 ( Pt 6), 1327-1330.
Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G. & Rickinson, A. (1993).
Epstein-Barr virus-coded BHRFl protein, a viral homologue of Bcl-2, protects 
human B cells from programmed cell death. Proc Natl Acad Sci U S A 90, 8479- 
8483.
Hinsliaw, V. S., Olsen, C. W., Dybdahl-Sissoko, N. & Evans, D. (1994). Apoptosis: a 
mechanism of cell killing by influenza A and B viruses. J Virol 68, 3667-3673.
Ho, D, W., Field, P. R., Irving, W. L., Packham, D. R. & Cunningham, A. L. (1993).
Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot 
(immunoblot) for diagnosis of initial heipes simplex virus type 2 genital 
infections. J Clin Microbiol 31, 3157-3164.
153
References
Holmes, G. P., Kaplan, J. E., Gantz, N. M., Komaroff, A. L., Schonberger, L. B., 
Straus, S. E., Jones, J. F., DuBois, R. E., Cunningham-Rundles, C., Paliwa, S. 
(1988). Chronic fatigue syndrome: a working case definition. Ann Intern Med 108, 
387-389.
Holmes, G. P. (1991). Defining the chronic fatigue syndrome. Rev Infect Dis 13 Suppl 1, 
S53-S55.
Holmes, G. P., Kaplan, J. E., Stewart, J. A., Hunt, B., Pinsky, P. F. & Schonberger, 
L. B. (1987). A cluster of patients with a chronic mononucleosis-like syndrome. Is 
Epstein-Barr virus the cause? JAMA 257, 2297-2302.
Honess, R. W. & Roizman, B. (1974). Regulation of heipesvirus macromoleculai* 
synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J 
Virol 14, 8-19.
Horikami, S. M. & Moyer, S. A. (1995). Alternative amino acids at a single site in the 
Sendai virus L protein produce multiple defects in RNA synthesis in vitro. 
Virology 211, 577-582.
Hotchin, N. A., Read, R., Smith, D. G. & Crawford, D. H. (1989). Active Epstein-Ban* 
virus infection in post-viral fatigue syndrome. J Infect 18, 143-150.
Howard, R. S., Russell, S., Losseff, N., Harding, A. E., Hughes, J. M., Wiles, C. M., 
Miller, D. H. & Hirsch, N. P. (1995). Management of mitochondrial disease on 
an intensive care unit. QJM 88, 197-207.
Hui, E. K. & Nayak, D. P. (2001). Role of ATP in influenza virus budding. Virology 
290, 329-341.
Ikoma, M., Liljeqvist, J. A., Groen, J., Glazenburg, K. L., The, T. H. & Welling- 
Wester, S. (2002). Use of a fragment of glycoprotein G-2 produced in the 
baculovirus expression system for detecting herpes simplex virus type 2-specific 
antibodies. J Clin Microbiol 40, 2526-2532.
154
References
Ito, M., Yamamoto, T., Watanabe, M., Ihara, T., Kamiya, H. & Sakurai, M. (1996).
Detection of measles virus-induced apoptosis of human monocytic cell line (THP- 
1) by DNA fragmentation ELISA. FEMS Immunol Med Microbiol 15, 115-122.
Jacotot, E., Ravagnan, L., Loeffler, M., Ferri, K. F., Vieira, H. L., Zamzami, N., 
Costantini, P., Druillennec, S., Hoebeke, J., Briand, J. P., Irinopoulou, T., 
Daugas, E., Susin, S. A., Cointe, D., Xie, Z. H., Reed, J. C., Roques, B. P., 
Kroemer, G. (2000). The HIV-1 viral protein R induces apoptosis via a direct 
effect on the mitochondrial peimeability transition pore. J Exp Med 191, 33-46.
Jerome, K. R., Chen, Z., Lang, R., Torres, M. R., Hofmelster, J., Smith, S., Fox, R., 
Froelich, C. J. & Corey, L. (2001). HSV and glycoprotein J inhibit caspase 
activation and apoptosis induced by granzyme B or Fas. J Immunol 167, 3928- 
3935.
Jerome, K. R., Fox, R., Chen, Z., Sears, A. E., Lee, H. & Corey, L. (1999). Heipes 
simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J 
Virol 73, 8950-8957.
Johns, D. R. (1995). Seminar's in medicine of the Beth Israel Hospital, Boston. 
Mitochondrial DNA and disease. N EnglJ Med 333, 638-644.
Johnson, D. C. & Ligas, M. W. (1988). Heipes simplex viruses lacking glycoprotein D 
are unable to inhibit virus penetration: quantitative evidence for virus-specific cell 
surface receptors. J Virol 62, 4605-4612.
Jordan, M. C., Jordan, G. W., Stevens, J. G. & Miller, G. (1984). Latent herpesviruses 
of humans. Ann Intern Med 100, 866-880.
Kaner, R. J., Baird, A., Mansukhani, A., Basilico, C., Summers, B. D., Florkiewicz, 
R. Z. & Hajjar, D. P. (1990). Fibroblast growth factor receptor is a portal of 
cellular entry for herpes simplex virus type 1. Science 248, 1410-1413.
Kaufmann, S. H. & Hengartner, M. O. (2001). Programmed cell death: alive and well 
in the new millennium. Trends Cell Biol 11, 526-534.
155
References
Kennedy P G (1991). Postviral fatigue syndrome: ciiiTent neurobiological perspective. 
British MedicalJoumal 47, 809-814.
Kerkhofs, P., Gatot, J. S., Knapen, K., Mammerickx, M,, Burny, A., Portetelle, D., 
Willems, L, & Kettmann, R. (2000). Long-term protection against bovine 
leukaemia virus replication in cattle and sheep. J Gen Virol 81, 957-963.
Kerr, J. F., Wyllie, A. H. & Currie, A. R. (1972). Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 
239-257.
Kerr, J. R., Bracewell, J., Laing, I., Mattey, D. L., Bernstein, R. M., Bruce, I. N. & 
Tyrrell, D. A, (2002). Chronic fatigue syndrome and aithralgia following 
parvovirus B19 infection. J Rheumatol 29, 595-602.
Kerr, J. F., Winterford, C. M. & Harmon, B. V. (1994). Apoptosis. Its significance in 
cancer and cancer therapy. Cancer 73, 2013-2026.
Kim, K. H. & Seong, B. L. (2003). Pro-apoptotic function of HBV X protein is mediated 
by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J 
22,2104-2116.
Kopp, M., Klupp, B. G., Granzow, H., Fuchs, W. & Mettenleiter, T. C. (2002).
Identification and characterization of the pseudorabies virus tegument proteins 
UL46 and UL47: role for UL47 in virion morphogenesis in the cytoplasm. J Virol 
76, 8820-8833.
Koppers-Lalic, D., Rijsewijk, F. A., Verschuren, S. B., Van Gaans-Van den Brink 
JA, Neisig, A., Ressing, M. E., Neefjes, J. & Wiertz, E. J. (2001).The UL41- 
encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are 
responsible for down-regulation of MHO class I molecules by bovine herpesvirus
1. J Gen Virol 82, 2071-2081.
156
References
Koundouris, A., Kass, G. E., Johnson, C. R., Boxall, A., Sanders, P. G. & Carter, M. 
J. (2000). Poliovirus induces an early impainnent of mitochondrial function by 
inhibiting succinate dehydrogenase activity. Biochem Biophys Res Commun 271, 
610-614.
Koyama, A. H. & Adachi, A. (1997). Induction of apoptosis by herpes simplex virus 
type 1. J Gen Virol 78 ( Pt 11), 2909-2912.
Kozak, M. (1980). Evaluation of the "scanning model" for initiation of protein synthesis 
in eucaryotes. Cell 22, 7-8.
Kroenke K (1991). Chronic fatigue syndrome: Is it real? Postgraduate Medicine 89, 44- 
55.
Lamarca, H. L., Sainz, B., Jr. & Morris, C. A. (2004). Permissive human 
cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line. 
VirolJl, 8.
Lamb, R. A. & Choppin, P. W. (1983). The gene structure and replication of influenza 
virus. Annu Rev Biochem 52, 467-506.
Lane, R. J., Woodrow, D. & Archard, L. C. (1994). Lactate responses to exercise in 
chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 57, 662-663.
Latchman DS (1988). Effect of herpes simplex virus type 2 infection on mitochondrial 
gene expression. J Gen Virol 69 , 1405—10.
Lee, J. Y., Marshall, J. A., Bowden, D. S. (1999). Localization of rubella virus core 
pai'ticles in vero cells. Virology 265, 110-119.
Lefebvre, L., Ciminale, V., Vanderplasschen, A., D Agostino, D., Burny, A., Willems, 
L. & Kettmann, R. (2002). Subcellular localization of the bovine leukemia vims 
R3 and G4 accessory proteins. J Virol 76, 7843-7854.
Leist, M. & Nicotera, P. (1997). The shape of cell death. Biochem Biophys Res Commun 
236, 1-9.
157
References
Leist, M., Single, B., Naumann, H., Fava, E., Simon, B., Kuhnle, S. & Nicotera, P. 
(1999). Inhibition of mitochondiial ATP generation by nitric oxide switches 
apoptosis to necrosis. Exp Cell Res 249, 396-403.
Leopardi, R., Van Sant. C. & Roizman, B. (1997). The heipes simplex virus 1 protein 
kinase US3 is required for protection from apoptosis induced by the virus. Proc 
Natl Acad Sci U SA94,  7891-7896.
Lerner, A. M., Beqaj, S. H., Deeter, R. G. & Fitzgerald, J. T. (2004). IgM serum 
antibodies to Epstein-Ban* virus are uniquely present in a subset of patients with 
the chronic fatigue syndiome. In Vivo 18, 101-106.
Lerner, M. A., Beqaj, S. H., Deeter, R. G. & Fitzgerald, J. T, (2002). IgM serum 
antibodies to human cytomegalovirus nonstructural gene products p52 and 
CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic 
fatigue syndrome. In Vivo 16, 153-159.
Li, F., Srinivasan, A., Wang, Y., Armstrong, R. C., Tomaselli, K. J. & Fritz, L. C. 
(1997). Cell-specific induction of apoptosis by microinjection of cytochrome c. 
Bcl-xL has activity independent of cytochiome c release. J Biol Chem 272, 30299- 
30305.
Li, H., Li, H., Li, W., Xiao, L., Jiang, Z., Li, M., Wang, X. & Zhang, L. (2003).
[Apoptosis of cancer cells induced by influenza virus and its elementaiy 
mechanism]. Sichuan Da Xue Xue Bao Yi Xue Ban 34, 409-412.
Liljeqvist, J. A., Trybala, E., Svennerholni, B., Jeansson, S., Sjogren-Jansson, E. & 
Bergstrom, T. (1998). Localization of type-specific epitopes of heipes simplex 
virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen 
Virol 19 {Ft 5), 1215-1224.
158
References
Lokensgard, J. R,, Cheeran, M. C., Gekker, G., Hu, S., Chao, C. C. & Peterson, P. 
K. (1999). Human cytomegalovirus replication and modulation of apoptosis in 
astrocytes. J Hum Virol 2, 91-101.
Lund, K., Ziola, B. (1986). Synthesis of mitochondrial macromolecules in herpes 
simplex type 1 virus infected Vero cells. Biochem Cell Biol 64, 1303—9.
Magrath, I., Jain, V. & Bhatia, K. (1992). Epstein-Bair virus and Burkitt's lymphoma. 
Se?nin Cancer Biol 3, 285-295.
Majno, G. & Joris, I. (1995). Apoptosis, oncosis, and necrosis. An overview of cell 
death. Am J Pathol 146, 3-15.
Manchester, M., Naniche, D. & Stehle, T. (2000). CD46 as a measles receptor: form 
follows function. Virology 274, 5-10.
Martin, W. J., Zeng, L. C., Ahmed, K. & Roy, M. (1994). Cytomegalovirus-related 
sequence in an atypical cytopathic virus repeatedly isolated from a patient with 
chronic fatigue syndrome. Am J Pathol 145, 440-451.
Mayer, B. & Oberbauer, R. (2003). Mitochondrial regulation of apoptosis. News 
Physiol Sci 18, 89-94.
McCormick, A. L., Smith, V. L., Chow, D. & Mocarski, E. S. (2003). Disruption of 
mitochondrial networks by the human cytomegalovirus UL37 gene product viral 
mitochondrion-localized inhibitor of apoptosis. J Virol 77, 631-641.
McFadden, G., Lalani, A., Everett, H., Nash, P. & Xu, X. (1998). Virus-encoded 
receptors for cytokines and chemokines. Semin Cell Dev Biol 9, 359-368.
McQuaid, S., McMahon, J., Herron, B. & Cosby, S. L. (1997). Apoptosis in measles 
virus-infected human central nervous system tissues. Neuropathol Appl Neurobiol 
23, 218-224.
159
References
McWhirter, S. M., Pullen, S. S., Holton, J. M., Crute, J. J., Kehry, M. R. & Alber, T. 
(1999). Crystallographic analysis of CD40 recognition and signaling by human 
TRAF2. Proc Natl Acad Sci U S A 96, 8408-8413.
Mettenleiter, T. C. (2002). Hei-pesvirus assembly and egress. J Virol 76, 1537-1547.
Minson, A. C., Hodgnian, T. C., Digard, P., Hancock, D. C., Bell, S. E. & 
Buckmaster, E. A. (1986). An analysis of the biological properties of monoclonal 
antibodies against glycoprotein D of herpes simplex virus and identification of 
amino acid substitutions that confer resistance to neutralization. J Gen Virol 67 ( 
Pt 6), 1001-1013.
Monto, A. S., Gravenstein, S., Elliott, M., Colopy, M. & Schweinle, J. (2000). Clinical 
Signs and Symptoms Predicting Influenza Infection. Archives of Internal 
Medicine 160, 3243-3247.
Mori, I., Komatsu, T., Takeuchi, K., Nakakuki, K., Sudo, M. & Kimura, Y. (1995).
In vivo induction of apoptosis by influenza virus. J Gen Virol 76 ( Pt 11), 2869- 
2873.
Mori, T., Ando, K., Tanaka, K., Ikeda, Y. & Koga, Y. (1997). Fas-mediated apoptosis 
of the hematopoietic progenitor cells in mice infected with murine 
cytomegalovirus. Blood 89, 3565-3573.
Morris, S. J., Price, G. E., Barnett, J. M., Hiscox, S. A., Smith, H. & Sweet, C. 
(1999). Role of neuraminidase in influenza virus-induced apoptosis. J Gen Virol 
80 (Pt 1), 137-146.
Munger, J., Chee, A. V. & Roizman, B. (2001). The U(S)3 protein kinase blocks 
apoptosis induced by the dl20 mutant of herpes simplex virus 1 at a 
premitochondrial stage. J Virol 75, 5491-5497.
160
References
Munger, J. & Roizman, B. (2001). The US3 protein kinase of herpes simplex virus 1 
mediates the posttranslational modification of BAD and prevents BAD-induced 
programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci 
USA9S,  10410-10415.
Murakami, S. (2001). Hepatitis B virus X protein: a multifunctional viral regulator. J 
Gastroenterol 36, 651-660.
Murata, T., Goshima, F., Daikoku, T., Inagaki-Ohara, K., Takakuwa, H., Kato, K. 
& Nishiyama, Y. (2000).Mitochondrial distribution and function in herpes 
simplex virus-infected cells. J Gen Virol 81, 401-406.
Murata, T., Goshima, F., Yamauchi, Y., Koshizuka, T., Takakuwa, H. & Nishiyama, 
Y. (2002). Heipes simplex virus type 2 US3 blocks apoptosis induced by sorbitol 
treatment. Microbes Infect 4, 707-712.
Nagata, S., Nagase, H., Kawane, K., Mukae, N. & Fukuyama, H. (2003). Degradation 
of chromosomal DNA during apoptosis. Cell Death Differ 10, 108-116.
Nakai, M. & Imagawa, D. T. (1969). Electron microscopy of measles virus replication. J 
Virol 3, 187-197.
Nakaya, T., Takahashi, H., Nakamur, Y., Kuratsune, H., Kitani, T., Machii, T., 
Yamanishi, K. & Ikuta, K. (1999). Boma disease virus infection in two family 
clusters of patients with chronic fatigue syndiome. Microbiol Immunol 43, 679- 
689.
Niaudet, P. (1998). Mitochondiial disorders and the kidney. Arch Dis Child 78, 387-390.
Nichols, J. E., Niles, J. A. & Roberts, N. J., Jr. (2001). Human lymphocyte apoptosis 
after exposure to influenza A virus. J Virol 75, 5921-5929.
Nicholson, D. W. & Thornberry, N. A. (1997). Caspases: killer proteases. Trends 
Biochem Sci 22, 299-306.
Noble, B. (2003). Bone microdamage and cell apoptosis. Eur Cell Mater 6,46-55.
161
References
Norkin LC (1997). Cell killing by simian virus 40: impairment of membrane formation 
and function . J Virol 21, 872-8799.
Nowotny, N. & Kolodziejek, J. (2000). Demonstration of borna disease virus nucleic 
acid in a patient with chronic fatigue syndrome. J Infect Dis 181, 1860-1862.
O'Brien, T. W., Denslow, N. D., Anders, J. C. & Courtney, B. C. (1990). The
translation system of mammalian mitochondria. Biochim Biophys Acta 1050, 174- 
178.
Ogg, P. D., McDonell, P. J., Ryckman, B. J., Knudson, C. M. & Roller, R. J. (2004).
The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by 
overexpression of a variety of Bcl-2 family members. Virology 319, 212-224.
Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S, M. & 
Weinman, S. A. (2002). Mitochondiial injury, oxidative stress, and antioxidant 
gene expression aie induced by hepatitis C virus core protein. Gastroenterology 
122, 366-375.
Park, J. R. & Hockenbery, D. M. (1996). BCL-2, a novel regulator of apoptosis. J Cell 
Biochem 60, 12-17.
Paula-Barbosa, M. M., Tavares, M. A. & Borges, M. M. (1984). Mitochondrial 
abnormalities in cortical dendrites from patients with early forms of subacute 
sclerosing panencephalitis (SSPE). Acta Neuropathol (Bed) 63, 117-122.
Paulose-Murphy, M., Ha, N. K., Xiang, C., Chen, Y., Gillim, L., Yarchoan, R., 
Meltzer, P., Bittner, M., Trent, J., Zeichner, S. (2001). Transcription program 
of human herpesvirus 8 (kaposi's saicoma-associated heipesvirus). J Virol 75, 
4843-4853.
Perkins, G., Renken, C., Martone, M. E., Young, S. J., Ellisman, M. & Frey, T. 
(1997). Electron tomography of neuronal mitochondiia: three-dimensional 
structure and organization of cristae and membrane contacts. J Struct Biol 119, 
260-272.
162
References
Perkins, G. A. & Frey, T. G. (2000). Recent structural insight into mitochondria gained 
by microscopy. Micron 31, 97-111.
Poffenberger, K. L. & Roizman, B. (1985). A noninverting genome of a viable herpes 
simplex virus 1: presence of head-to-tail linkages in packaged genomes and 
requirements for circularization after infection. J Virol 53, 587-595.
Pollack, M. & Leeuwenburgh, C. (2001). Apoptosis and aging: role of the 
mitochondria. J Gerontol A Biol Sci Med Sci 56, B475-B482.
Pomeroy, C. & Englund, J. A. (1987). Cytomegalovirus: epidemiology and infection 
control. Am J Infect Control 15, 107-119.
Portner, A., Murti, K. G., Morgan, E. M. & Kingsbury, D. W. (1988). Antibodies 
against Sendai virus L protein: distribution of the protein in nucleocapsids 
revealed by immunoelectron microscopy. Virology 163, 236-239.
Qian, H. & Atherton, S, (2003). Apoptosis and increased expression of Fas ligand after 
uniocular anterior chamber (AC) inoculation of HSV-1. Curr Eye Res 26, 195- 
203.
Radovanovic, J., Todorovic, V., Boricic, I., Jankovic-Hladni, M. & Korac, A. (1999).
Comparative ultrastructural studies on mitochondrial pathology in the liver of 
AIDS patients: clusters of mitochondria, protuberances, "minimitochondria," 
vacuoles, and virus-like paitides. Ultrastruct Pathol 23, 19-24.
Rahmani, Z., Huh, K. W., Lasher, R. & Siddiqui, A. (2000). Hepatitis B virus X 
protein colocalizes to mitochondria with a human voltage-dependent anion 
channel, HVDAC3, and alters its transmembrane potential. J Virol 74, 2840-2846.
Raj, K., Berguerand, S., Southern, S., Doorbar, J. & Beard, P. (2004). El empty set 
E4 protein of human papillomavirus type 16 associates with mitochondria. J Virol 
78,7199-7207.
Rail, G. F. (2003). Measles virus 1998-2002: progress and controversy. Annu Rev 
Microbiol 57, 343-367.
163
References
Reed, J. C. (1995). Regulation of apoptosis by bcl-2 family proteins and its role in cancer 
and chemoresistance. Curr Opin Oncol 7, 541-546.
Reynolds, A. E., Wills, E. G., Roller, R. J., Ryckman, B. J. & Baines, J. D. (2002).
Ultrastructural localization of the heipes simplex virus type 1 UL31, UL34, and 
US3 proteins suggests specific roles in primary envelopment and egress of 
nucleocapsids. J Virol 76, 8939-8952.
Roizman, B. (1996). The function of heipes simplex virus genes: a primer for genetic 
engineering of novel vectors. Proc Natl Acad Sci U SA93,  11307-11312.
Roizman, B. (1979). The structure and isomerization of herpes simplex virus genomes. 
Cell 16,481-494.
Roizman, B. and Sears, A. E. (1996). In Fields Virology, editors: Fields, B. N., Knipe, 
D. M. & Howley, P. M. (Lippincott-Raven, Philadelphia), Vol. 3, pp. 2231-2295.
Rostovtseva, T. K. & Bezrukov, S. M. (1998). ATP transport through a single 
mitochondrial channel, VDAC, studied by current fluctuation analysis. Biophys J 
74, 2365-2373.
Roulston, A., Marcellus, R. C. & Branton, P. E. (1999). Viruses and apoptosis. Annu 
Rev Microbiol 53, 577-628.
Sairenji, T., Yamanishi, K., Tachibana, Y., Bertoni, G. & Kurata, T. (1995).
Antibody responses to Epstein-Baix virus, human herpesvirus 6 and human 
herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology 38, 269- 
273.
Saraste, M. (1999). Oxidative phosphorylation at the fin de siecle. Science 283, 1488- 
1493.
Scheffler, I. E. (2001). A century of mitochondrial research: achievements and 
perspectives. Mitochondrion 1, 3-31.
164
References
Schneider-Schaulies, J., Niewiesk, S., Schneider-Schaulies, S. & ter, M., V. (1999).
Measles virus in the CNS: the role of viral and host factors for the establishment 
and maintenance of a persistent infection. J Neurovirol 5, 613-622.
Schrag, J. D., Prasad, B. V., Rixon, F. J. & Chiu, W. (1989). Three-dimensional 
structure of the HSVl nucleocapsid. Cell 56, 651-660.
Schultz-Cherry, S., Dyhdahl-Sissoko, N., Neumann, G., Kawaoka, Y. & Hinshaw, V. 
S. (2001). Influenza virus nsl protein induces apoptosis in cultured cells. J Virol 
75,7875-7881.
Servet-Delprat, C., Vidalain, P. O., Azocar, O., Le, D. F., Fischer, A. & Rabourdin- 
Combe, C. (2000). Consequences of Fas-mediated human dendritic cell apoptosis 
induced by measles virus. J Virol 74, 4387-4393.
Severs, N. J. & Robenek, H. (1983). Detection of microdomains in biomembranes. An 
appraisal of recent developments in freeze-fracture cytochemistry. Biochim 
Biophys Acta 737, 373-408.
Shapiro, G. I. & King, R. M. (1988). Influenza virus RNA replication in vitro: synthesis 
of viral template RNAs and virion RNAs in the absence of an added primer. J 
Virol 62, 2285-2290.
Shaw, M. W., Arden, N. H, & Maassab, H. F. (1992). New aspects of influenza viruses. 
Clin Microbiol Rev 5, 74-92.
Sherratt, H. S. (1991). Mitochondria: structure and function. Rev Neurol (Paris) 147, 
417-430.
Shieh, M. T., WuDunn, D., Montgomery, R. I., Esko, J. D. & Spear, P. G. (1992).
Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. 
J Cell Biol 116, 1273-1281.
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., 
Eisenberg, R. J., Rosenberg, R. D., Spear, P. G. (1999). A novel role for 3-0- 
sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13-22.
165
References
Silic-Benussi, M., Cavallari, I., Zorzan, T., Rossi, E., Hiraragi, H., Rosato, A., Horie, 
K., Saggioro, D., Lairmore, M. D., Willems, L., Chieeo-Bianchi, L., 
D Agostino, D. M., Ciminale, V. (2004). Suppression of tumor growth and cell 
proliferation by p i311, a mitochondrial protein of human T cell leukemia virus 
type 1. Proc Natl Acad Sci U SA  101, 6629-6634.
Sindre, H., Rollag, H., Olafsen, M. K., Degre, M. & Hestdal, K. (2000). Human 
cytomegalovirus induces apoptosis in the hematopoietic cell line M07e. APMIS 
108, 223-230.
Sinzger, C., Grefte, A., Plachter, B., Gouw, A. S., The, T. H. & Jahn, G. (1995).
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells aie major 
targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J 
Gen Virol 76 ( Pt 4), 741-750.
Skaletskaya, A., Bartle, L. M., Chittenden, T., McCormick, A. L., Mocarski, E. S. & 
Goldmacher, V. S. (2001). A cytomegalovirus-encoded inhibitor of apoptosis 
that suppresses caspase-8 activation. Proc Natl Acad Sci U S A9S,  7829-7834.
Spear, P. G. & Longnecker, R. (2003). Heipes virus entry: an update. J Virol 77, 10179- 
10185.
Stagno, S., Pass, R. F., Cloud, G., Britt, W. J., Henderson, R. E., Walton, P. D., 
Veren, D. A., Page, F. & Alford, C. A. (1986). Primary cytomegalovirus 
infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. 
JAMA: The Journal of the American Medical Association 256, 1904-1908.
Stanziale, S. F., Petrowsky, H., Adusumilli, P. S., Ben-Porat, L., Gonen, M. & Fong, 
Y. (2004). Infection with oncolytic herpes simplex virus-1 induces apoptosis in 
neighboring human cancer cells: a potential taiget to increase anticancer activity. 
Clin Cancer Res 10, 3225-3232.
Steinhauer, D. A. & Skehel, J. J. (2002). Genetics of influenza viruses. Annu Rev Genet 
36, 305-332.
166
References
Stewart, S. A., Poon, B., Song, J. Y. & Chen, I. S. (2000). Human immunodeficiency 
virus type 1 vpr induces apoptosis through caspase activation. J Virol 74, 3105- 
3111.
Stewart, T. L., Wasilenko, S. T. & Barry, M. (2005). Vaccinia virus FIL protein is a 
tail-anchored protein that functions at the mitochondria to inhibit apoptosis. J 
Virol 79, 1084-1098.
Streblow, D. N. & Nelson, J. A. (2003). Models of HCMV latency and reactivation. 
Trends Microbiol 11, 293-295.
Suzuki, Y., Taniyama, M., Muramatsu, T., Ohta, S., Murata, C., Atsumi, Y. & 
Matsuoka, K. (2003). Mitochondiial tRNA(Leu(UUR)) mutation at position 3243 
and symptomatic polyneuropathy in type 2 diabetes. Diabetes Care 26, 1315- 
1316.
Swanink, C. M., Melchers, W. J., Van der Meer, J. W., Vercoulen, J. H., 
Bleijenberg, G., Fennis, J. F. & Galama, J. M. (1994). Enteroviruses and the 
chronic fatigue syndrome. Clin Infect Dis 19, 860-864.
Takada, S., Shirakata, Y., Kaneniwa, N. & Koike, K. (1999). Association of hepatitis 
B virus X protein with mitochondiia causes mitochondrial aggregation at the 
nucleai' periphery, leading to cell death. Oncogene 18, 6965-6973.
Takase, K., Kelleher, C. A., Terada, N., Jones, J. F., Lucas, J. J. & Gelfand, E. W. 
(1996). Dissociation of EB V genome replication and host cell proliferation in anti- 
IgG-stimulated Akata cells. Clin Immunol Immwiopathol 81, 168-174.
Takizawa, T., Matsukawa, S., Higuchi, Y., Nakamura, S., Nakanishi, Y. & Fukuda, 
R. (1993). Induction of programmed cell death (apoptosis) by influenza virus 
infection in tissue culture cells. J Gen Virol 74 ( Pt 11), 2347-2355.
Tam, P. E. & Messner, R. P. (1999). Molecular mechanisms of coxsackievirus 
persistence in chronic inflammatory myopathy: viral RNA persists through 
formation of a double-stranded complex without associated genomic mutations or 
evolution. J Virol 73, 10113-10121.
167
References
Tenser, R. B., Edris, W. A. & Hay, K. A. (1993). Neuronal control of heipes simplex 
virus latency. Virology 195, 337-347.
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., 
Kostura, M. J., Miller, D. K., Molineaux, S. M,, Weidner, J. R., Aunins, J. 
(1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta 
processing in monocytes. Nature 356, 768-774.
Thornberry, N. A. & Lazebnik, Y. (1998). Caspases: enemies within. Science 281, 
1312-1316.
Thurlow, J. K., Rixon, F. J., Murphy, M., Targett-Adams, P., Hughes, M. & Preston, 
V. G. (2005). The heipes simplex virus type 1 DNA packaging protein UL17 is a 
virion protein that is present in both the capsid and the tegument compartments. J 
y /ra /79, 150-158.
Tropea, F., Troiano, L., Monti, D., Lovato, E., Malorni, W., Rainaldi, G., Mattana, 
P., Viscomi, G., Ingletti, M. C., Portolani, M. (1995). Sendai virus and heipes 
virus type 1 induce apoptosis in human peripheral blood mononucleai" cells. Exp 
Cell Res 218, 63-70.
Tsujimoto, Y. (1997). Apoptosis and necrosis: Intracellulai* ATP level as a determinant 
for cell death modes. Cell Death and Differentiation 4, 434-429.
Tsurumi, T., Lehman, I. (1990). Release of RNA polymerase from vero cell 
mitochondria after herpes simplex virus type 1 infection. J Virol 64, 450-2.
Uchide, N., Ohyama, K., Bessho, T., Yuan, B. & Yamakawa, T. (2002). Apoptosis in 
cultured human fetal membrane cells infected with influenza virus. Biol Pharm 
Bull 25, 109-114.
Van Gurp. M., Festjens, N., Van Loo. G., Saelens, X. & Van denabeele, P. (2003).
Mitochondrial intennembrane proteins in cell death. Biochem Biophys Res 
Commun 304, 487-497.
168
References
Van Loo. G., Saelens, X., Van Gurp. M., MacFarlane, M., Martin, S. J. & 
Vandenabeele, P. (2002). The role of mitochondrial factors in apoptosis; a 
Russian roulette with more than one bullet. Cell Death Differ 9, 1031-1042.
Van Minnebruggen. G., Favoreel, H. W., Jacobs, L. & Nauwynck, H. J. (2003).
Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown. J 
Virol 77, 9074-9080.
Van Zijl. M., Van der, G. H., de, W. N., Gielkens, A. & Berns, A. (1990).
Identification of two genes in the unique short region of pseudorabies virus; 
compaiison with heipes simplex virus and varicella-zoster virus. J Gen Virol 71 ( 
Pt 8), 1747-1755.
Vuorinen, T., Peri, P. & Vainionpaa, R. (2003). Measles virus induces apoptosis in 
uninfected bystander T cells and leads to granzyme B and caspase activation in 
peripheral blood mononuclear cell cultures. Eur J Clin Invest 33, 434-442.
Wadsworth, S., Hayward, G. S. & Roizman, B. (1976). Anatomy of herpes simplex 
virus DNA. V. Temiinally repetitive sequences. J Virol 17, 503-512.
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V. & 
Boldin, M, P. (1999). Tumor necrosis factor receptor and Fas signaling 
mechanisms. Annu Rev Immunol 17, 331-367.
Wallace, D. C. & Murdock, D. G. (1999). Mitochondria and dystonia: the movement 
disorder connection? Proc Natl Acad Sci U S A96,  1817-1819.
Wallace, H. L., Natelson, B., Gause, W. & Hay, J. (1999). Human heipesviruses in 
chronic fatigue syndrome. Clin Diagn Lab Immunol 6, 216-223.
Wang, X. (2001). The expanding role of mitochondiia in apoptosis. Genes Dev 15, 2922- 
2933.
Wasilenko, S. T., Stewart, T. L., Meyers, A. F. & Barry, M. (2003). Vaccinia virus 
encodes a previously unchaiacterized mitochondrial-associated inhibitor of 
apoptosis. Proc Natl Acad Sci USA  100, 14345-14350.
169
References
Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J. J. & Wiley, D. C. 
(1988). Structure of the influenza virus haemagglutinin complexed with its 
receptor, sialic acid. Nature 333, 426-431.
Whitley, R. J. & Roizman, B. (2002). Herpes simplex viruses: is a vaccine tenable? J 
Clin Invest 110, 145-151.
Wild, T. F., Malvoisin, E. & Buckland, R. (1991). Measles virus: both the 
haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 72 ( 
Pt 2), 439-442.
Wong, L. J., Craigen, W. J. & O'Brien, W. E. (1994), Postpartum Coma and Death due 
to Caibamoyl-Phosphate Synthetase I Deficiency. Annals of Internal Medicine 
120, 216-217.
Woodfin, B. M. & Kazim, A. L. (1993). Interaction of the amino-teiTninus of an 
influenza virus protein with mitochondiia. Arch Biochem Biophys 306, 427-430.
WuDunn, D. & Spear, P. G. (1989). Initial interaction of heipes simplex vims with cells 
is binding to heparan sulfate. J Virol 63, 52-58.
Wyllie, A. H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with 
endogenous endonuclease activation. Nature 284, 555-556.
Wyllie, A. H. (1997). Apoptosis: an overview. Br Med Bull 53, 451-465.
Yamada, H., Chounan, R., Higashi, Y., Kurihara, N. & Kido, H. (2004).
Mitochondrial tai'geting sequence of the influenza A virus PB1-F2 protein and its 
function in mitochondiia. FEBS Lett 578, 331-336.
Yamanishi K (1992). Chronic fatigue syndrome and virus infection: human herpesvirus 6 
(HHV-6), infection Nippon Rinsho 1992 Nov. infection Nippon Rinsho 50, 2612- 
2616.
170
References
Yamauchi, Y., Shiba, C., Goshima, F., Nawa, A., Murata, T. & Nishiyama, Y. (2001).
Herpes simplex virus type 2 UL34 protein requires UL31 protein for its relocation 
to the internal nuclear membrane in transfected cells. J Gen Virol 82, 1423-1428.
Yoshida, H., Sumichika, H., Hamano, S., He, X., Minamishima, Y., Kimura, G. & 
Nomoto, K. (1995). Induction of apoptosis of T cells by infecting mice with 
murine cytomegalovirus. J Virol 69, 4769-4775.
Yoshimura, A. & Ohnishi, S. (1984). Uncoating of influenza virus in endosomes. J 
Virol 51, 497-504.
Young, J. F. & Palese, P. (1979). Evolution of human influenza A viruses in nature: 
recombination contributes to genetic variation of H lN l strains. Proc Natl Acad 
Sci U S A I 6, 6547-6551.
Yu, P., Yu, D. M., Liu, D. M., Wang, K. & Tang, X. Z. (2004). Relationship between 
mutations of mitochondiial DNA NDl gene and type 2 diabetes. Chin Med J 
(Engl) 117, 985-989.
Zanotto, P. M., Gibbs, M. J., Gould, E. A. & Holmes, E. C. (1996). A réévaluation of 
the higher taxonomy of viruses based on RNA polymerases. J Virol 70, 6083- 
6096.
Zhao, L. J., Wang, L., Mukherjee, S. & Narayan, O. (1994). Biochemical mechanism 
of mV-1 Vpr function. Oligomerization mediated by the N-tenninal domain. J 
Biol Chem 269, 32131-32137.
Zhirnov, O. P., Konakova, T. E., Wolff, T. & Klenk, H. D. (2002). NSl protein of 
influenza A virus down-regulates apoptosis. J Virol 76, 1617-1625.
Zhou, G., Galvan, V., Campadelli-Fiume, G. & Roizman, B. (2000). Glycoprotein D 
or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a heipes 
simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J Virol 
74, 11782-11791.
171
References
Zhou, G. & Roizman, B, (2000). Wild-type herpes simplex virus 1 blocks programmed 
cell death and release of cytochrome c but not the translocation of mitochondrial 
apoptosis-inducing factor to the nuclei of human embryonic lung fibroblasts. J 
Virol 74, 9048-9053.
Zhou, G. & Roizman, B. (2002). Cation-independent mannose 6-phosphate receptor 
blocks apoptosis induced by herpes simplex virus 1 mutants lacking glycoprotein 
D and is likely the target of antiapoptotic activity of the glycoprotein. J Virol 76, 
6197-6204.
Zhu, H., Shen, Y. & Shenk, T. (1995). Human cytomegalovirus lE l and IE2 proteins 
block apoptosis. J Virol 69, 7960-7970.
Zoullm, F., Saputelli, J. & Seeger, C. (1994). Woodchuck hepatitis virus X protein is 
required for viral infection in vivo. J Virol 68, 2026-2030.
172
General Solutions and Materials Appendix I
Appendix 1 
General Solutions and Materials:
10% (v/v) formai saline
10 ml fomialdehyde (Fisher Chemicals)
90 ml saline (0.89 g NaCl in 100 ml MQ H2O)
Phosphate buffered saline (PBS Ix)
One tablet (Invitrogen) in 100 ml MQ H2O. Autoclaved, Stored at 4°C
Each 5 g tablet contains 3000 mg/1 NaCl, 200 mg/1 KCl, 1150 mg/1 Na2HP4 and 200
mg/1 KH2PO4
Trypsin/Versin
10 ml Trypsin 2.5% (25 g/L trypsin (1:250) and 8.5 g/L NaCl) (Invitrogen), 100 ml 
Versine
1/5000 (Invitrogen). Stored at 4°C 
Agar medium for plaque assay:
0.8 g agar (Invitrogen), 100 ml MQ H2O, autoclaved. Melted and equilibrated to 
42°C, mixed with an equal volume of pre-equilibrated double-strength MEM
Crytal violet stain
(0.1% crystal violet in ethyl alcohol 20%)
0.1 g crystal violet (Sigma)
100 ml ethyl alcohol 20% (Fisher Chemicals)
General Solutions and Materials Appendix 1
Respiration Buffer
210 mM mannitol (Sigma), 70 mM sucrose (Fisher) 1 mM EGTA 
(Ethyleneglycotetraacetic acid) (Sigma), 5 mM Hepes (Sigma) pH 7.1 at room 
temperature. Respiration buffer was prepared by mixing two stock solutions:
Solution “A” was made by dissolving 19.15 g mannitol, 12.0 g sucrose and 596 mg 
Hepes in 400 ml MQ H2O.
Solution “B” was prepared by adding 380 mg EGTA to 2 ml MQ H2O. The pH of 
solution “B” was adjusted to pH 7.8 by KOH using pH meter.
Respiration buffer was then prepared by adding 5 ml of solution “B” to 400 ml of 
solution A and was stored at 4°C
Digitonin: (BDH)
50 mg/ml (in MQ H2O), stored at 4°C 
Malate/ Pyruvate(M/P): (Sigma)
500 mM sodium malate, 500 mM sodium pyruvate MQ H2O.
Prepai'ation of the solution:
156 mg sodium malate and 110 mg sodium pyruvate were dissolved in 2 ml MQ H2O. 
Stored at -20“C
General Solutions and Materials Appendix 1
Roteiione (Sigma)
0.3 mg/ml (in dimethyl sulfoxide, DMSO)
Preparation of the solution:
10 mg rotenone was dissolved in 1 ml DMSO then from this 100 |Lil was to 2.9 ml 
DMSO, stored at 4°C
Succinate (Sigma)
500 mM potassium succinate (in MQ H2O)
Preparation of the solution:
135 mg sodium succinate was dissolved in 1 ml MQ H2O, stored at -20°C
Antimycin A (Sigma)
0.3 mg/ml (in DMSO)
Preparation of the solution: Dissolved 10 mg antimycin A in 1 ml DMSO (stock 10 
mg/ml). 100 j.il stock was added to 2.9 ml DMSO to give a 0.3 mg/ml working 
solution, stored at -20°C
TMPD/Ascorbate (Sigma)
50 mM TMPD, 100 mM ascorbate (in MQ H2 O)
Preparation of the solution:
Dissolved 24 mg N, N, N’, N’-tetramethyl-p-phenylenediamine (TMPD) in 2 ml MQ 
H2O. Dissolved 79.2 mg sodium ascorbate in 4 ml MQ H2O. Stored at -20°C
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NaNs (Sigma)
500 mM (in MQ H2O),
65 mg sodium azide (NaNs) was dissolved in 2 ml MQ H2 O, stored at 4°C
Solutions and materials used in SDS-polyacrylamide-gel- 
electrophoresis (SDS-PAGE) and Western Blot
Stacking gel buffer (BX2):
0.25MTris-HCl,pH6.8
15.12 g Tris was dissolved in MQ H2O; pH was adjusted to 6.8 with HCl. Final 
volume 500 ml
Resolving gel buffer (AX2)
0.75MTris-HCl, pH 8.8
45.3 g Tris was dissolved in MQ H2O; pH was adjusted to 8.8 with HCl. Final volume 
500 ml
Sodium dodecyl sulfate, 20% (w/v) (SDS)
20 g electrophoresis-grade SDS 
Made to 100 ml with distilled water
Adjusted at pH 7.2 with HCl and then was sterilized using 0.22 pm filter
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2x sample buffer
5 ml BX2, 2 ml 20% SDS, 4 g glycerol 0.5 ml 2-mercaptoethanol, small amount of 
solid 1% bromophenol blue,
MQ H2O, final volume 10 ml
Acrylamiderbis-acrylamide (Biorad)
40 g acrylamide and 1.08 g bisacrylamide was mixed with MQ H2O to a final volume 
100 ml. Stored at 4°C. (Disposable nitrile gloves must be worn because it is a 
neurotoxin)
Ammonium per sulphate (APS) (Sigma)
20 mg APS, 1 ml MQ H2O
Resolving gel (10%)
4.6 ml MQ H2O, 10 ml AX2, 5 ml acrylamide: bis-acrylamide, 100 pi SDS 20%, 200 
pi ammonium per sulphate, 50 pi N,N,N',N'-Tetramethylethylenediamine (TEMED) 
(Sigma)
SDS-PAGE running buffer
3 g Tris (Roche)
14.4 g glycine (Sigma)
Dissolved in MQ H2O up to 995 ml and then 5 ml SDS 20% was added
General Solutions and Materials Appendix 1
Coomassie stain for protein gel
1.25 g coomassie brilliant blue 
125 ml methanol (Fisher Chemicals)
50 ml glacial acetic acid (Fisher Chemicals)
325 ml MQ H2O
Destain
125 ml methanol,
50 ml glacial acetic acid 
325 ml MQ H2O
Blocking solution
5% (w/v) Marvel in Ix TB S/Tween-20 
Western blot transfer buffer
3.03 g Tris (25 mM), 14.4 g glycine (192 mM), 200 ml methanol 20%, 800 ml MQ 
H2O
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lOx TBS/Tween-20
24.2 g Tris 
80 g NaCI
Made up to 800 ml with MQ H2O 
Adjusted to pH 7.6 with concentrated HCl,
Added 10 ml Tween-20 (BDH, UK)
Made up to final volume 1000 ml (with MQ H2 O). Stored at 4°C
Stacking gel 4%
3.75 ml MQ H2O 
5 ml BX2
1 ml acrylamide:bis-acrylamide 
50 pi SDS 20%
100 pi ammonium per sulphate, 30 pi TEMED (Sigma)
• Materials and solutions used in working with RNA and DNA 
T4 DNA polymerase buffer (Promega)
Tris-HCl (pH 7.9) 0.33 mM, Potassium acetate 0.66 mM, MgC^O.l M, DTT 5 mM
5x first strand buffer (Promega)
Tris-HCl (pH 8.3) 250 mM, KCl 375 mM, MgCl2l5 mM
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lOx ligation buffer (Promega)
Tris-HCl (pH 7.6) 660 mM, MgCl% lOOmM, DTT 5 mM, spermidine 10 mM, BSA 2 
mg/ml
2xYT medium
Bacto tryptone 16 g (Oxoid)
Bacto yeast extract 10 g (Oxoid)
NaCl 10 g
Made up to 1 litre with MQ H2O to and was sterilized by autoclaving 
Agar plates
1.2 g of bacto agar was added to 100 ml 2x YT medium and was boiled to dissolve. 
The agar was cooled to 50°C and then ampicillin (50 pg/ml) was added. Finally, X- 
Gal (2% X-Gal was made in dimethyl formamide at 1/200 concentration) and IPTG 
(0.1 M IPTG dissolved in water at 1/400 concentration) was then added to the 
medium
lOx TBE buffer
Tris base 107.8 g, boric acid 55 g (Sigma), EDTA 9.3 g (Sigma), MQ H2O up to 1 
litre
2x TBE sample buffer
12 ml MQ H2O, 4 ml lOx TBE, 4 ml glycerol (Fisher chemicals), small amount of 
two dyes; bromophenol blue and xylene cyanol (BDH, UK)
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Ethidinum bromide (EtBr)
10 mg/ml: One 100 mg tablet in 10 ml MQ H2O, used at 0.5 mg/ml concentration for 
agarose gel and running buffer
Additives for bacterial transformation
Ampicillin (25 mg/ml in MQ H2O and stored at -20°C) and used at 1/500 dilution, X- 
Gal (5-bromo-4-chloro-3-indolyl-b-D-galactoside) (2% in dimethyl formamide, stored 
at -20°C) and used at 1/200, IPTG (isopropyl b-D-thiogalactoside) (0.1 M in distilled 
MQ H2O, stored at -20°C) and used at 1/400
Resuspension buffer for diatom mini preparation
50 mM Tris pH 7.5 (5 ml of 1 M Tris ph 7.5), 10 mM EDTA (5 ml of 0.2 M EDTA), 
100 pg/ml RNase A (1 ml of 10 mg/ml RNase A), 89 ml MQ H2O
Lysis buffer for diatom mini preparation
0.2 M NaOH (5 ml of 4M  NaOH), 1 % SDS (10 ml of 10% SDS), 85 ml MQ H2O
Neutralization buffer for diatom mini preparation
55 M potassium acetate. pH was adjusted to 4.8 with glacial acetic acid
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Diatom suspension for diatom mini preparation
4 M guanidine thiocyanate (47.28 g guanidine thiocyanate), 20 mM Tris pH 7.2 (2 ml 
of 1 M Tris pH 7.2), 20 mM EDTA (10 ml of 0.2 M EDTA), 10 mg/ml diatomaceous 
earth (Sigma), 8 ml of a 12.5% suspension of diatoms in MQ H2O, made up to 100 ml 
with MQ H2O
Pellet wash solution for diatom mini preparation
0.1 M NaCl (5 ml of 4 M NaCl), 10 mM Tris pH 7.5 (2 ml of 1 M Tris pH 7.5), 2.5 
mM EDTA (2.5 ml of 200 mM EDTA), 50% ethanol (100 ml absolute ethanol and 
100 ml MQ H2O)
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Cell culture Media:
Cell growth medium
Ingredients Used volume Finalconcentration
Foetal bovine serum heat inactivated 
(PBS) (Gibed) 15 ml, 10 ml or 2 ml 15%, 10% or 2%*
Penicillin (10000 U/ml) (Gibed) 1 ml 1%
Streptomycin (10000 pg/ml) (Gibed) 1 ml 1%
Non essential amino acid (NEA) 
(Gibed) 1 ml IX
Minimal essential medium (MEM) 
(Gibed) 100 ml —
* The different concentrations of bovine serum were used to tailor the medium for 
different puiposes; 10% was used for general growth of cultures, and 2% for 
maintenance of monolayers once confluent. The 15% PBS medium was used for the 
ID50 procedure.
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Cell-Freezing Medium
Ingredients Used volume Final
concentration
Foetal bovine serum heat inactivated 
(Gibco) 20 mis 20%
Penicillin (10000 U/ml) 
(Gibco) 100 Unit/ml 0.5%
Streptomycin (10000 pg/ml) (Gibco) 100 pg/ml 0.5%
Non essential amino acid (NEA) (Gibco) 1 ml IX
Dimethyl sulfoxide (DMSO) (Fisher) 1 ml 1%
Minimal essential medium (MEM) (Gibco) 77 ml 77%
Double strength medium
Ingredients Used volume Finalconcentration
Sterile MQ H2O 33 ml 54%
10X MEM (Gibco) 10 ml 20%
Heat inactivated foetal bovine serum 
(Gibco) 2 ml 4%
Penicillin (10000U/ml) (Gibco) 1 ml 2%
Streptomycin (lOOOOpg/mi) (Gibco) 1 ml 2%
Non-essential amino acid (NEA) 
(Gibco) 1 ml 2X
Sodium bicarbonate 7.5% 3 ml 6%
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